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Abstract 
Campylobacter is the most common cause of bacterial gastroenteritis in the developed world, with 
approximately 70,000 cases reported in the UK per annum. It is well accepted that Campylobacter spp. 
form biofilms which aid its survival in both the environment and the host. The formation of biofilms in 
poultry processing plants are of particular concern, as they are potential sources of contamination 
between meat batches, and facilitate the transmission of the pathogen through the human food chain. 
However, despite the importance of biofilms, the molecular mechanisms and metabolic pathways 
associated with biofilm formation in Campylobacter have not been well elucidated.  
Here, 30 C. jejuni strains were isolated from commercial chicken meat and assayed for their motility 
and ability to form biofilms, using crystal violet staining at 37ᵒC and 42ᵒC. Only five of the 30 isolates 
were able to form biofilms, with more complex biofilm phenotypes observed at 37ᵒC. Although all 
isolates were motile, a weak correlation between motility and biofilm formation was observed, 
indicating that motility is not essential to the phenotype. Ten isolates were selected, representing the 
five most competent, and five poorest biofilm formers. These isolates were screened for their virulence 
profiles using Galleria mellonella and adhesion and invasion of Caco-2 models.  No correlation between 
the ability to form biofilms and virulence phenotypes was observed. 
A competent biofilm former (isolate CJP13) was selected and a mariner transposon mutant library was 
constructed in this strain. Over 3,000 of the resulting transposon mutants were individually screened 
for their ability to form biofilms. Thirteen of the 3,000 transposon mutants showed reduced ability to 
form biofilms across two independent biological replicates. Of those, individual knock-out mutants of 
Cj0080, Cj1623 (memP), hydA and trbJ and complemented mutants were constructed in CJP13 and 
NCTC11168 strains. All mutants showed reduced ability to form biofilms compared to wild type strains, 
although the NCTC11168 ΔmemP mutant showed the most significant reduction, with almost no 
biofilm ability observed (p<0.001). Complemented mutants presented a mixed ability to restore biofilm 
formation to wild type levels. 
Next-Generation Sequencing (NGS) and subsequent pangenome analysis revealed genes which were 
differentially present/absent in competent and poor biofilm genomes, two of which are involved with 
sialic acid synthesis and transport. Phylogenetic analysis revealed CJP17 and CJP19 strains (competent 
and poor biofilm formers respectively) to be almost genetically identical, with three gene mutations in 
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the CJP17 genome. One such mutation is predicted to cause truncation of pflA, which is suggested to 
be the cause of reduced motility in this strain compared to CJP19. Despite this mutation, CJP17 
displayed a competent biofilm phenotype, suggesting the mechanisms involved in biofilm formation 
are motility independent. 
The panel of 10 isolates were subjected to Biolog phenotypic array analysis to study the ability of 
Campylobacter to metabolise 95 different carbon substrates. Competent biofilm formers were able to 
significantly metabolise several carbon sources more readily; D-ribose and L-lyxose when using lag 
phase to define utilisation, and L-lactic acid when using max utilisation and max slope to represent 
substrate utilisation parameters. However, varying concentrations of L-lactic acid failed to induce 
biofilm formation in chicken isolates when added to complex media. 
The studies reported here demonstrate significant differences in the metabolism and genetic 
composition between poor and competent biofilm isolates. Moreover, this work provides evidence 
that multiple C. jejuni genes are responsible for the biofilm phenotype in currently circulating C. jejuni 
isolates. This study suggests that the role of membrane proteins, such as memP, is key in the formation 
of biofilm in NCTC11168, but less so for CJP13, indicating strain-specific mechanisms for C. jejuni 
biofilm formation. The continuation of genomic and metabolic analysis of biofilm formation is required 
to facilitate the development of novel control strategies aimed at mitigating biofilm formation in 
poultry processing plants, to prevent subsequent human infection. 
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1 Introduction 
1.1 History 
Campylobacter was first reported in 1886 by a German paediatrician, Theodor Escherich, who 
observed spiral bacteria in the colons of children who had died from cholera type symptoms (Butzler, 
2004). It wasn’t until 1913, where McFadyean and Stockman, two veterinary surgeons researching 
abortion in ewes, reported an unknown bacterium that resembled a Vibrio, which was frequently 
found in aborted foetuses. A few years later in 1919, Smith and Taylor found a similar bacterium 
causing abortion in cows in the US and, familiar with the work of McFadyean and Stockman, proposed 
the name Vibrio fetus (Altekruse et al., 1999, Butzler, 2004). 
In 1957, Elizabeth King isolated a similar Vibrio organism from the blood of children with severe 
diarrhoea, however, these organisms were able to grow at 42°C which differed from the Vibrio fetus 
description from Smith and Taylor. She named her subgroup ‘related vibrios’, and later in 1957 
discriminated between V. fetus and V. jejuni and V. coli (King, 1957, King, 1962). 
Sebald and Véron later highlighted the differences in fermentation, oxidation, microaerophilic nature, 
and nucleotide sequence between the Vibrio species described by King, and the traditional cholera-
causing Vibrio. They proposed the name ‘Campylobacter’ for these microorganisms, which derives 
from a Greek word meaning ‘curved rod’ (Sebald and Veron, 1963). 
Due to Campylobacter’s fastidious growth and ease of contamination with faecal coliforms, it took 
almost a decade for Campylobacter to be isolated from human faecal samples. In the 1970s the first 
selective medium was developed using a blood base and an array of antibiotics (Skirrow, 1977). This 
was the first time that Campylobacter was able to be easily isolated from stool samples, and cultured 
in the laboratory. This would mark the beginning of the realisation of Campylobacter’s high prevalence 
and huge importance in the development of human gastroenteritis. 
1.2 Campylobacter culture characteristics and morphology 
The Campylobacter genus includes bacteria that are Gram-negative, microaerophilic, non-sporulating, 
spiral shaped rods, that take a more coccoid form with age (Figure 1.1) (Penner, 1988). They possess 
polar unsheathed flagellum at either one or both ends of the cell and move in a corkscrew-like darting 
motion. Campylobacter is also  known to enter a viable but non-cultureable state (VBNC) (Rollins and 
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Colwell, 1986), when cells are unable to grow in a standard culture medium, although respiration, 
transcription, protein synthesis and other cellular functions are maintained (Patrone et al., 2013, 
Kassem et al., 2013). This is often due to the cells being exposed to unfavourable conditions. 
Campylobacter growth conditions are fastidious compared to other food-borne pathogens, requiring 
microaerophilic conditions (5% oxygen, 10% carbon dioxide and 85% nitrogen), 42°C for optimum 
growth (unable to grow below 30°C) and between pH 6.5 - 7.5. Selective media often contains blood 
or charcoal, which are oxygen scavenging agents, and antibiotics such as Cefoperazone and 
Amphotericin B that are present in the modified charcoal cefoperazone deoxycholate (mCCDA) media 
used to eliminate contaminants. Campylobacter can be identified by simple laboratory biochemical 
tests such as Gram stains, oxidase, and motility tests. Campylobacter jejuni is differentiated from other 
species in the genus by the hippurate hydrolysis test, which detects glycine. However, polymerase 
chain reaction (PCR) amplification of the hipO gene in C. jejuni is considered to be the more reliable 
method for identifying C. jejuni (Denis et al., 1999). 
 
Figure 1-1: Electron Photomicrograph of C. jejuni in the process of division. 
Scanning electron micrograph (SEM) image of a Campylobacter cell dividing. The two cells 
measure 3.9 µm in length. Image was taken at x15,000 magnification, with a Jeol JSM7100F 
scanning electron microscope, and image capture and annotation performed by the Joel 
software. 
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1.3 Taxonomy 
The taxonomy of Campylobacter has changed dramatically over the last few decades due to advances 
in typing methods. In the early 90s, Vandamme et al. (1991) completely revised the taxonomy and 
nomenclature of the Campylobacter genus by DNA-rRNA hybridisation and cross referencing other 
phenotypic and genetic analysis data. From this, Campylobacter is now classified as the rRNA 
superfamily VI, or the epsilon-division of the Proteobacteria (Engberg, 2006). The order 
Campylobacteriales includes two other genera; Helicobacter and Wolinella (Young et al., 2007). 
The genus Campylobacter comprises 17 species (Korczak et al., 2006), however Campylobacter species 
can be divided into thermophilic and non-thermophilic species, depending on their optimum 
temperature (Figure 1-2). C. jejuni has an optimum growth temperature of 42ᵒC (Le and van Vliet, 2014).  
 
Figure 1-2: Phylogeny of the species within the genus Campylobacter grouped into 
thermophilic and non-thermophilic groups. 
Tree is based on 16S rDNA sequences showing 12 species of Campylobacter, aligned from 
ClustalX2, and tree generated by neighbour joining method of Phylip software suite v3.69 
(Felsenstein, 1989). Image taken from (Le and van Vliet, 2014). Tree shows grouping of non-
thermophilic and thermophilic Campylobacters.  
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1.4 The Campylobacter genome 
The C. jejuni NCTC11168 strain was the first C. jejuni genome to be annotated and published (Parkhill 
et al. (2000) and due to technological advances the genome sequence was re-annotated in 2007 
(Gundogdu et al., 2007). Of note, there was a lack of insertion site sequences, phage associated 
sequences and few repeat sequences in the NCTC11168 genome. However, there is a high presence of 
hypervariable sequences, with homopolymeric runs of nucleotides found in genes associated with 
biosynthesis or modification of surface structures, which are thought to lead to a high rate of sequence 
variation (Parkhill et al., 2000).  
Since this landmark paper, a number of other C. jejuni genomes have been published, such as 81-176 
(Hofreuter et al., 2006) and 81116 (Pearson et al., 2007). Campylobacter genomes are highly variable, 
both in their core genomes (conserved genes) and accessory genomes (changeable genes that are 
additional to the core genome). Nevertheless, generally, the Campylobacter spp. genomes are 1.6-
1.8Mbp in length and have a G+C content of approximately 32%, similar to that described for the 
reference strain NCTC11168 above. As Parkhill et al. (2000) identified, there are a number of 
hypervariable or ‘plasticity regions’ within Campylobacter genomes that tend to consist of 
homopolymeric tracts. These can result in slipped-strand mispairing, and lead to phase variation. Here, 
variables are due to phase variation, gene duplication, frameshifts and point mutations. The 
hypervariability between strains is often found in genes encoding biosynthesis or modification of 
surface structures including the capsular polysaccharide (CPS), lipooligosaccaride (LOS) and flagella 
modification. Areas of hyper variability include regions responsible for glycosylation and other sugar 
based modification. These are thought to be integral to the survival strategy of C. jejuni (Parkhill et al., 
2000, Young et al., 2007). 
C. jejuni can acquire genes from the environment, and the recombination between strains allows for 
greater genetic diversity. Natural transformation between plasmid and chromosomal DNA occurs in 
vitro and in vivo which adds to genome plasticity. However, C. jejuni in vitro tends to favour uptake of 
DNA from other C. jejuni strains (Young et al., 2007). Adding to the genetic diversity, a subset of C. 
jejuni strains contain plasmids and insertion elements, particularly 81-176 which contains pVir and 
pTet, of which the former contains a type IV secretion system (Bacon et al., 2000), and the latter 
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contains tetracycline resistance (Batchelor et al., 2004). The RM1221 C. jejuni strain contains four 
insertions elements, which contain the genes for extracellular DNases which therefore makes strains 
non competent for natural transformation (Gaasbeek et al., 2010). There is also variation in gene 
content related to metabolism, for example some strains are able to metabolise fucose (Muraoka and 
Zhang, 2011) which provides a competitive advantage. 
1.5 Prevalence, transmission and epidemiology of Campylobacter 
C. jejuni is the leading cause of bacterial food-borne gastroenteritis in humans worldwide, and costs 
the UK economy £900 million per annum (Humphrey et al., 2007, FSA, 2015). Public Health England 
(PHE) has reported increasing cases of campylobacteriosis in the UK over the last decade, with marginal 
reductions of reported cases despite huge efforts to reduce them (PHE, 2017, FSA, 2017), with 
approximately 55,000 cases in 2015. However, it is estimated that actual community cases are 
approximately nine-fold higher (Reuter et al., 2010, Tam et al., 2012). Around 10% of the individuals 
with reported cases are hospitalised with severe and chronic sequelae (Zia et al., 2003). 
 
Figure 1-3: Annual laboratory reports of Campylobacter in England and Wales 2006-
2015. 
Public Health England data of annual laboratory confirmed Campylobacter infections (PHE, 
2017). Trends show increasing numbers of reported cases, with a marginal decrease since 2012. 
 
There are large discrepancies between the incidences of campylobacteriosis (the infection caused by 
Campylobacter) in developed and developing countries. In developing countries it is estimated that 
40,000-60,000 per 100,000 children under the age of five contract campylobacteriosis (Rao et al., 2001, 
Coker et al., 2002) and is thought to contribute to the high level of infant mortality in such countries. 
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In contrast, approximately 300 per 100,000 children contract the same infection in developed 
countries. The difference in incidences is largely due to the consumption of contaminated food and 
water. It is interesting to note however that the general incidence in the overall population in both 
developed and developing countries are similar, indicating that campylobacteriosis is very much a 
paediatric disease in developing countries (Coker et al., 2002).  
Developed countries show seasonal variation traits which are not observed in developing countries 
(Figure 1-4). The summer and autumn months are associated with Campylobacter enteritis epidemics, 
probably due to extreme temperature variation and increased likelihood of outdoor cooking activities, 
which often results in the consumption of inadequately cooked meat (Coker et al., 2002, Epps et al., 
2013). C. jejuni infections are sporadic as they tend to involve individual cases of infection. However, 
rare outbreaks have been reported due to consumption of raw milk and contaminated water (Wood 
et al., 1992). 
 
Figure 1-4: Seasonality of laboratory reports of Campylobacter reported in England 
and Wales in 2015. 
Number of laboratory confirmed cases of Campylobacater infections in England and Wales in 
2015 shows a peak of incidence in June, with a slow decline into and through the winter months. 
Data taken from public health England Campylobacter data report (PHE, 2017). 
 
The two most clinically important species of Campylobacter are C. coli and C. jejuni with C. jejuni 
responsible for 80-85% of Campylobacter infections in humans and C. coli 10-15%. (Moore et al., 2005). 
Campylobacter lari, Campylobacter upsaliensis and Campylobacter fetus infections are significantly 
rarer (Moore et al., 2005). The main route of C. coli infection is through the consumption of pig 
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products, wheras C. jejuni is mostly associatd with raw poultry products (Snelling et al., 2005).  
Campylobacter transmission from animals to humans are outlined in Figure 1-5. This can occur in the 
form of contaminated food, or other animal products, contaminated water or direct contact with 
animals (WHO, 2012).  
The infectious dose for C. jejuni is extremely low compared to other food-borne pathogens, with 
between 500-800 organisms required to cause infection (Black et al., 1988). Couple this with high levels 
of Campylobacter on meat sold to consumers, such as 106 colony forming units (CFU)/ml of 
Campylobacter found in water used to rinse supermarket chicken carcasses (Josefsen et al., 2010), and 
it is clear why campylobacteriosis is the most common form of bacterial food poisoning worldwide. 
 
Figure 1-5: Overview of transmission of zoonotic diseases, such as 
Campylobacteriosis. 
Framework showing the transmission of Campylobacteriosis. Animal reservoirs or amplifying 
hosts can infect humans by direct contact, through occupations such as farming and animal 
handling, through the contamination of water (either consumed or recreational), or through 
the food chain, by consuming contaminated meat or other animal products. Such information 
can be used by the World Health Organisation to develop models for strategies to reduce 
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campylobacteriosis incidence. Image adapted from World Health Organisation report (WHO, 
2012). 
1.6 Human disease and symptoms 
Campylobacteriosis causes classic bacterial enteritis symptoms, such as watery diarrhoea that is 
sometimes bloody, abdominal pain, fever, headaches, malaise and nausea, but rarely vomiting 
(Acheson and Allos, 2001). The infection is, in the majority of cases, self-limiting and usually clears 
within a week, although the incubation period before symptoms can be between 2-5 days. If necessary 
in serious cases, patients can be treated with ciprofloxacin or erythromycin (Acheson and Allos, 2001). 
(Gibreel et al., 2005, Kovac et al., 2015). Complications of acute infection include intestinal 
haemorrhage, toxic megacolon, cholecystitis, pancreatitis and peritonitis, but can extend to 
extraintestinal manifestations such as endocarditis, meningitis, septic arthritis, osteomyelitis and 
neonatal sepsis (Acheson and Allos, 2001). In addition, 25% of post infectious irritable bowel syndrome 
(IBS) may be caused by Campylobacter infection (Neal et al., 1997).  
The most important and most recognised sequelae of C. jejuni infection include Guillain-Barré 
syndrome (GBS) and its variant, Miller Fisher Syndrome (MFS) (Humphrey et al., 2007). GBS is the most 
common cause of flaccid paralysis worldwide (Nachamkin, 2002) and C. jejuni infections cause around 
30% of these cases (Acheson and Allos, 2001). The infection affects the peripheral nervous system and 
causes an autoimmune disease by the phenomenon known as molecular mimicry. This is when a target 
on the surface of a pathogen is molecularly similar to a host antigen. In the case of C. jejuni infections 
causing GBS, the C. jejuni surface lipooligosaccharide mimics the human peripheral nerve gangliosides. 
As a result, the B- or T- cell receptor recognises both of these structures, and produces cross reactive 
antibodies or T-cells to destroy the target, be it host or bacterial. The immune system targets the 
Schwann cells which can cause damage to the myelin that ensure reception and speed of nerve 
impulses along axons (Nyati and Nyati, 2013). Luckily, not all strains of C. jejuni can cause GBS with 1 
in 1,000 infections causing the disease (Nachamkin, 2002). 
1.7 Pathogenesis 
The exact mechanisms of adhesion, invasion and transmigration across the intestinal enterocytes for 
the pathogenesis of C. jejuni infections in humans and other hosts is not fully understood. C. jejuni 
must first break through the mucus layer lining of the GI tract; this can be done by the motility and 
chemotaxis of Campylobacter and short O-sidechains of LOS that allow nonspecific binding to the 
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mucin glycoproteins. The cells then translocate into the intestinal cells and disrupt its normal 
absorptive function and cause typical enteritis symptoms. The pathogen is then able to enter the 
lamina propria and access organs such as the spleen, liver, lymph nodes and blood.  
It is important to have a comprehensive understanding of the virulence mechanisms possessed by 
Campylobacter to be able to determine new measures of control of the pathogen. Moreover, many of 
the virulence factors associated with pathogenesis can be linked to the increased environmental 
survival of Campylobacter. Many of the virulence mechanisms of the organism’s pathogenesis are 
discussed below. 
1.7.1 Flagella 
Campylobacters possess a darting motility which is mediated by polar flagella. Flagella are considered 
important virulence factors in Campylobacter particularly in host colonisation, virulence secretion and 
invasion (Young et al., 2007). 
Campylobacter flagella consist of a hook–basal body, embedded in the cytoplasm and inner 
membrane, a periplasmic rod that crosses the cell wall and the filament which is an external helical 
structure (Penn, 2001, Lertsethtakarn et al., 2011). The basic structure of Campylobacter flagellum is 
illustrated in Figure 1-6. As indicated in Figure 1-6, the hook–basal body complex is composed of an 
inner membrane MS ring that attaches the rod assembly to the cell membrane (FliF), the type III 
secretion system (T3SS) (FlhA, FlhB, FliO, FliP, FliQ and FliR), the C ring (FliG and FliN) with FliM and FliY 
serving as a motor switch for the motor components (MotA and MotB), P ring in the peptidoglycan 
(FlgI), L ring in the outer membrane (FlgH) and minor hook components (FlgE and FliK) (Bolton, 2015). 
The extracellular filament composed of a major flagellin protein, FlaA and a minor flagellin protein, 
FlaB (Bolton, 2015) (see Figure 1-6).The filaments are composed of two flagellin proteins which are 
translationally modified by O-linked glycosylation which provides antigenic variation (Szymanski et al., 
1999).  FlaA, the major subunit, is regulated by the σ28 promoter, and FlaB, the minor, regulated by the 
σ54-dependent promoter. The latter promoter also regulates the basal-body and hook genes. The 
major regulatory control of the expression of flagella is by the regulation of the σ54 genes by the FlgS 
sensor kinase, and σ54 response regulator FlgR (Guerry, 2007, Young et al., 2007, Hendrixson, 2006). 
Flagella are important in host colonisation, as shown by a series of aflagellate mutants that are unable 
to colonise a variety of models in vivo (Morooka et al., 1985, Nachamkin et al., 1993). Moreover, 
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virulence is reduced in aflagellate mutants as non-motile strains have been shown to reduce invasion 
of host epithelial cells (Szymanski et al., 1995). 
C. jejuni flagella secrete virulence proteins, which are considered an important mechanism since 
Campylobacter lack type III secretion systems (Guerry, 2007). Konkel and colleagues have described 
the secretion of eight proteins through the Campylobacter flagella, namely the Campylobacter invasion 
antigens (Cia) proteins, in the presence of INT407 cells (Konkel et al., 1999b). The CiaB protein, that 
plays a role in protein secretion and invasion of host cells, is particularly important as it holds no 
resemblance to any other known protein, but is conserved throughout the Campylobacter genus. 
Mutants in flhB, flgB, flgC, flgE that encode export and flagella structural proteins do not facilitate Cia 
protein secretion (Konkel et al., 1999b, Konkel et al., 2004, Rivera-Amill et al., 2001). Flagella also 
secrete FlaC, which is somewhat homologous to flagellin proteins FlaA and FlaB. FlaC has been found 
to bind to HEp-2 cells in vitro, suggesting it plays an important role in cell invasion (Song et al., 2004).  
The FspA protein has also been found to be secreted and has two variants; it is expressed under the 
σ28 promoter (Poly et al., 2007). The two variants FspA1 and FspA2 have been found to be 
immunogenic in mice, however only FspA2 induces apoptosis in INT407 cells indicating it is an 
important virulence factor (Poly et al., 2007). 
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Figure 1-6: Main components and proteins of Campylobacter flagellar assembly. 
Campylobacter flagella consisting of a hook–basal body, the filament which is an external helical 
structure. The hook–basal body complex is composed of: inner membrane MS ring that 
attaches the rod assembly to the cell membrane (FliF), the type III secretion system (T3SS) 
(FlhA, FlhB, FliO, FliP, FliQ and FliR), the C ring (FliG and FliN) with FliM and FliY serving as 
flagellar motor switch proteins, motor components (MotA and MotB), P ring in the 
peptidoglycan (FlgI), L ring in the outer membrane (FlgH), minor hook components (FlgE and 
FliK). The extracellular filament composed of a major flagellin protein, FlaA and a minor 
flagellin protein, FlaB. Figure adapted from Bolton (2015). 
 
1.7.2 Chemotaxis 
Chemotaxis is the movement of an organism to a response to an extracellular stimulus. This allows the 
cell to move towards chemoattractants (such as mucins (Alemka et al., 2012), metabolic substrates 
such as glutamate,α-ketoglutarate (Westfall et al., 1986) and L serine (Velayudhan et al., 2004)), 
electron donors (including, L-malate, D-lactate and succinate) and electron acceptors (such as 
fumarate, dimethyl sulfoxide, nitrite, nitrate and hydrogen peroxide) (Weingarten et al., 2008). 
Contrarily, chemotaxis allows Campylobacter cells to move away from chemorepellents, such as bile 
(Hugdahl et al., 1988). Campylobacter mediate this by alternating between clockwise and anticlockwise 
rotation of the flagellum. 
The main chemotaxis pathways have been extensively studied in E. coli, however similar mechanisms 
are used by Campylobacter. The mechanism uses a two-component histidine protein kinase dependent 
signal transduction pathway, comprising six chemotaxis proteins (CheA, CheB, CheR, CheW, CheY and 
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CheZ) and methyl-accepting chemotaxis proteins (MCPs). MCPs are chemoreceptors which bind 
signals, such as amino acids, in the periplasmic domain.  
The signal is then relayed to the histidine kinase CheA, which then binds to a complex with adaptor 
scaffold protein CheW. CheA autophosphorylates and transfers a phosphoryl group to CheY, the 
response regulator, which can bind to a motor switch in the flagella, FliM, and rotate the flagella to 
change to forward movement to a sideways tumbling motility (Young et al., 2007, Bolton, 2015, Hamer 
et al., 2010). CheR regulates the process by adding methyl groups to the MCPs enhancing their ability 
to activate CheA.  The process can be reversed by phosphorylated CheB which removes methyl groups 
from MCPs, therefore CheA cannot be activated (Bolton, 2015). 
Although this pathway is used by most ε-proteobacteria, some steps may differ in the C. jejuni 
mechanism. For example, instead of CheW, Campylobacter uses CheV, a similar scaffold protein, but 
encompassing an additional response regulator domain. Another response regulator domain is also 
present in the CheY homologue (Zautner et al., 2012, Young et al., 2007). This implies that 
Campylobacter possess complex and specific pathways for chemotaxis that can aid survival in the host, 
and possibly in the environment. 
Mutations in NCTC11168 transducer-like proteins (tlp), similar to MCPs, reduce colonisation in 
chickens (Hendrixson and DiRita, 2004) indicating the chemotaxis mechanisms are important for 
pathogen colonisation and survival. 
1.7.3 Adhesion and invasion 
Unusually, pili (a common adhesin of many Gram-positive and Gram-negative bacteria), are not 
present in the C. jejuni genome (Young et al., 2007). However, a type II secretion system associated 
with pilus assembly in Vibrio and Neisseria species have been discovered in C. jejuni, with no evidence 
of a pilus structure (Wiesner et al., 2003). C. jejuni adhesion is therefore mediated by 
lipooligosaccharide (LOS), flagella and glycoproteins, along with some Campylobacter specific adhesins 
such as CadF, JlpA, Peb1 and CapA.  
Campylobacter adherence to fibronectin (CadF) is a 37kDa surface exposed outer membrane protein 
that binds to fibronectin in the extracellular matrix of epithelial cells (Konkel et al., 1997). The binding 
of C. jejuni to fibronectin via CadF activates the GTPases Rac1 and Cdc42 which leads to the 
Campylobacter internalisation (Krause-Gruszczynska et al., 2007). 
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As well as a key Campylobacter adhesin to host cells, the CadF protein is also a virulence factor. The 
immunogenic epitope of the protein is cleaved to produce small polypeptides able to bind to the 
fibronectin. These, unlike the uncleaved protein, are unable to be recognised by the host humoral 
immune response (Scott et al., 2010). Indeed, cadF mutants have been shown to reduce colonisation 
in leghorn chicks (Ziprin et al., 1999). FlpA is an additional 250-kDa glycoprotein which binds to 
fibronectin (Konkel et al., 2010), and a recent study suggests that FlpA coordinates with CadF and 
secreted Cia proteins from the flagella that cause membrane ruffling and host cell internalisation of 
campylobacter (Eucker and Konkel, 2012). 
The Campylobacter adhesin protein A (CapA) is an autotransporter lipoprotein which has been found 
to aid attachment to human and chicken intestinal epithelial cells, with mutations in capA resulting in 
reduced invasion of human epithelial cells (Ashgar et al., 2007). There is conflicting evidence regarding 
its role in chick colonisation, with one study reporting a complete lack of colonisation (Ashgar et al., 
2007), while another reported no reduction of colonisation capacity in capA mutants (Flanagan et al., 
2009). CapA is absent in a number of C. jejuni poultry isolates, indicating CapA adhesion is a strain 
specific mechanism.  
The ‘Peb’ proteins have also been linked to adhesion in C. jejuni (Pei and Blaser, 1993). Peb1, a 21-kDa 
protein, encoded by the peb1A gene, is known to be located in the periplasm. Mutants in peb1 showed 
a 50- to 100-fold less adherence to and 15-fold less invasion of human epithelial cells in culture (Leon-
Kempis Mdel et al., 2006, Pei et al., 1998). However, Flanagan et al. (2009) reported that the peb1A 
mutant does not colonise broiler chickens, suggesting the role of peb1 not as an adhesin but as an ABC 
(ATP binding cassette) transporter of aspartate and glutamate, both important carbon sources during 
microaerobic growth (Flanagan et al., 2009). In addition, Peb4 has been suggested to play a role as a 
chaperone protein (Kale et al., 2011), and Peb3 is a transport protein that functions in utilization of 3-
phosphoglycerate or other phosphate-containing molecules from the host (Min et al., 2009). 
JlpA is a surface 42-kDa lipoprotein that contains a signal peptide and lipoprotein-processing site at 
the N-terminus (Jin et al., 2001). JlpA contains a lipid that binds to HEp-2 cells, with a jIpA mutant 
exhibiting a 19% adherence of the wild type (Jin et al., 2001). However, Flanagan et al. (2009) failed to 
determine any binding mediated by JlpA to chicken cells in vitro. JlpA also interacts with Hep-2 cell 
surface heat shock protein (Hsp90α) and activates NF-κB and p38 MAPK (mitogen-activated protein 
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kinases). This implies this molecule is important in the host inflammatory response to Campylobacter 
infection (Jin et al., 2003). 
Campylobacter cells are able to invade host gut epithelial cells once they have colonised the mucus 
lining. As well as motility, flagella function as export apparatus as a type III secretion system (Poly and 
Guerry, 2008). FlaC and Cia proteins are delivered to the host cell through the flagella during invasion, 
and have been reported as being essential in C. jejuni invasion (Konkel et al., 2004). ciaB and ciaC 
mutants show significantly reduced invasion potential (Konkel et al., 1999b, Eucker and Konkel, 2012). 
Proteins injected into the host cells manipulate signalling events, and activate Rho GTPases and 
cytoskeletal reorganization to induce membrane ruffling. This leads to Campylobacter internalisation 
into a vacuole, which induces intracellular survival mechanisms  (O Croinin and Backert, 2012).  
1.7.4 Lipooligosaccaride and capsular polysaccharide 
C. jejuni produces two types of complex carbohydrates on the bacterial surface; lipooligiosaccaride 
(LOS) and capsular polysaccharide (CPS). The CPS was originally thought to be a high molecular weight 
lipopolysaccharide (LPS), but recent data has found that C. jejuni does not express LPS and instead 
expresses LOS and CPS that coat the surface of the pathogen. 
The LOSs of Campylobacter cells are highly variable, and resemble neuronal gangliosides which leads 
to the autoimmune disease Guillain-Barre syndrome (GBS) and Miller-Fisher syndrome, as explained 
previously. Mutations in genes responsible for the synthesis of LOS also affect serum resistance and 
adherence and invasion of cells.  Sialylation of the LOS contributes to epithelial invasion by C. 
jejuni  (Louwen et al., 2008) and reduces immunogenicity (Guerry et al., 2000). 
C. jejuni is unusual for an enteric pathogen in that it is encapsulated. The CPS consists of an 
oligosaccharide repeated into a chain that comprises sugars such as galactose, ribose and glucose 
(Szymanski et al., 2003). The CPS varies in sugar composition and linkage, and is therefore used as the 
basis of the Penner typing scheme for Campylobacter (Karlyshev et al., 2000). There are currently 47 
serotypes of C. jejuni although this is thought to reduce due to structural similarities in some of the 
CPS variants (Guerry et al., 2012). CPS expression and modifications are affected by phase variation 
and mismatch repair which is responsible for its variability (Bacon et al., 2001). The CPS is one of the 
few identified virulence factors in C. jejuni and has therefore been made a target for development of 
a vaccine (Pike et al., 2013). The capsule has an important role in serum resistance, the adhesion and 
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invasion of epithelial cells and chick colonisation (Jones et al., 2004). The capsule has also been 
associated with biofilm formation, although Joshua et al. (2006) showed no decrease in biofilm 
formation with mutants in the capsule transport protein (KpsM). 
1.7.5 N and O linked glycoslyation 
Protein glycosylation is an important posttranslational modification common in C. jejuni. The two most 
common methods are O- and N-linked glycosylation.  
N-linked glycosylation modifies the asparagine residues on many proteins and is highly conserved in C. 
jejuni strains. The N-linked glycosylation system is encoded by the pgl genes (Szymanski et al., 1999). 
Most proteins that are modified by the pgl system are periplasmic (Young et al., 2002), although some 
are surface exposed, implying N-linked glycosylation could be involved in evasion of the host immune 
system. The sequon (sequence of amino acids that allow attachment of the polysaccharide) has been 
identified in the N-linked modifications (Kowarik et al., 2006). However, the effect of sequon mutants 
vary, depending on the protein, as to whether normal function is affected (Kakuda and DiRita, 2006, 
Larsen et al., 2004). Pgl mutants however show reduced adherence and invasion of human (Larsen et 
al., 2004), chick (Kakuda and DiRita, 2006) and mouse (Szymanski et al., 2002) models. 
O-linked glycosylation modifies the serine and threonine residues on flagellin by attaching a sugar 
molecule to an oxygen atom in these amino acid structures (Szymanski et al., 1999). It has been found 
that pseudaminic acid glycosylates the C. jejuni strain 81-176 flagellin at 19 different sites (Thibault et 
al., 2001). This type of glycosylation is required for the correct assembly of the flagella filament (Goon 
et al., 2003), and defects in the wild type glycosylation results in reduced motility, adherence and 
invasion to host cells (Guerry et al., 2006). 
1.7.6 Toxins 
The cytolethal distending toxin (CDT) is the only C. jejuni toxin studied in detail, and is produced by a 
variety of other bacteria including E. coli (Young et al., 2007). The toxin causes arrest of the cell cycle 
in the G2/M phase (Whitehouse et al., 1998, Pickett and Whitehouse, 1999). 
The tripartite CDT is encoded by three genes cdtA, cdtB and cdtC (Lara-Tejero and Galan, 2001). The 
protein produced from the cdtB gene is known to be the toxic component and acts as a DNase enzyme. 
It can localise in the nucleus and cause damage to DNA and therefore phosphorylation of the histone 
protein H2AX (Hassane et al., 2003). The CdtA and CdtC proteins are required for binding and 
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internalisation of the toxin (Lara-Tejero and Galan, 2001). It is uncertain what role CDT plays in 
virulence as not all C. jejuni strains possess the genes for CDT (AbuOun et al., 2005). 
1.7.7 Campylobacter stress response 
Campylobacter possess a number of stress response mechanisms in order to withstand harsh 
environments. The spoT gene is responsible for control of the C. jejuni stress response. For example, 
under amino acid starvation, RelA or SpoT is activated which produces guanosine tetraphosphate 
(ppGpp). Together with an RNA polymerase associated protein, DksA, ppGpp diverts the cell’s 
responses to amino acid synthesis, ensuring survival, rather than growth and division (Gaynor et al., 
2005). Mutants in spoT show reduced aerotolerance, adhesion, invasion and survival in human 
epithelial cells (Gaynor et al., 2005). 
Oxidative stress is caused by exposure to reactive oxygen species such as the superoxide anion and 
hydrogen peroxide, which are generated from aerobic respiration. These products of incomplete 
reduction of oxygen may interact to form the highly toxic hydroxyl radical. Reactive oxygen species can 
cause damage to bacterial proteins, membranes and nucleic acids. Campylobacter responds to 
exposure of such reactive oxygen species by increasing activity of glutathione, catalase, peroxiredoxin 
alkyl hydroperoxide reductase and other peroxiredoxins, cytochrome c peroxidases and superoxide 
dismutase, which are involved in the antioxidant defence system (Storz and Imlay, 1999). 
KatA, C. jejuni’s only catalase enzyme converts hydrogen peroxide to water and oxygen when 
cytoplasmic concentrations are high (Atack and Kelly, 2009). However, alkyl hydroperoxide reductase 
(AhpC), primarily detoxifies hydrogen peroxide when at low levels. Thiol peroxidise (Tpx), 
bacterioferritin comigratory protein (Bcp), Cj0358 and Cj0020c  (encoding two Cytochrome c 
peroxidises) all act on removal of hydrogen peroxide in Campylobacter (Atack and Kelly, 2009). 
Superoxide dismutase, encoded by sodB, is responsible for protecting C. jejuni from superoxide anion 
toxicity, and is synthesised constitutively (Garenaux et al., 2008). Mutants in sodB do not survive well 
in the avian gut (Purdy et al., 1999). 
Another stress response utilised by C. jejuni is the viable but non-culturable (VBNC) state, which is 
implemented when exposed to sub-optimal conditions such as low pH, or nutrient starvation 
(Chaveerach et al., 2003). Interestingly, cells are still metabolically active, and have been reported to 
maintain their ability to adhere to host intestinal epithelial cells (Klancnik et al., 2009). 
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1.8 Campylobacter metabolism 
Unlike many other gut bacteria, C. jejuni is unable to conserve energy for growth and maintenance by 
fermentation of carbohydrates. Campylobacter lacks the appropriate transporters to take up sugars 
such as glucose and galactose (Velayudhan and Kelly, 2002) and lacks key enzymes from the glycolytic 
pathway, despite a full set of gluconeogenesis enzymes to synthesise glucose-6-phosphate from 
pyruvate. For example, C. jejuni lacks the 6-phophofructokinase enzyme in glycolysis which 
phosphorylates fructose-6-phosphate to fructose-1,6-diphosphate. Interestingly, C. jejuni still possess 
pyruvate kinase required at the end of glycolysis but not at all for gluconeogenesis (Velayudhan and 
Kelly, 2002). C. jejuni is thought to be able to metabolise glycerol-3-phosphate by the presence of the 
transporter GlpT in the 81-176 strain (Hofreuter et al., 2006). This, along with the presence of pyruvate 
kinase, implies that the C. jejuni genome at least encompasses the latter portion of the glycolytic 
pathway (Stahl et al., 2012).  
C. jejuni is also thought to have a disjointed pentose phosphate pathway (PPP) as it possesses key 
enzymes in the reversible non-oxidative section of the PPP, without any enzymes of the irreversible 
oxidative phase. It is therefore thought that C. jejuni is not able to metabolise pentose sugars using 
this process (Velayudhan and Kelly, 2002). 
There have been many reports on the presence of an L-fucose pathway in some C. jejuni strains 
(Muraoka and Zhang, 2011, Stahl et al., 2011). L-fucose permease has been identified which has a 32% 
similarity amino acid identity to the L-fucose permease present in E. coli (Stahl et al., 2012). In addition, 
a recent study has reported that C. jejuni containing the fuc locus are able to utilise L-fucose and are 
chemotactic towards fucose. The addition of fucose reduces biofilm formation in these strains 
(Dwivedi et al., 2016). These findings suggest that strains possessing the fuc locus have a competitive 
advantage when colonising animal hosts, since fucose is present in human and chicken mucin (Stahl et 
al., 2011). 
C. jejuni must rely on amino acid utilisation and the intermediates of the citric acid cycle for energy 
(Epps et al., 2013). C. jejuni, depending on strain, tend to utilise certain amino acids in a sequential 
order of preference, with serine being the most preferred, then aspartate, asparagine and glutamate 
respectively. Proline is metabolised to a lesser extent, but is increased with exhaustion of the other 
amino acids (Wright et al., 2009). It should be noted also that these amino acids are the most common 
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amino acids in chicken excreta, making it clear why C. jejuni colonises the chicken host so successfully 
(Parsons, 1984). 
To fully explain the unconventional metabolism of carbon and nitrogen sources in C. jejuni, further 
research is required. The understanding of metabolic pathways in biofilm formation is also in its 
infancy, and there may be a strong metabolic link between biofilm formation and metabolism of 
substrates. Furthermore, a biofilm community may provide for the organism where its metabolism 
lacks. Mixed communities of microorganisms may provide excess amino acids, iron and scavenging 
iron-containing siderophores that are beneficial for C. jejuni growth and survival, resulting in a more 
successful biofilm (Hanning et al., 2008). 
1.9 Campylobacter in poultry 
It is fairly well understood that campylobacteriosis in humans is largely caused by the consumption of 
contaminated poultry products coupled with inadequate cooking (Moore et al., 2005). C. jejuni was 
considered for many years as non-pathogenic to chickens and termed a gut commensal, which allowed 
asymptomatic colonisation in high numbers (densities as high as 108/g of caecal contents (Hermans et 
al., 2011, Rosenquist et al., 2006)) to accumulate in the gastrointestinal tract of the bird. 
Campylobacter form densely packed colonies of cells in the luminal crypts in poultry intestines, which 
attaches to the mucus but not directly to the epithelium (Beery et al., 1988). 
However, a recent landmark study reported that Campylobacter may not be a harmless gut 
commensal, with evidence of a strong immune response to the pathogen in four modern rapidly 
growing chicken breeds (Humphrey et al., 2014). In addition, the poultry infected with Campylobacter 
can lead to diarrhoea which can damage feet and legs. This can have a considerable effect on the 
welfare of the birds, and could compromise bird growth and therefore profit.     
Once one bird from a Campylobacter-free flock is colonised the entire flock can be contaminated 
within three days (Shanker et al., 1990) and by possibly more than one strain of C. jejuni (Pielsticker et 
al., 2012). Transmission is thought to occur horizontally by contaminated water, wild birds, rodents, 
faecal contact, and farm personnel (Keener et al., 2004). The pathogen colonises the bird after 2-4 
weeks, although the mother’s antibodies have been proven to have an effect on the onset of 
colonisation. Little else is known about the immune response involved in the control of C. jejuni 
colonisation in avian species. 
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Efforts have been made worldwide to enforce on-farm procedures with the aim of reducing the caecal 
load of C. jejuni in chicken flocks ((Hermans et al., 2011, Lin, 2009). These include chlorination of 
drinking water, the addition of organic acids, addition of prebiotics in animal feed, and a number of 
hygiene and biosecurity practises to be implemented by workers, such as changes of clothing and boots 
between chicken houses (Hermans et al., 2011). EU regulations limit the use of chemicals in water, so 
washes of chicken carcasses are limited to the use of potable water. A vaccination to reduce the caecal 
load of Campylobacter is not yet available due to the limited knowledge of the chicken immune system 
and the genomic instability of C. jejuni (Hermans et al., 2011). 
It is essential that strategies to reduce cross contamination of Campylobacter-infected to uninfected 
birds in poultry processing plants match efforts implemented on farm for effective reduction in 
contaminated carcasses sold to the consumer.  In particular, Campylobacter contamination of chicken 
carcasses in poultry processing plants has been linked to biofilm formation. Efforts into understanding 
the mechanisms of biofilm formation and Campylobacter environmental survival will aid the 
development of new stratagies to reduce contamination during poultry processing. 
1.10 The slaughter process and contamination risk 
Chickens are normally transported to poultry processing plants in crates, with up to 24 chickens per 
crate. Live birds are then suspended by their legs on a moving line where they are then stunned and 
killed by bleeding (Corry and Atabay, 2001). The carcasses are subsequently dipped in a warm water 
bath (with temperatures varying from 50-60°C) to open the feather follicles in order to facilitate 
feather removal (Corry and Atabay, 2001). The carcasses are eviscerated mechanically, often without 
opening the carcasses, and finally chilled before packaging (Corry and Atabay, 2001). 
Many poultry processing plants deal with over 12,000 birds per hour. With such volumes of livestock 
being processed quickly, it becomes clear that cross contamination of Campylobacter from infected 
birds to any uncontaminated carcasses can occur all too easily. Every step of the slaughter process, 
down to the packaging, will risk contamination of raw meat. Perhaps the step that causes greatest 
concern is the warm water bath used to facilitate feather removal. Many birds will be submerged in 
the same water, which may provide ideal conditions for Campylobacter survival. In addition, the 
opening of the feather follicles allows entry of Campylobacter, and indeed other food pathogens. 
Subsequent chilling of the carcass will then close the follicle and trap any bacteria inside. 
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The poultry processing plant environment may provide ideal locations for bacterial biofilms to 
accumulate. In particular, biofilms are known to form in water supplies and plumbing systems (Lehtola 
et al., 2006), on abiotic surfaces such as plastics, stainless steel and glass, and in solid and liquid 
interfaces (Reeser et al., 2007). Campylobacter biofilms forming on the surfaces of machinery in these 
processing plants ensures Campylobacter long-lived survival and, as a result, a higher risk of 
contaminated raw meat sold to consumers, and subsequent human infection. 90% of chicken carcasses 
sold to the public are positive for Campylobacter (Kalmokoff et al., 2006), although not all flocks sent 
for slaughter are Campylobacter positive. This implies that poultry processing plants are responsible 
for large amounts of cross contamination. 
There are precautions used in processing plants used to reduce the bacterial load of the poultry meat, 
such as the use of chlorine and other chlorine derivatives as a disinfectant in the water used to rinse 
and wash the carcasses, organic acids and irradiation (Keener et al., 2004). Despite these, 
Campylobacter in the form of a biofilm are able to survive. Research into understanding the molecular 
and metabolic associations and environmental requirements for biofilm formation is essential in order 
to prevent formation and spread of the pathogen in meat processing facilities. 
1.11 Biofilms 
Biofilms are defined as ‘matrix-enclosed bacterial populations adherent to each other and/or surfaces 
or interfaces’ (Costerton et al., 1995).  Bacterial cells, when encased in a biofilm, are protected from 
harsh environments such as extreme temperatures, acidic conditions, antibiotics and antimicrobials 
(Siringan et al., 2011). In fact, biofilms are reported to be 1,000-fold more resistant to disinfectants 
and other antimicrobials than their planktonic counterparts (Fux et al., 2005).  A typical biofilm will 
consist of many bacterial cells that are protected by an extracellular matrix or ECM. 
1.11.1 Extracellular matrix (ECM) 
The ECM, also known as extracellular polymeric substance (EPS), can be accountable for up to 90% of 
the biofilm mass, and mainly consists of polysaccharides, proteins, nucleic acids (Svensson et al., 2009), 
phospholipids, humic like substances and uronic acids (Donlan, 2002, Lu et al., 2012b, Siringan et al., 
2011). The latter is important as it gives an anionic property to the biofilms, which allows association 
of divalent cations which crosslink with polymers resulting in a stronger developed biofilm (Donlan, 
2002). The presence and structure of the polysaccharides in the EPS can highly influence the 
conformation and properties. For example, biofilm EPS that contains 1,4-beta-linked hexose residues 
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are more rigid and tend to be more insoluble (Donlan, 2002). Moreover, the chemical composition and 
structure of the EPS varies depending on the cell species, metabolic activity, nutrient availability, 
biofilm age, maturity level, and physicochemical conditions (Lu et al., 2012a). 
The EPS is often highly hydrated, as large amounts of water can be added to the structure through 
hydrogen bonding, which can prevent desiccation of the cells. The EPS may be hydrophilic and 
hydrophobic, and vary in solubility (Donlan, 2002). The EPS also mediates cell-cell communication 
known as quorum sensing, and protects the biofilm from environmental stresses, such as the harmful 
effects of antibiotics (Lu et al., 2012a, Lu et al., 2012b). 
Little is known about the C. jejuni extracellular matrix, although some recent studies suggest that 
extracellular DNA (eDNA) forms the backbone structure of the matrix (Brown et al., 2015b, Brown et 
al., 2015a, Svensson et al., 2014). McLennan et al. (2008) also indicate the presence of 
lipooligosaccharides, calcofluor-white reactive carbohydrates, and capsular polysaccharides as being 
important components of the ECM. A study using fluorescence lectin-binding analysis used to 
determine the glycoconjugates present in the C. jejuni biofilm matrix, revealed strain-specific patterns 
of glycoconjugates, with most common sugar moiety galactose and N-acetylgalactosamine in 
NCTC11168 and 81-176 C. jejuni ECM (Turonova et al., 2016). N-acetylglucosamine and sialic acid were 
also identified, which probably originate from the capsular polysaccharides, lipooligosaccharides and 
N-glycans of C. jejuni (Turonova et al., 2016). 
1.11.2 Gene transfer 
The nature of biofilms, with a high concentration of bacterial cells in close proximity, provides a 
suitable environment for gene transfer through conjugation (Donlan, 2002). Interestingly, it has been 
shown that bacterial cells that contain conjugative plasmids are more likely to produce biofilms. This 
is due to the presence of the F conjugative pilus on the F plasmid that acts as an adhesive for cell 
surface and cell-cell interactions in E. coli (Ghigo, 2001). Gene transfer, especially of antibiotic 
resistance genes, will significantly increase biofilm persistence and survival. In addition, any genes 
beneficial for survival in the given environment may be conserved by natural selection and shared 
throughout the biofilm. This is particularly evident in C. jejuni strain 81-176, which carries pTet and 
pVir plasmids. The pTet plasmids carries tetracycline resistance and conjugal transfer genes to enable 
horizontal gene transfer (Bacon et al., 2000). Other than genes, bacterial cells can share exopolymers, 
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nutrients, enzymes and secondary metabolites due to their close proximity, to ensure growth and 
survival within the bacterial community (Xavier and Foster, 2007). 
1.11.3 Stages of biofilm formation 
Biofilm formation can be divided into five specific stages (Figure 1-7). Firstly, a few pioneer planktonic 
cells attach reversibly to a solid surface, and then irreversibly by the production of surface 
polysaccharides (Kalmokoff et al., 2006) and ECM (Sauer, 2003). Specific biofilm genes are activated, 
depending on the bacterial species, in order for additional planktonic cells to be recruited by quorum 
sensing. The first maturation phase is marked by the early development of biofilm architecture, and 
the second maturation step marks a fully mature biofilm with complex biofilm architecture. Finally, 
the biofilm will enter the dispersion phase, by which bacterial cells are released which can continue to 
colonise surrounding surfaces and create a secondary biofilm (Brown et al., 2013, Monroe, 2007, 
Sauer, 2003). 
 
Figure 1-7: Stages of biofilm development. 
The biofilm cycle can be described by five main stages; (1) initial attachment, (2) irreversible 
attachment, (Walters et al.) (3) maturation I, (4) maturation II and (5) dispersion. Adapted from 
Monroe (2007). 
 
1.12 Campylobacter jejuni biofilms 
Despite Campylobacter’s fastidious nature in laboratory settings, its survival in the environment is 
surprisingly common. It is generally considered that Campyloacters’ survival is mediated by the 
formation of biofilms (Buswell et al., 1998). Three distinct types of monoculture C. jejuni biofilms 
formed in liquid culture have been reported (Joshua et al., 2006). The first, a surface attached biofilm 
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which attaches to the container of the liquid culture, the second, an unattached aggregate, or floc, and 
the third, a pellicle, which forms at the liquid-gas interface when grown in stationary culture. 
Many of the unattached aggregate biofilm share the properties and characteristics of attached biofilms 
(Hall-Stoodley et al., 2004, Joshua et al., 2006). This type of biofilm is thought to be similar to the 
aggregates found in the luminal crypts of chickens in vivo (Siringan et al., 2011). Aggregate and 
attached biofilms grown in liquid culture look identical under Scanning Electron Microscopy 
(Chandrashekhar et al., 2015), with visible extensive and flattened ECM which adhere the bacterial 
cells. However, the pellicle biofilm extracellular material differs with an unflattened structure (Joshua 
et al., 2006). 
1.13 Factors already known to influence C. jejuni biofilm formation 
1.13.1 Environmental 
Biofilm formation in the laboratory is more successful in broths that have lower nutrient 
concentrations such as MHB, rather than the more nutrient-rich Bolton and Brucella broth (Reeser et 
al., 2007). This complies with the general consensus that biofilms form under harsh environmental 
conditions i.e. low nutrient availability, to increase survival.  
Lab-grown C. jejuni biofilms tend to form more readily under optimal temperatures for Campylobacter 
growth, i.e. 42°C/37°C (Reeser et al., 2007). Growth in liquid culture is impossible for Campylobacter 
under 30°C.  
High concentrations of osmolytes also decrease biofilm formation and stimulate a morphological 
change in the cell structure, from a healthy spiral shaped rod, to a coccoid shape, which implies 
damage to the cell membrane (Reeser et al., 2007). This could be a result of the high osmotic pressure 
of the medium which degenerates the cell components. Biofilms form under stressful conditions, but 
the osmolytes used in this particular study (Reeser et al., 2007) may have gone beyond the capacity of 
C. jejuni survival. 
1.13.2 Atmospheric conditions 
The microaerophilic nature of C. jejuni requires specific atmospheric conditions, including 5% oxygen, 
10% carbon dioxide and 85% nitrogen, for successful growth. Many studies incorporate these optimal 
atmospheric conditions for C. jejuni biofilm formation. However, Reuter et al. (2010) report that 
increased biofilm formation is observed under aerobic conditions, which is supported by the findings 
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of Asakura et al. (2007). Here, they suggest that C. jejuni is well adapted for survival in the environment 
in the form of a biofilm, and the centre of the biofilm may provide reduced oxygen levels similar to a 
microaerophilic environment. In addition, oxygen has been shown to penetrate only the first 90 µm of 
a Pseudomonas biofilm, creating an oxygen concentration gradient throughout the biofilm mass 
(Walters et al., 2003). Optimal concentrations of oxygen in the centre of the biofilm may aid the 
survival and growth of C. jejuni, providing temperatures exceed 30ᵒC, which will eventually lead to the 
shedding of viable cells to either initiate a new biofilm, (Reuter et al., 2010), or infect a new host.   
Interestingly, other studies have reported the reduction in biofilm formation of the M129 strain in 
aerobic conditions, and suggest optimal conditions for C. jejuni growth, i.e. microaerophilic 
environments and 37-42°C incubation temperature, mimic optimal conditions for biofilm formation 
(Reeser et al., 2007) . This highlights that the mechanisms used by C. jejuni to form biofilms are perhaps 
strain-specific, with some strains better adapted to aerobic environments through well conserved 
oxidative stress mechanisms. Over expression of CadF, the fibronectin binding protein, has been 
observed in oxygen-acclimatised cells (Sulaeman et al., 2012), indicating exposure to increased oxygen 
concentrations initiates attachment. 
1.13.3 Surfaces 
C. jejuni biofilms have been known to attach to abiotic surfaces such as glass, stainless steel and a 
variety of plastics. Formation of these biofilms inside commercial water pipes and on poultry 
processing plant machinery are of particular concern and thought to be the cause of a high percentage 
of meat contamination. The texture, surface area and hydrophilicity of the material can greatly affect 
attachment of a biofilm (Kalmokoff et al., 2006). 
Studies have reported that bacteria will attach more rapidly to hydrophobic surfaces such as 
polystyrene, polypropylene, polycarbonate and polyvinyl chloride (PVC) and other plastics, rather than 
hydrophilic materials (such as glass and metals), and hydrophobic materials (Donlan, 2002, Reeser et 
al., 2007). It is reported that C. jejuni formed biofilms more readily on hydrophobic materials, but to 
varying degrees. The surfaces of bacterial cells are negatively charged which would repel the 
hydrophobic surface, however, flagella and other exopolysaccharides are thought to aid attachment 
by overcoming the repulsive forces from the surface (Reeser et al., 2007). C. jejuni biofilms can readily 
form on stainless steel, an important material common in poultry processing plants (Sanders et al., 
2007).  
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Joshua et al. (2006) reported that C. jejuni biofilms did not readily attach to polystyrene, however its 
adherence to this plastic is well documented in the literature. This may be linked with the 
hydrophobicity of the bacterial cells in liquid culture which is thought to highly influence biofilm 
formation. Aflagellate mutants have been shown to have significantly reduced hydrophobicity which 
coincides with reduced biofilm formation attached to surfaces (Joshua et al., 2006). Moreover the 
thickness of biofilm formation is affected by the surface to which it is attached. Kalmokoff et al. (2006) 
observed a noticeably thicker biofilm grown on nitrocellulose and glass fibre, than stainless steel. They 
also suggest this is due to the hydrophobicity, but also texture and surface area of the material. 
1.14 Molecular understanding of C. jejuni biofilm formation 
1.14.1 Flagella 
Flagella play a fundamental role in biofilm formation in multiple bacterial species including Vibrio 
(Guttenplan and Kearns, 2013b), Yersinia (Kim et al., 2008), Aeromonas (Kirov et al., 2004) and 
Pseudomonas (Martínez-Granero et al., 2014, Reuter et al., 2010). 
Mutants in flaA and flaB genes (flaAB), encoding flagellin in C. jejuni, (Guerry et al., 1991, Meinersmann 
et al., 1997) exhibit a reduction in biofilm formation compared to the wild type (Reeser et al., 2007). 
Mutations in flagella assembly (fliS) are also defective in adhering to glass (Joshua et al., 2006).   
Flagella are thought to play a key role in initial stages of biofilm formation and attachment (Svensson 
et al., 2014), with studies reporting reduced motility after the initiation of biofilm formation (Lazazzera, 
2005). However, a proteomic study performed by Kalmokoff et al. (2006), reported an increased 
expression of motility complex proteins including FlaA and FlaB, the filament cap (FliD), the basal body 
(FlgG, FlgG2) and the chemostatic protein (CheA), in mature biofilms. In addition to this, an aflagellate 
mutant (flhA) could not form a pellicle, or attach to a solid matrix (Kalmokoff et al., 2006). This implies 
that flagella are important in not only the attachment of biofilm formation to solid surfaces, but also 
in cell-to-cell interactions required for pellicle formation. The continued expression of the motility 
complex in mature biofilms suggests a role for flagella in the biofilm phenotype. 
Although flagella are important in biofilm formation, it is not the sole prerequisite. Reuter et al. (2010) 
observed the formation of C. jejuni biofilms of aflagellate mutants and wild type strains in conditions 
of varying temperature and oxygen concentration. Although reduced, the aflagellate mutants were 
still able to produce biofilms. Moreover, Joshua et al. described identical scanning electron micrograph 
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images of maf5 aflagellate and wild type aggregate biofilms, suggesting an unimportant role of 
flagella in biofilm formation and assembly in this case. Moreover, Svensson et al. (2014) summarise 
their finding by reporting the physical filament of the flagella aids attachment, but the cell’s motility  
aids the kinetic of biofilm formation. Reports where biofilm formation is still successful in aflagellate 
mutants highlight the presence of flagella-dependent and flagella-independent mechanisms of biofilm 
formation and attachment. 
1.14.2 Quorum sensing and LuxS 
Quorum sensing is part of a complex series of pathways that allows cell-cell communication and for 
bacterial biofilms to coordinate their gene expression. Quorum sensing in C. jejuni biofilms is thought 
to be mediated by the presence of the luxS gene, Cj1198 (Elvers and Park, 2002), which encodes 
autoinducer-2 (AI-2). This mechanism is used by a variety of Gram-positive and Gram-negative bacteria 
and is considered a major contributor to interspecies communication. LuxS and AI-2 are involved in 
the activated methyl cycle that includes the formation of S-adenosyl-L-methionine (SAM) responsible 
for methylating DNA, RNA and proteins. SAM is converted to S-adenosyl-L-homocyteine (SRH) by 
methyltranferases and then detoxified to S-ribosyl-L-homocyteine (SRH) by the Pfs enzyme. The LuxS 
enzyme then converts SRH into 1) homocysteine, which can subsequently be converted into 
methionine and recycled in the methyl cycle, and 2) more importantly, 4,5-dihydroxy-2,3-
pemtanedione (DPD) which when cyclised , forms AI-2 (Plummer, 2012). 
The use of LuxS in quorum sensing/biofilm formation, and subsequently AI-2, has been confirmed by 
the use of a bioluminescence assay (Bassler et al., 1993) and insertional mutation of the luxS gene 
(Cloak et al., 2002, Elvers and Park, 2002). Cloak et al. (2002) investigated the levels of AI-2 in milk and 
chicken broth which indicated the nutrients required for AI-2 synthesis are present in common food 
sources. Such evidence may contribute to a high prevalence of C. jejuni biofilms in poultry processing 
plants. In addition, LuxS has been found to be present in many Campylobacter species in the genus, 
including C. coli, C. upsaliensis and C. fetus with the exception of C. lari (Tazumi et al., 2011). 
LuxS does not appear to affect growth of the organism, however, through the use of luxS mutants it 
has been found to highly influence motility. Some reports have noted that motility had been partially 
restored in the complementation of the luxS gene (Quinones et al., 2009).  
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LuxS is also thought to be involved in the colonisation of the gastrointestinal tract of chickens (Quinones 
et al., 2009), environmental adaptation, cytolethal distending toxin expression (Ligowska et al., 2011) 
and oxidative stress (He et al., 2008). Biofilm formation is also affected in luxS mutants (Reeser et al., 
2007), however it is not clear if the loss in biofilm formation is directly as a result from the mutated luxS 
gene, or from the decrease in motility as a downstream effect. A similar problem arises with the 
observation that autoagglutination is reduced in the luxS mutant which is also mediated by flagella (Jeon 
et al., 2003). Other factors should be taken into consideration however, since the luxS mutant could be 
affecting additional surface structures other than flagella, resulting in reduced autoagglutination. 
Regardless of this, LuxS and AI-2 are important in inter- and intra-species communication which is 
proven to be highly influential in biofilm formation and survival. A more in-depth understanding of 
these cell signalling pathways in Campylobacter will allow us to understand biofilm mechanisms and 
develop preventative actions to facilitate the removal of biofilms. 
1.14.3 Signalling mechanisms and regulatory proteins 
Very little is known about the molecular mechanisms of pathogenesis and how virulence is regulated 
in C. jejuni, including the underlying signalling mechanisms of biofilm formation. There are only a few 
identified global regulators in C. jejuni, with many mechanisms of gene regulation to be found. C. jejuni 
orthologs of the E. coli CsrA (carbon starvation regulator) global posttranscriptional regulator have 
been identified (Parkhill et al., 2000), which binds to mRNA inhibiting the binding of ribosomes and 
translation initiation. CsrA is known to regulate stationary phase metabolism, repress glycogen 
synthesis, gluconeogenesis and biofilm formation and activate glycolysis and motility in E. coli (Fields 
and Thompson, 2008).  
Fields and Thompson (2008) reported that a csrA mutant reduced biofilm formation compared to the 
wild type and complement strains. This is likely to be due to the decreased flagella function and 
oxidative stress responses. In addition, the mutant also showed reduced ability to adhere to INT407 
cells. C. jejuni is thought therefore to use CsrA in the regulation of stress responses and virulence 
determinants including biofilm formation. 
Two component signal transduction systems are used in C. jejuni to regulate gene expression in 
response to changes in the environment. The two components consist of a membrane bound histidine 
kinase sensor and a cytoplasmic DNA binding response regulator. Signals are sent between the two via 
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a phosphorelay (Eppinger et al., 2004). The C. jejuni genome has a small number of response regulators 
and sensor histidine kinases (12 and seven respectively) (Svensson et al., 2009), that are likely to 
regulate phenotypes for virulence and survival of the pathogen. Svensson et al. (2009) have identified 
the CprRS (Campylobacter planktonic growth regulation) system, which modulates essential survival 
functions under certain stresses and also is thought to control biofilm formation. The cprS sensor 
kinase mutant resulted in enhanced and accelerated biofilm formation implying cprS is a major 
regulator of biofilm formation. 
1.15 Stratages to reduce biofilm and Campylobacter 
There are a number of strategies implemented by food processing plants to prevent and eliminate 
biofilms. The most effective way to prevent the formation of biofilms is efficient and thorough cleaning 
directly after processing.  In most cases using heated water is an effective way of removing food or 
meat residue. In addition to this chemical products such as surfactants and alkali products are used 
which suspend and dissolve food deposits by decreasing surface tension, denaturing proteins and 
emulsifying fats (Simões et al., 2010). However, full-scale cleaning of all contaminated equipment 
means that machinery cannot be in use, which reduces processing time. It is important that the 
chemicals used do not remain on surfaces and contaminate food.  Sensors have been developed to be 
able to detect biofilm formation in the early stages, and even detect the presence of cleaning products 
on surfaces which has facilitated the assessment of various control strategies (Pereira et al., 2008). 
Other than traditional chemicals other studies have other approaches to treat biofilms in food 
processing environments. One study reported between a 61-96% reductions in E. coli biofilm attached 
to stainless steel with ultrasonic waves and proteolytic and glycolytic enzyme treatment (Oulahal-
Lagsir et al., 2003). Moreover, Lu and Collins (2007)engineered a bacteriophage to express a biofilm 
degrading enzyme. This allowed the phage to infect the bacteria, while the enzyme degraded the 
extracellular matrix.  
The Foods Standards Agency (FSA), Defra, and the UK poultry industry set a target to reduce the 
number of highly contaminated birds (>1000CFU/g) from 27% to 10% by 2015 (Food Standards Agency, 
2013). It is proposed that this will help reduce the incidence of Campylobacter infections in humans by 
30%. A survey in 2016 reported that 61.3% of fresh whole UK-produced chicken was contaminated 
with Campylobacter; 11.4% of samples had >1000 colony forming units (CFU) per gram of skin (FSA, 
2017). This is a slight reduction in numbers from the previous year (2015, 73.3% chicken contaminated, 
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19.4 >1000CFU/g) however further analysis needs to be conducted to confirm that this is a true decline 
(FSA, 2017). 
1.16 Project aims and hypothesis 
As discussed, despite efforts in recent years to reduce numbers of Campylobacter on chicken meat 
(FSA, 2015), the majority of chicken carcasses sold in UK supermarkets are contaminated with the 
organism. Campylobacter survival in the environment by biofilm formation is thought to be key in the 
current contamination issues we face (Joshua et al., 2006) (discussed section 1.12). Moreover, poultry 
processing plants, which are exposed to high bacterial loads, provide a variety of temperatures and 
conditions ideal for biofilm formation which can result in meat contamination (discussed section 1.10). 
There is a paucity of knowledge surrounding the genetic and metabolic associations of biofilm 
formation in C. jejuni. A more comprehensive understanding of the specific mechanisms involved in C. 
jejuni biofilm formation may lead to the development of novel and tailored procedures implemented 
in poultry processing plants to reduce Campylobacter contamination. The main aim of this project was 
therefore to research the genetic and metabolic associations to biofilm formation in C. jejuni. This was 
achieved through the following objectives: 
 To phenotypically characterise a number of chicken C. jejuni strains isolated from UK chicken 
meat, using biofilm, motility, autoagglutinaion assays (discussed in Chapter 3). 
 To assess the correlation between biofilm formation and virulence by selecting a panel of 
representative poor and competent biofilm isolates, and screening for 1) their ability to adhere 
and invade human epithelial intestinal cells and 2) their infection potential using the Galleria 
mellonella infection model (discussed in Chapter 3) 
 To identify genes associated with biofilm formation by the construction and screening of a 
transposon mutant library in a strong biofilm-producing chicken C. jejuni isolate (discussed in 
Chapter 4) 
 To compare the gene content of panels of competent and poor biofilm chicken C. jejuni isolates 
through comparative pangenome approaches (discussed in Chapter 5). 
 To determine the metabolic profile of C. jejuni poor and competent biofilm isolates in order to 
investigate a link between biofilm formation and bacterial metabolism (discussed in Chapter 
6).  
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2 Materials and Methods 
2.1 Bacterial strains and growth media 
In order to gather the chicken C. jejuni isolates used in this study, chicken meat was purchased from 
various supermarket retailers in Surrey, UK, between the months of April and June 2013. To isolate 
Campylobacter isolates, poultry skin samples (25g) were collected from chicken legs and thighs, and 
placed in 240ml of Bolton selective enrichment broth with Bolton selective supplement (Oxoid) in a 
250ml Duran. These were incubated for 24 hours at 42°C. Following incubation, a 10 µl loop of the broth 
culture was streaked on to modified Campylobacter blood-free selective agar (mCCDA) with mCCDA 
selective supplement containing Cefoperazone (32 mg/L) Amphotericin B (10 mg/L) (Oxoid) and 
incubated again at 42°C for 24 hours in a microaerophilic environment generated using a CampyGen pack 
(Oxoid). Colonies suspected to be Campylobacter were subsequently purified on Brain Heart Infusion 
agar (BHI) supplemented with 5% defibrinated horse blood with 5 µg/ml Trimethoprim (bBHI-Trm). 
Purified strains were stored at -80°C in Mueller-Hinton broth (MHB) with 25% glycerol. Isolates taken 
forward for further study were assigned CJP numbers (Campylobacter jejuni poultry) 1-30. 
Laboratory strains used in this study consisted of C. jejuni NCTC11168, C. coli NCTC11366 (National 
Collection of Type Cultures (NCTC), Public Health England), Escherichia coli JM109 competent cells 
(Promega), and Salmonella Typhimurium SL1344 (SAP16) an invasive strain provided by Roberto La 
Ragione. 
All media and media supplements were purchased from Oxoid (Basingstoke, UK). Media were 
prepared using reverse osmosis water and sterilised by autoclaving at 121°C for 15 minutes.  
2.1.1 Growth conditions 
Unless otherwise stated, C. jejuni isolates were cultured from -80ᵒC on to bBHI-Trm and incubated for 
48 hours at 42ᵒC in microaerophilic conditions generated by CampyGen packs (Oxoid) in air tight 
containers. After incubation cultures were subcultured on to fresh bBHI-Trm media and incubated in 
the same conditions for 16 hours. It is this subculture that was used for all assays, typically performed 
using three technical and three biological replicates. E. coli and Salmonella strains used for adhesion 
and invasion assays, and cloning protocols, were routinely grown from -80ᵒC vials on LB agar, and 
subcultured into LB broth for 16 hours, aerobically in 37ᵒC. 
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2.2 Molecular biology techniques  
2.2.1 DNA extraction  
2.2.1.1 Boiling lysis 
DNA was extracted by the boiling lysis method ‘boilates’. Briefly, colonies from fresh cultures were 
suspended in 1 ml of nuclease free molecular grade water (Promega) and heated to 95ᵒC for 10 
minutes before immediately placing on ice for 10 minutes. Boiled suspensions were then centrifuged 
at 13,000rpm for 2 minutes at ambient temperature. 
2.2.1.2 DNA extraction using kits 
C. jejuni genomic DNA was extracted using DNeasy Blood & Tissue Kit (Qiagen). Genomic DNA was 
extracted for sequencing by the ArchivePure DNA Cell (5′Prime) following the manufacturer’s 
guidelines. 
2.2.2 Polymerase chain reaction (PCR) 
Unless otherwise stated, all PCR reactions were performed using the q5 high-fidelity 2x master mix 
(NEB), with a final concentration of 1x of the master mix, 0.5 µM of forward and reverse primer, 
≤1000ng of DNA as template, and nuclease free water (Promega) to adjust to the desired volume. As 
standard, the thermocycler conditions were as described in Table 2-1. 
Step Temperature ᵒC Time 
Initial denaturation 98 30 seconds 
x35 cycles 
98 10 seconds 
* 30 seconds 
72 30 seconds/kb of product 
Final extension 72 2 minutes 
Hold 4 ∞ 
Table 2-1: Routine PCR thermocycler settings using q5 high-fidelity 2x master mix. 
*annealing temperature depended on the pairs of primers used. The appropriate temperature 
was calculated using the Tm calculator on the NEB website (http://tmcalculator.neb.com/#!/). 
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2.2.2.1 Colony PCR 
Colony PCR was routinely used to screen transformation colonies for a correct insertion. PCR reactions 
were set up as described in 2.2.2, with a small aliquot of the colony directly added to the PCR tube. 
This provided the template and avoided individual DNA extraction for each colony.  
2.2.3 PCR product clean-up 
Purifying of PCR products was performed by using the QIAquick PCR Purification Kit (Qiagen) using the 
manufacturer’s instructions. Briefly, PB buffer at 5 times the volume of the PCR product was added to 
the PCR product before pipetting into a spin column. The column was then centrifuged at 13,000 rpm 
for 1 minute at ambient temperature before washing with PE buffer. The column was centrifuged again 
using the same settings, air dried, and the DNA on the membrane filter eluted with nuclease-free 
water. DNA was quantified using the Nanodrop. 
2.2.4 Agarose gel electrophoresis 
PCR products were combined with 6x loading dye (Promega) at a ratio of 1:6 (loading dye to PCR 
product) and run on a 1% agarose gel using TBE buffer alongside a 1kb DNA ladder (Promega) at 100 
Volts for 40 minutes. The gel bands were visualised by the use of SYBR Safe DNA Gel Stain 
(Thermofisher Scientific) under UV light. 
2.2.5 Gel extractions  
PCR products requiring a gel extraction were cut from the gel using a UV light box. The cut band was 
placed in an Eppendorf tube and extracted using the QIAquick Gel Extraction Kit (Qiagen) following the 
manufacturer’s instructions. Briefly, three times the weight of the gel was used to calculate the volume 
of QC buffer to add to the gel. The sample was then incubated at 50ᵒC for 10 minutes, before placing 
the sample in the provided spin columns and centrifuging for 1 minute at 13,000 rpm. The DNA was 
then washed with 750 µl of PE buffer and centrifuged again. The DNA was then eluted in 30 µl of 
nuclease free water.  
2.2.6 Restriction enzyme digestions  
All restriction digests were used following Promega’s suggested guidelines using the correct buffer and 
enzyme combination with the addition of bovine serum albumen (BSA). Typically a 20 µl digest would 
consist of 5U of restriction enzyme, 2µg of BSA, 1µg DNA, 1x digestion buffer sterile deionised water 
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to adjust the volume. Calf-intestinal alkaline phosphatase (CIAP) (Promega) was added when digesting 
vector backbones to prevent re-circularisation. Digests were incubated at 37ᵒ for 4 hours. 
2.2.7 Ligations  
Ligations were typically performed in 10 µl volumes, using T4 DNA ligase and ligase buffer (Promega). 
100ng of the vector was used in a 1:3 ratio of vector to insert. The reaction was incubated overnight 
at 4ᵒC. 5 µl of the ligation mixture was used in transformations into JM109 cells. A control of digested 
vector with no insert was run in all experiments. 
2.2.7.1 Ligation of mutant/complement constructs into pGEM®-T Easy Vector System or pSV009 
complementation plasmid 
Mutant constructs containing the flanking sequences with the chloramphenicol resistance cassette 
were cloned into pGEM®-T Easy Vector System (Promega) using manufacturer’s instructions. Briefly, 
the region desired for cloning was amplified using GoTaq® G2 Green Master Mix (Promega) following 
the manufacturer’s instructions. This generates a poly-a tail on the end of the product. The vector, the 
pGEM®-T Easy Vector System is linearised with a poly-T tail. In addition, complement constructed were 
ligated into the pSV009 complemention plasmid, supplied by Andrew Grant’s group, University of 
Cambridge (de Vries et al., 2015). The vector and insert were combined at a ratio of 1:3, unless 
otherwise stated, using 50ng of vector, T4 DNA ligase (3U/ul) and ligation buffer, and incubated 
overnight at 4ᵒC. The resultant plasmids are listed in Table 2-2. 
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Plasmid Description 
pGEM®-T Easy General cloning vector (NEB) 
pSV009 
Complementation plasmid containing Cj0046 pseudogene flanks, kanamycin 
resistance cassette, allows native or cat promoter complementation 
pRC001 pGEM®-T Easy Vector containing memP (Cj1623)  
pRC002 memP (Cj1623) disruption plasmid, CatR 
pRC003 memP (Cj1623) complementation plasmid (pSV009), KanR 
pRC004 hydA complementation plasmid (pSV009), KanR 
pRC005 Cj0080 complementation plasmid (pSV009), KanR 
pRC006 trbJ complementation plasmid (pSV009), KanR 
Table 2-2: Plasmids used in this study. 
CatR, chloramphenicol resistance, KanR, kanamycin resistance. 
 
2.2.8 Transformation into JM109 E. coli competent cells 
Plasmids listed in Table 2-2 were routinely transformed into E. coli JM109 high-efficiency competent 
cells (Promega) by gently thawing 50 µl vials on ice, adding 5 µl of ligation mixture, and incubating for 
10 minutes on ice. The cells were then heat shocked by placing in a 42ᵒC waterbath for 45 seconds, 
and then immediately on ice for 2 minutes. 950 µl of warmed SOC media (Appendix I) was added and 
incubated shaking in 37ᵒC for 1.5 hours. After incubation 100 µl of the transformation was plated on 
LB media supplemented with 100 µg/mL ampicillin (final concentration, LB-amp) for pGEM based 
plasmids, or kanamycin (50 µg/mL, LB-kan) for pSV009 based plasmids for selection. The remaining 
900 µl was centrifuged, resuspended in 100 µl and again plated on LB-amp or LB-kan. Plates were 
incubated aerobically at 37ᵒC for 16 hours.  
2.3 C. jejuni electroporation 
The protocol was based on the methods described in Holt et al. (2012). Briefly, C. jejuni strains were 
grown (as described in section 2.1.1). 2ml of BHI broth was used to harvest the plate of C. jejuni, placed 
in an eppendorf tube and centrifuged for 5 minutes at 10,000 rpm at 4ᵒC. The broth supernatant was 
removed and the pellet washed and resuspended in 1 ml of ice cold wash buffer (Appendix I). The 
pellet was washed four times. The electroporation cuvettes (2mm gap) (Thermofisher Scientific) were 
kept on ice and 100 µl of the suspension was added to the cuvette, with 10 µl of appropriate DNA 
construct (≥3µg) and the electroporation performed at 2.5 kV, 200 Ω and 25µF. A cuvette containing 
no DNA was always used as a negative control. Pre-warmed SOC media (Appendix I) was immediately 
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added to the cuvette, before the entire contents was pipetted on to the surface of bBHI-Trm in a 
universal tube. The lids were loosely screwed and placed in 42ᵒC in microaerophilic conditions for 5 
hours. After incubation, 1 ml of pre-warmed BHI broth was added to the culture, and collected in an 
eppendorf tube. 100 µl of the culture was then plated on bBHI-Trm plates with the addition of a second 
antibiotic to select for transformants (typically 100 µg/mL ampicillin for mutants, or kanamycin 50 
µg/mL, for complemented mutants), while the remainder was centrifuged and resuspended in 100 µl. 
This was then plated on the same media. Generally the negative control (no DNA) was plated on bBHI-
Trm-Cat plate, which generated no growth, and diluted 1:1000 and plated on bBHI without antibiotics, 
so an electroporation efficiency could be calculated. Plates were incubated for 2-5 days in 42ᵒC under 
microaerophilic conditions. 
2.4 Characterisation of chicken C. jejuni isolates  
2.4.1 Multiplex PCR for Campylobacter species confirmation 
A multiplex PCR containing primers identifying the hipO gene in C. jejuni, glyA gene in C. coli, and a 23S 
ribosomal subunit control was performed to confirm the genus presence and confirm the poultry 
isolates to species level. Isolates CJP1-30 were grown as described in section 2.1.1 and DNA extracted 
by the boiling method described in section 2.2.1.1. The PCR was performed as follows, each multiplex 
PCR had a final concentration of 1x of a 5x green buffer (Promega) with 1.04 mM of MgCl2, 1.6mM of 
Deoxynucleotide Triphosphates (dNTPs), 1 µM of the primers detailed in Table 2-3, 2.5U of GoTaq Hot 
Start polymerase (Promega) and 2 µl of boiled lysate as template. Volume was adjusted with sterile 
distilled DNase and nuclease free water to amount to 25 µl total. The PCR thermocycler conditions 
consisted of an initial denaturation phase of 95°C for 6 minutes, then 35 cycles of 95°C for 1 minute, 
59°C for 1 minute and 72°C for 1 minute, and a final extension at 72°C for 5 minutes. The PCR product 
was run on a 1% agarose gel as described in section 2.2.4.  
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Primer 
Amplicon 
Size 
(in bp) 
Sequence (5'–3')  
GenBank 
accession no.  
Target 
gene  
Gene 
location (bp) 
CJF  
323 
ACTTCTTTATTGCTTGCTGC  
 Z36940  
C. jejuni 
hipO 
1662–1681 
CJR GCCACAACAAGTAAAGAAGC 1984–1965 
CCF  
126 
GTAAAACCAAAGCTTATCGTG 
 AF136494  
C. coli  
glyA 
337–357 
CCR  TCCAGCAATGTGTGCAATG 462–444 
23SF  
650 
TATACCGGTAAGGAGTGCTGGAG  
 Z29326 
C. jejuni 
23S rRNA 
3807–3829 
23SR  ATCAATTAACCTTCGAGCACCG  4456–4435 
Table 2-3: Primer sequences used in the multiplex PCR assay to identify C. jejuni and 
C. coli.  
The expected sizes of the amplicons, GenBank number, and gene location. (Taken from Wang 
et al. (2002)). 
 
2.4.2 Biofilm assay 
The ability of the poultry isolates CJP01-30, genetic mutants, and complemented mutants to form 
biofilms was determined through the biofilm assay using crystal violet staining, as described in 
Woodward et al. (2000). Briefly, isolates CJP1-30 and NCTC 11168 were cultured as described in section 
2.1.1. Bacterial suspensions were made in BHI broth (Oxoid) and adjusted to an optical density (OD600) 
of 0.2. 30 µl of the adjusted suspension was added to 100 µl of sterile BHI broth in the wells of a 96 
well polystyrene plate in triplicate (technical replicates). The plates were incubated at 42°C and 37°C 
for 72 hours in a microaerophilic environment generated by CampyGen packs (Oxoid). Post incubation, 
broth was carefully removed from each of the wells, and washed with PBS. 130 µl of 0.5% (w/v) crystal 
violet stain was added to each well and left at ambient temperature for 30 minutes. The crystal violet 
stain was then carefully removed and washed with PBS twice. Bound crystal violet was then dissolved 
in 130 µl of absolute methanol to elute the colour. The OD540 of each well was read in a plate reader. 
Initially, the biofilm assay was repeated 10 times when assaying the CJP isolates, generating 10 
biological replicates for each of the two temperatures, with each biological replicate an average of 
three technical repeats. The assay was performed five times when assaying genetic mutants and 
complemented mutants.  
2.4.2.1 Biofilm data analysis 
The biofilm data generated by the 30 CJP chicken isolates was ranked 1-30 in order of crystal violet OD 
value, which represents the isolates ability to form biofilms. A ranking of 1 would correspond to the 
highest OD, (strongest biofilm), and 30 would represent the lowest OD, (poorest biofilm). Each of the 
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10 biological replicates were ranked, and then the product of the rank values calculated. The product 
values were then ranked themselves, which dictated the most competent biofilm formers (ranked 1-
5) and the poorest biofilm formers (ranked 26-30). Biofilm ability of CJP isolate were compared using 
an unpaired students T-test, and wild type, mutant and complemented mutant strains were compared 
using one-way analysis of variance (ANOVA) followed by Tukey’s multiple-comparison test (GraphPad 
Prism software, version 7.0). The levels of significance, represented by P values, were taken to be 
significant when P < 0.05. 
2.4.3 Antibiotic sensitivity testing (AST)  
In order to investigate the diversity of the poultry isolates, antibiotic resistance profiles were 
determined using either BSAC (British Society for Antimicrobial Chemotherapy) or EUCAST methods 
appropriate breakpoints. These breakpoints state the diameter (mm) of the zone of inhibition required 
for determination of a strain to be sensitive or resistant to a particular antibiotic. 
Isolates CJP1-30 and NCTC 11168 were grown as described in section 2.1.1. Bacterial cells were then 
suspended in phosphate buffered saline (PBS) (pH 7.3) and adjusted to an OD600 0.1, the equivalent to 
a 0.5 McFarland suspension.  
Suspensions were swabbed evenly on to Mueller-Hinton agar supplemented with 5% sheep blood 
(bMHA) and 20mg/L NAD plates for gentamicin (10µg), tetracycline (30µg) and erythromycin (15 µg) 
antibiotic discs (Oxoid) (following EUCAST guidelines), and on to Iso-Sensitest agar supplemented with 
5% defibrinated horse blood and 20mg/L NAD plates for nalidixic acid (20µg) and ciprofloxacin (1µg) 
antibiotics (following BSAC guidelines). Antibiotic discs were placed on the surface and bMHA plates 
were incubated for 40 hours at 37ᵒC and iso-sensitest plates were incubated at 42ᵒC for 24 hours in 
microaerophilic conditions. Following incubation, the zones of inhibition were measured in millimetres 
(mm) and compared to the published BSAC and EUCAST breakpoints for sensitivity determination 
(BSAC, 2015, EUCAST, 2017).  
2.4.4 Multi-locus Sequence typing (MLST) 
Multi-locus sequence typing involving the amplification of seven C. jejuni housekeeping genes were as 
follows. Isolates CJP1-30 were grown as described in section 2.1.1 and DNA extracted by the boiling 
method described in section 2.2.1.1. PCR amplification reactions were performed in a total volume of 
50μl as described in section 2.2.2. Annealing temperatures and PCR primer sequences (previously used 
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by Dingle et al. (2001)), are detailed in Table 2-4. Nuclease-free water was used as a negative DNA 
control. The amplified PCR products were subjected to gel electrophoresis as described in section 2.2.4.  
Products of the correct size (as detailed in Table 2-4) were purified using the QIAquick PCR Purification 
Kit (Qiagen), following the manufacturer’s instructions, and detailed in section 2.2.3. The DNA from 
purified amplicons was adjusted to 20 ng/µl and sent for Sanger sequencing using Genewiz services 
(GENEWIZ, UK). Forward and reverse reactions were sequenced using the primers listed in Table 2-5 
as taken from (Dingle et al., 2001). FASTA sequences generated from sequencing were submitted to 
the PubMLST Campylobacter database (https://pubmlst.org/ campylobacter/) to determine the allele 
number for each gene. A seven digit number for the seven alleles was then inserted into the pubMLST 
search tool to identify the sequence type and clonal complex (ST and CC), respectively.  
Gene 
target 
Forward/ 
reverse 
primer  
Primer sequence 5'-3' 
Annealing 
temperature ᵒC 
Amplicon 
size (bp) 
aspA 
Forward AGTACTAATGATGCTTATCC 
56 941 
Reverse ATTTCATCAATTTGTTCTTTGC 
glnA 
Forward TAGGAACTTGGCATCATATTACC 
62 1305 
Reverse TTGGACGAGCTTCTACTGGC 
gltA 
Forward GGGCTTGACTTCTACAGCTACTTG 
65 1112 
Reverse CCAAATAAAGTTGTCTTGGACGG 
glyA 
Forward GAGTTAGAGCGTCAATGTGAAGG 
66 1052 
Reverse AAACCTCTGGCAGTAAGGGC 
tkt 
Forward GCAAACTCAGGACACCCAGG 
62 1133 
Reverse AAAGCATTGTTAATGGCTGC 
pgm 
Forward TACTAATAATATCTTAGTAGG 
42 1195 
Reverse CACAACATTTTTCATTTCTTTTTC 
uncA 
Forward ATGGACTTAAGAATATTATGGC 
56 1259 
Reverse ATAAATTCCATCTTCAAATTCC 
Table 2-4: Multi-locus sequence typing primers annealing temperatures, and 
ampicon size. 
Primer sequences taken from Dingle et al. (2001). 
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Gene 
target 
Forward/reverse 
primer  
Primer sequence 5'-3' 
aspA 
Forward CCAACTGCAAGATGCTGTACC 
Reverse TTCATTTGCGGTAATACCATC 
glnA 
Forward CATGCAATCAATGAAGAAAC 
Reverse TTCCATAAGCTCATATGAAC 
gltA 
Forward CTTATATTGATGGAGAAAATGG 
Reverse CCAAAGCGCACCAATACCTG 
glyA 
Forward AGCTAATCAAGGTGTTTATGCGG 
Reverse AGGTGATTATCCGTTCCATCGC 
tkt 
Forward GCTTATAAGGTAGCACCTACTG 
Reverse TCCAGAATAGCGAAATAAGG 
pgm 
Forward GCTTAGCAGATATTTTAAGTG 
Reverse AAGCCTGCTTGTTCTTTGGC 
uncA 
Forward AAAGTACAGTGGCACAAGTGG 
Reverse TGCCTCATCTAAATCACTAGC 
Table 2-5: Multi-locus sequencing typing primers used for Sanger sequencing. 
Primer sequences taken from Dingle et al. (2001). 
 
2.4.5 Motility and diffusion assay 
Motility was assessed using the method previously described by Golden and Acheson (2002). Briefly, C. 
jejuni strains were cultured as described in section 2.1.1. After incubation, cell suspensions were made 
in PBS and adjusted to an OD 0.2 (A580). Mueller-Hinton agar (MHA) plates containing 0.4% biological 
agar were stabbed with 5 µl of the strain inoculum. These plates were incubated at 42°C for 24 hours in 
microaerophilic conditions and the halo of growth measured in millimetres (mm). This experiment was 
repeated in triplicate generating three biological replicate data points, of which each biological replicate 
consisted of three technical repeats. Data was presented using GraphPad Prism software, version 7.0, 
and direct comparisons between strains were compared using an unpaired Student’s t-test. The levels of 
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significance, represented by P values, were taken to be significant when P < 0.05. Motility was correlated 
to biofilm formation by Pearson correlation, calculated in Microsoft Excel. 
2.4.6 Autoagglutination assay 
A panel of ten chicken C. jejuni isolates including competent biofilm isolates: CJP11, CJP12, CJP13, 
CJP17, CJP27, and poor biofilm isolates: CJP01, CJP19, CJP21, CJP22, CJP28 along with NCTC11168 were 
screened for their ability to autoagglutinate. Isolates were grown as described in section 2.1.1. Isolate 
suspensions were made in 2ml of PBS, adjusted to an OD600 of 1 and incubated statically at 37ᵒC for 24 
hours. After incubation, the top ml of suspension was removed with a 1ml pipette tip, and OD600 
measurements were taken. The OD reading was subtracted from the starting OD value (1), and 
expressed as a percentage of the starting OD to represent percentage autoagglutination. This 
experiment was repeated in triplicate generating three biological replicates, each biological replicate 
consisted of three technical replicates in three separate tubes. Data was presented using GraphPad 
Prism software, version 7.0, and motility was correlated to biofilm formation by Pearson correlation, 
calculated in Microsoft Excel. 
2.4.7 Caco-2 cell culture assays  
2.4.7.1 Caco 2 cells and routine culture 
The same panel of 10 chicken C. jejuni isolates used in section 2.4.6, comprising the most competent 
and poor biofilm formers in this study, along with the reference strain NCTC11168 and hyper-invasive 
S. Typhimurium (SAP16) strains, were incorporated into cell culture assays to assess their adhesion and 
invasion ability to human intestinal epithelial cells. This was performed using the Caco-2 cell line which 
consists of human colon carcinoma cells, as an effective model for studying adhesion and invasion of 
Campylobacter of intestinal epithelia (Everest et al., 1992).  
Caco-2 cells were supplied by the Animal and Plant Health Agency (APHA) and were stored in 90% 
foetal bovine serum (FBS) and 10% Dimethyl sulfoxide (DMSO) in liquid nitrogen. Cells were cultivated 
in Dulbecco’s modified Eagle medium (DMEM) (Invitrogen) supplemented with 10% (v/v) FBS 
(Invitrogen), 1× non-essential amino acids and 100 U/ml penicillin and streptomycin (Sigma). Cells were 
incubated in 95% air/5% CO2 at 37 °C.  
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2.4.7.2 Seeding  
Routinely, cells were seeded into T75 (75cm2) flasks at approximately 106 cells/cm2 and incubated for 
five days. Cells were harvested by treating with 0.25% (w/v) trypsin and incubation for 5 minutes in 
37ᵒC to detach, and resuspended in DMEM. 
For adhesion and invasion assays, cells were seeded in polystyrene 24 well plates at 4x105 cells per 
well. The media was changed every 48 hours. Cells were cultured until semi-confluent and partial 
differentiation observed before the commencement of the assays. 
2.4.7.3 Infection of Caco-2 cells 
C. jejuni isolates were grown as described in section 2.1.1. Isolate suspensions were made in PBS and 
adjusted to an OD of 1.1 (A590) which equates to approximately 1x108 CFU/ml. The invasive S. 
Typhimurium (SAP16), used as a positive control, was grown in LB broth at 37˚C on shaking at 225 rpm 
for 16 h and adjusted to an OD540 1.2 in PBS (approximately 1x108 CFU/ml). 100 µl of inoculum was 
added to the wells of a 24 well plate creating a multiplicity of infection (MOI) of 100:1. 
2.4.7.4 Adhesion and invasion assays 
To assess the C. jejuni adherence to Caco-2 cells, 100 µl of inoculum (1x107 cells) was added to each 
well containing semi-confluent Caco-2 cells with DMEM media with no antibiotics, and incubated at 
37ᵒC in 5% CO2 for 4 hours to allow attachment. Following incubation, all media was removed and 
washed with PBS, and the Caco-2 cells lysed by 1% (v/v) triton X. The contents of the wells were 
removed, and serially diluted to 10-7, and 20 µl volumes plates on bBHI plates for C. jejuni isolates using 
the Miles and Misra method (Miles et al., 1938), and MHA for the S. Typhimurium (SAP16) strain. Miles 
and Misra dilutions were also performed on the starting inoculum to identify the exact number of 
colony forming units (CFU) entered into the assays. 
For invasion, a similar protocol was used to adhesion (above paragraph) with the exception of the 
additional gentamicin protection assay performed after 4 hours of incubation. Briefly, media 
containing a final concentration of 100µg/ml of gentamicin was added to each well, and incubated for 
a further 2 hours. This gentamicin protection assay selects for bacteria which have become internalised 
in the Caco-2 epithelial cell. Following incubation, cells were washed, lysed, and plated as explained 
for adhesion (section 2.4.7.4, first paragraph). 
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Plates inoculated with C. jejuni (bBHI) were incubated for 48 hours in microaerophilic conditions, and 
S. Typhimurium (SAP16) (MHA) plates were incubated at 37ᵒC in aerobic conditions for 24 hours. 
Colonies were counted and CFU/ml values were calculated for starting inoculums, adhesion and 
invasion. Each assay was performed in triplicate, consisting of three technical and three biological 
replicates. Adhesion and invasion efficiency for each strain was calculated by dividing the CFU/ml value 
by the starting inoculum CFU/ml value.  Data was presented and analysed using GraphPad Prism 
software, version 7.0, and statistical significance between competent and poor biofilm isolates were 
determined through unpaired T-tests. P values of <0.05 were determined significant. Correlation of 
adhesion and invasion efficiency to biofilm formation by was analysed by Pearson correlation, 
calculated in Microsoft Excel.   
2.4.8 Galleria mellonella infection model 
The same 10 chicken C. jejuni isolates used in section 2.4.6, along with the reference strain NCTC11168, 
were subjected to the Galleria mellonella infection model which have been used to screen C. jejuni 
virulence determinants (Senior et al., 2011). The G. mellonella larvae were purchased from Livefood 
UK Ltd (Rooks Bridge, Somerset, UK) and stored at 15ᵒC. Ten G. mellonella larvae of similar size were 
separated into 13 petri dishes lined with filter paper (total 130 larvae per biological replicate). Ten G. 
mellonella larvae were injected with 10 µl each of C. jejuni bacterial suspensions in PBS (1 x108 CFU/ml) 
in the top right proleg using a Hamilton syringe. Ten of the larvae were left uninfected, and ten were 
injected with 10 µl of sterile PBS negative controls. 
Subsequently, G. mellonella larvae were incubated at 37ᵒC for 24 hours, aerobically. After incubation, 
the number of larvae that survived were counted, and % survival calculated. Each larva was also given 
an individual infection score. This consisted of mortality (0/1, alive or dead), colour/melanisation 
(ranging from creamy white, 0, to dark black, 3) and mobility, where larvae would be flipped on their 
backs, and their ability to turn back over (scored from 0-2). The sum of these values would be 
calculated and assigned an individual infection score per isolate.  
Differences between percentage survival compared to the PBS control was analysed using one-way 
Analysis of Variance (ANOVA), using GraphPad Prism (version 7). Differences in percentage survival 
and infection score between poor and competent biofilm isolates were analysed by unpaired T-tests 
in Microsoft Excel. A p-value of <0.05 was suggestive of a significant difference. Percentage survival 
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and infection score correlation to biofilm formation was assessed by Pearson correlation coefficient in 
Microsoft Excel.  
2.4.9 Scanning Electron Microscopy (SEM) 
CJP13 biofilms were grown on polypropylene coupons using a similar method outlined in section 2.4.2, 
with increased volumes. The coupons were placed in 24 well plates to allow the biofilm to form. 
Biofilms were washed three times with PBS and then submerged in 2.5% gluteraldehyde solution for 
30 minutes to allow fixation. The samples were then dipped in 70%, 90% and absolute ethanol for 30 
minutes in each concentration, to dehydrate the sample. The coupons were subsequently air-dried, 
and gold coated by the Emitech K575X vacuum sputter coater. The samples were examined by the Jeol 
JSM7100F scanning electron microscope, and imaging performed by the Joel software, assisted by Mr 
David Jones of the Microscopy & Analysis Technician MicroStructural Studies Unit, University of Surrey, 
Guildford, UK. This program was able to measure individual cell sizes (µM) and observe biofilm 
structure including the extracellular matrix. 
2.5 Transposon mutant library construction 
A transposon mutant library was contracted using the chicken C. jejuni isolate CJP13, which was 
identified as being the most competent biofilm former. Construction was performed in Dr Andrew 
Grant’s laboratory, Department of Veterinary Medicine, University of Cambridge, UK. Methods for 
transposon library construction are summarised in de Vries et al. (2017). 
2.5.1 Purification of Himar1-C9 transposase 
Transposon insertion into the CJP13 C. jejuni genome was mediated by a transposase which was 
extracted from an E. coli harbouring the pMAL plasmid containing a hyperactive form of Himar1 
transposase cloned into the maltose-binding protein (MBP) fusion plasmid (pMAL-cri, NEB). The 
protocol is derived from Akerley and Lampe (2002).  
2.5.1.1 Pre-culture and expression of the Himar1-C9-MBP fusion protein 
The E. coli containing the pMALC9 plasmid was grown in LB broth supplemented with 100 µg/ml 
ampicillin and 10 µg/ml chloramphenicol (LB-amp-cat) for 16 hrs at 37ᵒC with agitation (200 rpm) to 
induce expression of Himar1-C9-MBP. After incubation, 80ml of LB-amp-cat was inoculated with 800 
µl of overnight culture and grown at 37ᵒC with agitation (200 rpm) until OD600 0.5 was reached. 
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Subsequently 0.3mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added, to induce expression 
of the transposase, and further incubated for two hours in the same conditions. 
2.5.1.2 Purification of the Himar1-C9-MBP fusion protein 
The E. coli cells harbouring the pMALC9 plasmid (section 2.5.1.1), were then harvested and centrifuged 
for 15 minutes at 4000 rpm at 4°C and resuspended in 10ml of ice cold column buffer (CB) (Appendix 
I) and frozen to -80ᵒ for 10 minutes. The sample was then thawed and sonicated (pulse 30 sec, cool for 
120 sec Frequency: 20 kHz). This was repeated six times, and kept on ice at all times. The sample was 
then spun for 10 minutes at 13,000 rpm at 4°C and supernatants pooled. Amylose resin was suspended 
and then centrifuged for 1 minute at 13, 000 rpm and washed 3 times in 1 ml transposase wash buffer 
(TWB) (Appendix I). The resin was resuspended in TWB and added to the lysate pellet fraction and 
incubated for 1 hour in a rotating wheel at 4°C. The resin was pelleted in 2 mls of TWB and washed 4 
times. The proteins were then eluted in the addition of 400 µl of transposase elution buffer (Appendix 
I) and mixed occasionally over a 5 minute period. The resin was then pelleted again by centrifuging for 
2 minutes 13,000 rpm at 4°C, the supernatant collected and aliquoted into tubes for storage at -80ᵒ. 
2.5.2 In vitro mariner transposon mutagenesis 
Chromosomal DNA of the chicken CJP13 isolate served as an acceptor for incorporation of the mariner 
transposon element. During in vitro transposon mutagenesis, the mariner transposon element was 
sliced out of the donor plasmid (pSV006 kindly donated by Stefan De Vries, from Dr Andrew Grant’s 
group, Department of Veterinary Medicine, University of Cambridge, UK) by Himar1 transposase 
(section 2.5.1) and inserted into TA-dinucleotide sites in the acceptor DNA. During the in vitro 
transposition, gaps are created at the site of insertion; these are repaired by filling in by DNA 
polymerase followed by a ligation step, as explained below. 
2.5.2.1 In vitro transposition reaction and purification 
A mix of final concentration 1x transposition buffer (Appendix I), 2 µg of chromosomal acceptor DNA, 
1 µg of mariner transposon donor plasmid, 1 µl purified Himar1 transposase, were vortexed, 
centrifuged and incubated for 4 hours at 30ᵒC, aerobically in a heating block for transposition to occur. 
The transposase was then deactivated by heating to 75°C for 10 minutes. 
To the transposition reaction, 10 µg of glycogen and sodium acetate (pH 5.4, final concentration 
82mM) with 50 µl of 100% ethanol was added and incubated for 30 minutes at -20°C. The samples 
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were then centrifuged at 13,000 rpm at 4°C for 15 minutes, and the supernatant removed. 250 µl of 
70% ethanol was added to the pellet. The sample was then centrifuged again at maximum speed for 5 
minutes. The supernatant was removed and the pellet was air-dried for 5-10 minutes, before being 
dissolved in molecular grade water. 
2.5.2.2 Repair of the transposition reaction  
A mix of final concentration 1x T4 DNA polymerase buffer (NEB2 buffer), 1µg of BSA, 50 µM dNTPs and 
3U T4 DNA polymerase (NEB) was added to the purified transposition reaction, which was then 
incubated for 30 minutes at 16°C. The T4 DNA polymerase was then deactivated by heating to 75°C for 
10 minutes in a heating block. 
Sodium acetate (pH 5.4), glycogen and 100% ethanol was added, just as in section 2.5.2.1, to the 
inactivated T4 DNA polymerase reaction, mixed and incubated for 30 minutes at -20°C. The sample 
was then centrifuged at 13,000 rpm at 4°C for 15 minutes, and the supernatant removed. 250 µl of 
70% ethanol was added to wash the pellet. The pellet was allowed to air dry for 5-10 minutes, before 
dissolving in sterile molecular grade water.  
Final concentration 1x of E. coli DNA ligase buffer and 2U of E. coli DNA ligase (NEB) was added to the 
T4 DNA polymerase reaction and incubated at 16°C in a waterbath. Sodium acetate (pH 5.4), glycogen 
and 100% ethanol was added to the E. coli DNA ligase reaction, and incubated for 30 minutes at -20ᵒC. 
The sample was then centrifuged, washed in ethanol, dried and dissolved in 20 µl of molecular grade 
water. The DNA concentration was then quantified using the Nanodrop. 
2.5.3 Natural transformation of C. jejuni 
C. jejuni strains (typically CJP13 for transposon mutagenesis, but other strains, including NCTC11168, 
subsequent experiments) were grown using the conditions detailed in section 2.1.1. C. jejuni cells were 
harvested from the overnight plate with 1 ml of BHI broth and an L-spreader. The OD of the suspension 
was then adjusted to OD600 0.5 in BHI broth. 0.5 mls of C. jejuni suspension was placed on the surface 
of bBHI-Trm in a universal tube. These were incubated for 3 hours under microaerophilic conditions at 
42°C. After incubation, 20 µl the DNA mix from section 2.5.2.2 was added to the culture and further 
incubated for 5 hours in microaerophilic conditions at 42°C.The suspensions were then plated on bBHI 
with 5 µg/ml TrM and 10 µg/ml Chloramphenicol to select for mutants (bBHI-Trm-Cat), and incubated 
for 72 hours at 42°C under microaerophilic conditions.  
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2.5.4 Transposon mutant picking 
After incubation, approximately 3,000 individual colonies were picked and inoculated into a well of a 
deep-well 96 well plate (Greiner Bio One) with each well containing a biphasic media consisting of 1ml 
bBHI-TrM-Cam, and 200 µl of BHI broth-Trm-Cat. 96-well plates were incubated for 24 hours at 42ᵒC 
in microaerophilic conditions. After incubation, the broth from each well was removed and placed in 
fresh deep well 96-well plates containing BHI broth and 25% glycerol suitable for -80ᵒC storage. 
2.6 Screening picked mutant library in biofilm assay 
Polystyrene 96 well plates containing biphasic media (100 µl of bBHI-Trm-Cat agar and 100 µl of BHI 
broth-Trm-Cat) were stab inoculated from the frozen individual mutants stored in glycerol using a 
multichannel pipette. These 96-well plates were incubated for 24 hours at 42ᵒC in microaerophilic 
conditions. After incubation, 1 µl of each mutant was inoculated into fresh 96 well plates, with each 
well containing 130 µl of BHI broth-Trm-Cat. These were then incubated for 72 hours at 37ᵒC, in 
microaerophilic conditions.  
After incubation, the plates were read in the plate reader at OD600 for growth. Subsequently, broth and 
planktonic cells were removed and washed with PBS (pH 7.2), and the remaining biofilm stained with 
crystal violet using the method outlined in section 2.4.2. The crystal violet was eluted in menthol and 
again read in the plate reader to obtain a crystal violet OD540 reading representing biofilm formation. 
This assay was repeated on two separate occasions generating two biological replicates. 
2.6.1 Mutant library biofilm analysis 
Spreadsheets containing both a growth OD reading (after 72 hours of incubation), and a crystal violet 
stain biofilm OD and were analysed in Microsoft Excel. Here, mutants were stratified by growth OD, 
ranging from 0.1 to 0.25 OD in 0.01OD intervals. Once grouped, those that exhibit a significantly 
different biofilm OD than their peers (mutants with similar growth ODs), could be identified by 
calculating Z-values. A Z-value, was determined for each mutant by the equation below, where z= Z-
value, x= the individual biofilm OD of a single mutant, µ = the mean biofilm OD across all mutants 
comprising the same growth OD stratification, and SEM = biofilm standard error of the mean (SEM). 
𝑧 =
𝑥 − 𝜇
𝑆𝐸𝑀
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Essentially, the Z-value is a measure of how different a mutant’s biofilm OD is compared to the mean 
(expected) OD of the stratification, in units of standard deviations; the more extreme the positive or 
negative Z-value, the larger the difference in biofilm OD. Using the Z-value distribution, and the  
degrees of freedom associated with the given growth OD stratification, each Z-value was transformed 
in to a p-value, representing the probability of the observed difference in biofilm OD under the null 
hypothesis that there is no difference between biofilm ODs of mutants in the same stratification. 
Subsequently, the mutants for both biological replicates of the library screen could be ranked in order 
of p-value. The mutants with the lowest p-value for both replicates were selected for further study. 
2.7 Linker PCR to determine where the transposon was inserted in the CJP13 genome  
2.7.1 Annealing oligo pairs 
Firstly, the oligos 254 and 256 listed in Table 2-6 were annealed together using annealing buffer 
(Appendix I) by incubation at 95°C for 3 minutes, and slow cooling to 30ᵒC on the bench top. 
2.7.2 RsaI digestion of mutant DNA and ligation of linker 
C. jejuni mutant DNA was extracted using the method described in section 2.2.1.2, and 1.5 µg of the 
chromosomal DNA was digested with RsaI (NEB) (final concentration 5U) along with CutSmart buffer 
(NEB) (1x final concentration) by incubation at 37°C. Wild type DNA was used as a control. The digest 
was purified using the method described in section 2.2.3 and eluted in sterile distilled water. 
50ng of RsaI digested DNA was incubated with the annealed oligo pair (254-256) with DNA ligase and 
ligase buffer (NEB) and incubated for 1 hour at room temperature. The ligation was then purified again 
by the Qiaquick PCR purification column kit, and eluted in 30 µl of molecular grade water. 
2.7.3 Linker PCR 
PCR reactions using the Q5 High-Fidelity Master Mix and 2.5 µl of the ligation mixture as a template 
were set up using oligos 258 and CAT15 (Table 2-6) at a final concentration of 4 pmol/µl. The PCR 
thermocycler conditions are detailed in section 2.2.2 with an annealing temperature of 55ᵒC and an 
extension time of 1.5 minutes. The PCR product was run on a 1% agarose gel as described in section 
2.2.4. Wild type DNA was used as a control, which showed no PCR product on the subsequent gel. 
Products were purified by the Qiaquick PCR purification column kit and sent for Sanger sequencing 
using the CAT15 primer (Genewiz, UK). FASTA files were subjected to a BLASTn (Basic Local Alignment 
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Search Tool at nucleotide level) search, using default settings. The top ‘hits’ above 80% identity would 
identify the gene to which transposon was inserted.  
Primer Sequence 5’-3’ 
Oligo 254 CGACTGGACCTGGA 
Oligo 256 GATAAGCAGGGATCGGAACCTCCAGGTCCAGTCG 
Oligo 258  GATAAGCAGGGATCGGAACC 
CAT15 TAGTGGTCGAAATACTCTTTTCGTG 
Table 2-6: Primers used for Linker PCR to determine transposon location in CJP13 
genome. 
Oligo primers 254 and 256 were annealed together to form the ‘linker’. The linker was ligated 
onto digested genomic DNA with inserted transposons. This DNA was used as template for a 
PCR using primer Oligo 258, complementary to the linker, and primer CAT15, complementary 
to the chloramphenicol cassette, located in the transposon.  
2.8 Individual mutant knock-out construction 
2.8.1 Mutant constructs by overlapping extension PCR (OE-PCR) 
Mutants were constructed using the overlapping extension PCR method outlined in Hansen et al. 
(2007). Primers for each PCR reaction were designed using Primer3Plus 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi).  
Overlapping PCRs require the amplification of three PCR products. Primers P1 and P2 were used to 
amplify the region upstream from the gene target, (either cj1623 (memP), cj0080, hydA or trbJ) using 
the wild type genomic DNA of CJP13 and NCTC11168 as a template. Primers C1 and C2 were used to 
amplify the 789bp chloramphenicol (cat) resistance cassette from pAV103 (plasmid containing 
chloramphenicol cassette in ahpC construct), and P3 and P4 were used to amplify the downstream 
region of the target gene also from the CJP13 and NCTC11168 wild type as template. Table 2-7 includes 
the primer sequences used for mutant construction, the size in base pairs (bp) of the PCR product and 
the appropriate annealing temperatures. After amplification, the products were purified using the 
QIAprep Spin Miniprep Kit (Qiagen), and DNA quantified using the Nanodrop. 
Primers P2 and P3 have regions (underlined and bold Table 2-7) that are complementary to primers C1 
and C1 (for the cat cassette), respectively. This allows the joining of the cat cassette to the upstream 
and downstream fragments by an annealing step. This consisted of 600ng and 200ng of each of the 
upstream and downstream fragments along with Q5 master mix being subjected to a short PCR run 
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consisting of an initial denaturation phase of 98°C for 30 seconds, then seven cycles of 98°C for 10 
seconds, 69°C for 20 seconds and 72°C for 30 seconds, and a final extension at 72°C for 2 minutes.  
This annealed mixture was then subjected to another PCR using primers P1 and P4 to amplify the entire 
mutant construct using the thermocycler settings outlined in section 2.2.2. Annealing temperatures 
were as follows; memP_P1 and memP_P4, 63ᵒC, for Cj80_P1 and Cj80_P4, 65ᵒC, for trbJ_P1 and 
trbJ_P4, 66ᵒC and for hydA_P1 and hydA_P4, 64ᵒC, with an extension time of 1 minute. 
Gene Target Primer name Primer sequence (5'-3') 
Target  
size (bp) 
Annealing 
Temp (ᵒC) 
memP 
(Cj1623) 
memP_P1 TGCTTGTAGTCGGTGGAGAA 
466 67 
memP_P2 CTTGGAAAGGAACACCGCCGAGTGTAGCTTGATAGGGTGTAGTCC 
memP_P3 ACCCTTTAGGAACTAAAGGGCGGGGAGTAATCAATCTTGGCTTGC 
429 63 
memP_P4 GGCAACAGTTTTAGGAGCTA 
Cj0080 
Cj0080_P1 AGCGAGGATTGATCCCATTTGC 
489 69 
Cj0080_P2 CTTGGAAAGGAACACCGCCGAGCCAAAGGGTCTTTCCAAGAG 
Cj0080_P3 ACCCTTTAGGAACTAAAGGGCGATCTTACACTCGAAGGAAAAT 
302 65 
Cj0080_P4 AATATCACCCACAAACCAGCT 
trbJ 
trbJ_P1 ACACATGCACAGGGGAATTT 
366 66 
trbJ_P2 CTTGGAAAGGAACACCGCCGAGTGCTCGTATTGTTGAAGTTGCA 
trbJ_P3 ACCCTTTAGGAACTAAAGGGCGGCTTACAAATTATTTAGCGTCGC 
306 66 
trbJ_P4 TGTTGTGTTTCATTGGAGTGCT 
hydA 
hydA_P1 AGATCTTATTCGAGTGATCGCTT 
470 64 
hydA_P2 CTTGGAAAGGAACACCGCCGAGGGAAGCTTTTCAAGAGCCGA 
hydA_P3 ACCCTTTAGGAACTAAAGGGCGTGGGACCTTTTGAAGAGCCT 
424 66 
hydA_P4 AGGCGGAGTAATACCTAAAGCA 
Chloram- 
phenicol 
cassette 
C1 CTCGGCGGTGTTCCTTTCCAAG 
798 68 
C2 CGCCCTTTAGTTCCTAAAGGGT 
Internal  
cat  
control 
CC069 ATATGTGCAGGGCGTATTGC     
Table 2-7: Primers used to construct individual knock-out mutants, with target gene 
sizes and annealing temperatures. 
Primers were designed using Primer3Plus (http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi) and complementary regions for primers were adapted from 
de Vries et al. (2015). Primers P1 and P2 are used to amplify the region upstream of the gene 
of interest, primers P3 and P4 are used to amplify the region downstream of the gene of 
interest, and C1 and C1 are used to amplify the chloramphenicol (cat) cassette. Underlined 
regions of the primers represent sequences complementary to the C1 and C2 primers, which 
allows the annealing of the three amplicons. Primer CC069, complementary to the 
chloramphenicol cassette was used in combination with P1 primers for PCR amplification of a 
region of the mutant construct to check for correct cat insertion. 
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2.8.2 ΔmemP construct by cloning 
Due to difficulties in constructing ΔmemP mutants using the overlapping extension PCR method, 
cloning methods were conducted. Firstly, amplification of the memP gene (cj1624) with upstream and 
downstream regions was performed using primers memP_P1 and memP_P4 (Table 2-7) with wild type 
reference strain NCTC11168 and CJP13 DNA as a template and GoTaq® G2 Green Master Mix 
(Promega) following the manufacturer’s instructions. Briefly, ≤250ng template DNA, final 
concentrations of 0.5 µM of upstream and downstream primer, and 1x final concentration of master 
mix was used. The PCR thermocycler conditions consisted of an initial denaturation phase of 95°C for 
2 minutes, then 35 cycles of 95°C for 45 seconds, 54°C for 45 seconds and 72°C for 1.5 minutes, and a 
final extension at 72°C for 5 minutes. The product was then purified as described in section 2.2.3, and 
ligated into the pGEM easy vector following methods described in 2.2.7.1.  
The plasmid pRC001 was transformed into E. coli JM109 cells following the methods in section 2.2.8. 
Colony PCR was then used to screen for the insert, described in section 0. Colonies harbouring the 
plasmid containing the construct were subcultured, the plasmid extracted and digested with BglII 
following the methods described in section 2.2.6.  
The plasmid pCAS036F, containing a cat cassette with two attached BamHI restriction sites, was kindly 
donated to us by Mark Reuter, from Arnoud van Vliet’s group at the Institute of Food Research 
(Norwich, UK). This plasmid was extracted, purified and digested by BamHI and run on a 1% agarose 
gel (section 2.2.4). The 798bp cat cassette was gel extracted as described in section2.2.5, and ligated 
to the digested pRC001 plasmid forming the pRC002 plasmid. This was transformed into E. coli for 
storage. Plasmid pRC002 was extracted, purified and used as a template for a PCR using memP_P1 and 
memP_P4, settings detailed above to amplify the entire mutant construct (including cat cassette).  
2.8.3 Mutant construct electroporation and natural transformation into C. jejuni 
Mutant constructs, either constructed by overlapping extension PCR or cloning were inserted into C. 
jejuni by electroporation, detailed in section 2.3. The subsequent colonies were subcultured, the 
genomic DNA extracted, and used in a natural transformation of C. jejuni, as described in section 2.5.3.  
2.9 Constructing complemented mutant strains 
Complementation of C. jejuni CJP13 and NCTC11168 ΔmemP, ΔCj0080, ΔtrbJ and ΔhydA mutants were 
constructed using the pSV009 complementation plasmid supplied by Dr Stefan De Vries from Dr 
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Andrew Grant’s group, University of Cambridge, UK. Complementation plasmid details are published 
in de Vries et al. (2015). Briefly, the pSV009 plasmid contains a kanamycin resistance gene for selection, 
a chloramphenicol (cat) promoter located in the middle of two Xhol restriction sites, and a multiple 
cloning site (MCS) directly downstream consisting of SacI, KpnL, XmaI, BamHI, XbaI, SalI, Spel and PstI 
restriction sites. The promoters, MCS, and antibiotic cassettes are flanked by two recombination 
regions consisting of the Cj0046 pseudogene in NCTC11168 with identical sequences also found in M1 
and 81-176 C. jejuni lab strains. Here, the plasmid gives the option to clone the gene of interest in the 
MCS under the cat promoter, or its native promoter. Constructs using both native and cat promoters 
were used in this study. 
Cj0080, memP and trbJ were expressed under the cat promoter, therefore these amplified genes and 
the pSV009 plasmid (extracted from E. coli using the QIAprep Spin Miniprep Kit Print (Qiagen)) were 
digested it with XbaI and BamHI. hydA was expressed under the native promoter, therefore amplified 
hydA and pSV009 DNA were digested with XhoI and BamHI. Use of XhoI removed the cat promoter 
region from the vector. 
Genes of interest inserted into the complementation plasmid were amplified using the respective 
mutant DNA as template, (extraction as described in section 2.2.1.2) using the primers listed in Table 
2-8  and thermocycler settings described in section 2.2.2 and Table 2-9. PCR products were purified as 
described in section 2.2.3 and digested with either XhoI and BamHI for native promoter, or XbaI and 
BamHI for cat promoter expression (digestion described in 2.2.6). Gene products were then ligated 
into respective cut pSV009 plasmids as described in sections 2.2.7 and 2.2.7.1. Plasmids containing 
complementation constructs were then transformed into JM109 E. coli cells for storage in -80ᵒC as 
described in section 2.2.8. Plasmids were subsequently extracted using the QIAprep Spin Miniprep Kit 
Print (Qiagen) and used as the template for two PCR reactions. The first PCR reaction used 
pSV009_seq_FW1 and pSV009_seq_RV1 which was used to amplify the gene cloned into the MCS. This 
product was then purified and sent for Sanger sequencing to confirm the gene had been inserted 
correctly. The second PCR using the pSV009_GCamplif_FW1 and pSV009_GCamplif_RV1 primers was 
used to amplify the entire genetic complementation region. This product was again purified and then 
electroporated into the respective C. jejuni mutants using methods described in 2.3. C. jejuni mutant 
complements were subcultured, and used in PCR using the pSV009_seq primers for confirmation of 
complementation. Complements were stored in 25% glycerol at -80ᵒC. 
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Target Primer name Primer sequence (5'-3') 
memP (Cj1623) 
memP_GC_cat_XbaI_P1: CAGTCTAGAATGGCATTTATGAACTTTAG 
memP_GC_cat_BamHI_P2: CTGCCTAGGTAGGTGGTCTTGCTACAAAT 
Cj0080 
Cj0080_GC_cat_Xbal_P1: CAGTCTAGAATGTTTTATTTTGTTGTTTTTA 
Cj0080_GC_cat_BamHI_P2: CTGCCTAGGCGCTCTTGACCAATCAACGC 
trbJ 
trbJ_GC_cat_Xbal_P1: CAGTCTAGAATGAAAAAATCTTTATTTGG 
trbJ_GC_cat_BamHI_P2: CTGCCTAGGTTAAAAATCCTTAATTTTTC 
hydA 
hydA_GC_native_Xhol_P1: CAGCTCGAGTTAAGCTTTAATTAAGAGTG 
hydA_GC_native_BamHI_P2: CTGCCTAGGCTTGTAATAGGATCTACGAT 
  Complementation control GCGTGGATTTAATTTCTAGCGG* 
Genetic 
complementation 
region 
pSV009_GCamplif_FW1 TAATAGAAATTTCCCCAAGTCCCA* 
pSV009_GCamplif_RV1 CTATTGCCATAGTAGCTCTTAGTGG* 
 Sequencing 
complemented 
gene  
pSV009_seq_FW1 GGAGACATTCCTTCCGTATCT* 
pSV009_seq_RV1 AGCGAGACAAAAACACTGAGC* 
Table 2-8: Primers used to construct complements to individual knock-out mutants. 
P1 and P2 primers used to amplify the genes required for complementation. Underlined 
sequences contain restriction sites as indicated in the primer name. For genes expressed under 
the cat promoter (memP, Cj0080 and trbJ) P1 primers contain XbaI restriction sites, and P2 
primers contain BamHI restriction sites. For genes under the native promoter (hydA), P1 primers 
contain XhoI restriction sites, and P2 primers contain BamHI restriction sites. Primer 
‘complementation control’ is complementary to the kanamycin cassette used in the 
complementation plasmid which can be used for screening transformant colonies. Primers for 
the ‘genetic complementation region’ enable amplification of the competition region which can 
be electroportaed into appropriate C. jejuni mutants. Primers for the ‘sequencing 
complemented gene’ amplify the region of gene insertion. These amplicons were sent for Sanger 
sequencing (GENEWIZ, UK) to confirm correct sequence for insertion.  
* Primers adapted from de Vries et al. (2015). Regions of primers bold and underlined are the 
restriction sites respective to the primer name. 
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Gene 
Target 
Expression 
under the 
native/cat 
promoter 
Primer pair 
Product size 
(&primer 
sequence) 
(bp) 
Annealing 
temperature 
(ᵒC) 
Extension 
time 
(seconds) 
memP 
(Cj1623) 
Cat 
memP_GC_cat_XbaI_P1& 
memP_GC_native/cat_BamHI_P2 
585 65 30 
hydA Native 
hydA_GC_native_Xhol_P1& 
hydA_GC_native/cat_BamHI_P2 
1315 67 40 
Cj0080 Cat 
Cj0080_GC_cat_Xhol_P1& 
Cj0080_GC_native/cat_BamHI_P2 
324 62 40 
trbJ Cat 
trbJ_GC_cat_Xhol_P1& 
trbJ_GC_cat_BamHI_P2 
886 62 40 
Table 2-9: Primer combination and PCR settings for amplification of genes used for 
complementation. 
 
2.10 Next generation Sequencing (NGS) 
Genomic DNA was extracted from the 10 C. jejuni isolates (Competent biofilm isolates: CJP11, CJP12, 
CJP13, CJP17, CJP27, Poor biofilm isolates: CJP01, CJP19, CJP21, CJP22, CJP28) using the ArchivePure 
DNA Cell extraction kit (5′Prime) according to manufacturer’s instructions. DNA was then quantified 
by the Nanodrop and adjusted to 20 ng/µl using nuclease-free water. DNA was then sent to the Animal 
Health Trust (AHT) for sequencing where libraries were constructed using Nextera DNA Library 
Preparation Kit (Illumina) following the manufacturer’s instructions. The MiSeq next-generation 
sequencer was used for sequencing using the paired ends method. 
2.10.1 De novo assembly and analysis 
Each sequenced genome was assembled de novo from the fastq files using the SPAdes assembler 
(Version 3.9.0) (Bankevich et al., 2012). The output was a multi-fasta *.fna file, comprising the set of 
assembled contigs, for each sequenced genome. These files were submitted to the ‘Rapid Annotation 
Subsystem Technology’ (RAST) (www.rast.nmpdr.org) server, an online tool which detects protein 
coding regions and assigns function based on sequence homology. RAST output .gff files were used for 
pangenome analysis of annotated features using Roary v. 3.6.8 (Page et al., 2015). Here, Roary clusters 
sequences with ‘Cluster Database at High Identity with Tolerance’ (CD-HIT) (Page et al., 2015) and 
BLASTp analysis compares all protein sequences against each other with a defined sequence identity. 
In this study, 90%, 95% and 99% sequence identity was used depending on the type of analysis. 
Sequences were clustered with the ‘Markov Cluster Algorithm’c00081 (Enright et al., 2002)), and then 
merged with the CD-HIT clustering. The analysis was performed with "paralog clustering" enabled, a 
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setting which does not split paralogs into clusters, and reduces the effects of allelic variation (van Vliet, 
2017). Genomes were grouped into competent and poor biofilm formers and ranked by the number 
of each gene present in each group, identifying genes which are more common or rare to poor and 
competent biofilm formers.  
2.10.2 Phylogenetic analyses 
Phylogenetic analysis of 10 CJP chicken isolates was performed by Arnoud van Vliet, University of 
Surrey. Briefly, chicken C. jejuni isolate genomes were phylogenetically clustered with 320 C. jejuni 
reference genomes selected to represent the different MLST clonal complexes, and the phylogenetic 
tree was generated from core genome single nucleotide polymorphisms (SNPs) identified by ParSNP 
(Treangen et al., 2014). The genomes included shared approximately 60% of the genome, with SNPs 
identified in these regions, and the tree was rooted with C. jejuni subsp. doylei genomes. Figtree 
(http://tree.bio.ed.ac.uk/software/figtree/) version 1.42 was used for visualisation of phylogenetic 
trees.  
Distribution analysis of specific genes linked to biofilm formation in C. jejuni was performed using 5,829 
C. jejuni genomes with known isolation source and MLST clonal complex data. The phylogenetic tree 
was constructed using the concatenated nucleotide sequences of 52 ribosomal genes (Jolley 2012), 
followed by generation of a nucleotide distance table using the Phylip version 3.69 DNAdist program 
(Felsenstein, 1989), with the tree generated using the Neighbor package from Phylip. Presence and 
absence of full or truncated genes in each genome were determined by BLASTp analysis, and visualised 
using Figtree. 
2.11 Biolog phenotypic microarrays (PM) 
The respiration of C. jejuni isolates when grown on different sole carbon sources was assessed using 
the Biolog ‘Phenotypic microarray’ system. Essentially, Biolog PM1 96 well plates with different carbon 
source substrates in each well were used in this study. 
Figure 2-1 shows the plate layout for PM1. C. jejuni strains were grown from -80°C glycerol stocks on 
MHA at 42°C for 48 hours. PM1 plates were inoculated by first creating a suspension of cells (from the 
MHA plates) at 16% absorbance in IF-Oa minimal media (Biolog). This suspension was diluted 1:2 in IF-
Oa minimal media containing tetrazolium dye D at 1.5%, additive (containing 0.05% bovine serum 
albumin (BSA) and 1.25mM NaHCO3) at 12.5%, and sterile H20 at 11%. 100 µl of the master mix with 
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cell suspensions was added into each well on the 96 well plate and sealed in an air tight bag with a 
compact CampyGen pack (Oxoid) to create a microaerobic environment. These plates were then 
placed in the OmniLog plate reader (Biolog) at 37°C for 96 hours which measured the colourmetric 
change of the reduction of the tetrazolium based dye. The reduction of the tetrazolium dye and 
subsequent colour change is proportional to the respiration of the C. jejuni on the specific carbon 
source. Data was analysed using the Biolog kinetic software (version 1.20.02). The entire experiment 
for each strain was replicated in triplicate. 
 
 
Figure 2-1: Plate layout for PM1 Biolog plate. 
Studies comparing carbon metabolism of C. jejuni poultry isolates were performed in PM1 
plates, illustrating the different carbon source in each well. 
 
2.11.1 Statistical analysis for Biolog data 
.csv files containing kinetic data for each well on a Biolog PM1 plate ~96hr at 37°C were imported into 
R, the statistical computing environment (R Development Core Team, 2008). Using R scripts, written 
by Dr Emma Laing, the data in the .csv file was processed to produce kinetic curves for each well on 
the plate with which four associated values for each kinetic curve could be calculated: 1) Maximum 
“growth” to assess the maximum respiration achieved; 2) Maximal Slope to assess how rapidly the 
organism is able to utilise the substrate; 3) Area Under the Curve to assess overall respiration; 4) Lag-
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phase to assess how quickly the organism starts to utilise the substrate. Reducing the dimensions of 
the data to single values for each replicate then allowed for direct statistical comparisons between 
strains.  Here we used analysis of variance (ANOVA) followed by Tukey’s honest significant difference 
(HSD) post-hoc test to identify statistically significant different utilisation of substrates between strains 
based on each of the four parameters. In other words, for each of the 96 substrates we performed 
four ANOVA statistical tests, one for each of the kinetic curve parameters, to confirm whether there 
was a significant difference between any of the strains or not. For those substrates we obtained an 
ANOVA p-value < 0.05 we then performed the Tukey HSD test to identify which strains were different 
(Tukey HSD p-value < 0.05).  
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3 Campylobacter jejuni strain isolation and characterisation 
3.1 Introduction 
Campylobacter jejuni is the leading bacterial cause of gastroenteritis in the world, with approximately 
70,000 reported cases in the UK each year. Such incidence is a significant economic burden and costs 
the UK economy approximately £900 million per annum (FSA, 2015). C. jejuni infections in humans are 
predominantly caused by the consumption of infected poultry meat, which normally causes a self-
limiting diarrhoeal disease, but can manifest as meningitis, endocarditis, Reiter’s syndrome and 
Guillain Barré syndrome, and is a major cause of infant mortality in developing countries (Acheson and 
Allos, 2001). 
Despite efforts in recent years to reduce the abundance of Campylobacter on chicken meat, 73% of 
chicken carcasses sold in UK supermarkets are contaminated with the organism (FSA, 2015). It is 
thought that Campylobacter survival in the form of biofilms in environments such as poultry processing 
plants could be responsible for such high contamination.  
As discussed, contamination within poultry processing plants is expected to be a major contributory 
factor to the incidence of Campylobacter infection in the UK. Thus, research investigating C. jejuni 
biofilm formation should include circulating strains that are present within poultry processing plants. 
This chapter focuses on the isolation and characterisation of C. jejuni strains from processed chicken 
meat to produce a collection of strains representative of C. jejuni circulating in the UK.   
The aims and objectives of this chapter were: 
 To isolate a number of relevant circulating Campylobacter jejuni chicken strains from supermarket 
chicken meat. 
 To determine the diversity of the isolates through typing methods and antibiotic resistance 
profiles. 
 To determine their ability to form biofilms using standard laboratory biofilm assays. 
 To build a phenotypic profile of each isolate and assess the correlation between biofilm formation 
and virulence. 
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3.2 Results 
3.2.1 Isolation of C. jejuni isolates from supermarket chicken 
Between the months of April and June 2013, fresh supermarket chicken meat, of various cuts and 
quality, was purchased from four supermarket retailers situated in the south of the UK. Mostly chicken 
legs and thighs were purchased due to the likelihood of chicken faecal contamination. In order to 
isolate Campylobacter spp, the meat was either swabbed directly, or the skin pre-incubated in Bolton 
broth with selective supplement, containing Cefoperazone, Vancomycin, Trimethoprim and 
Cycloheximide for 24 hours at 42ᵒC, and subsequently streaked onto mCCDA agar to select for the 
presence of Campylobacter spp. These plates were then incubated for 48 hours at 42ᵒ. Fifty individual 
colonies were picked, with a maximum of 2 colonies picked from one chicken sample, from selective 
mCCDA agar, sub-cultured, purified and frozen into three separate vials in 25% glycerol, and stored at 
-80ᵒC.  
Following isolation, each isolate was cultured on solid agar and in broth liquid culture to ensure 
sufficient growth could be obtained for incorporation into future experiments. Isolates that displayed 
poor growth were discarded. Thirty of the most competent growers were assigned an isolate number 
- C. jejuni poultry (CJP) 1-30 and catalogued in a -80 freezer for further study. The isolates and their 
origin of isolation are detailed in Table 3-1. Since C. jejuni is the Campylobacter species causing the 
majority of human infections, this study focused on the isolation of C. jejuni only. 
3.2.2 Confirmation of isolate identity 
Prior to any experiments, selected isolates were Gram stained and subjected to catalase and oxidase 
tests. All isolates were then confirmed to be Gram negative curved shaped rods, which were catalase 
and oxidase positive.  
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Isolate Cut of meat Supplier Isolated from Additional details 
CJP01 Leg Supermarket 1 swab Value 
CJP02 Leg Supermarket 1 skin Value 
CJP03 Leg Supermarket 1 swab Value 
CJP04 Leg Supermarket 1 skin Organic 
CJP05 Leg Supermarket 1 swab Organic 
CJP06 Leg Supermarket 1 skin Free-range 
CJP07 Leg Supermarket 2 skin Value 
CJP08 Leg Supermarket 2 swab Value 
CJP09 Leg Supermarket 2 swab Value 
CJP10 Thigh Supermarket 2 skin Value 
CJP11 Thigh Supermarket 2 skin Organic 
CJP12 Leg Supermarket 2 swab Free-range 
CJP13 Leg Supermarket 2 swab Free-range 
CJP14 Leg Supermarket 3 skin Value 
CJP15 Leg Supermarket 3 skin Value 
CJP16 Leg Supermarket 3 skin Value 
CJP17 Leg Supermarket 3 skin Organic 
CJP18 Leg Supermarket 3 skin Organic 
CJP19 Leg Supermarket 3 swab Organic 
CJP20 Thigh Supermarket 3 swab Free-range 
CJP21 Thigh Supermarket 3 swab Free-range 
CJP22 Thigh Supermarket 3 swab Free-range 
CJP23 Lower leg Supermarket 4 skin Value 
CJP24 Lower leg Supermarket 4 skin Value 
CJP25 Lower leg Supermarket 4 skin Value 
CJP26 Lower leg Supermarket 4 skin Organic 
CJP27 Thigh Supermarket 4 skin Organic 
CJP28 Thigh Supermarket 4 swab Free-range 
CJP29 Thigh Supermarket 4 swab Free-range 
CJP30 Lower leg Supermarket 4 swab Free-range 
Table 3-1: Campylobacter spp. isolated from fresh supermarket chicken meat. 
Campylobacter spp. isolated from various cuts and quality of fresh supermarket chicken meat. 
Most Campylobacter isolates from thigh or leg cuts, and from a range of quality and priced 
meats. Thirty of the pure isolates that showed competent growth in the laboratory were 
assigned a number (CJP1-CJP30). Colours represent the four supermarket retailers used in this 
study. 
60 
 
3.2.2.1 Multiplex PCR to confirm Campylobacter spp. 
All 30 Campylobacter spp. isolates (CJP1 - CJP30) selected for further study were subjected to PCR 
amplification of the 23S portion of the ribosomal subunit. In addition, for confirmation of the 
Campylobacter species, PCR using specific primers for the genes hipO and glyA was also conducted, 
with amplification of the former confirming the presence of C. jejuni and the latter confirming C. coli. 
These species represent the two most prevalent Campylobacter species to infect humans. 
Amplification of the 23S (650bp), incorporated as an internal control, and hipO genes (323bp) was 
successful for every C. jejuni isolate. glyA amplification was successful in the C. coli control strain 
(126bp) and no bands were present in the E. coli control strain, and negative control, containing no 
DNA (see Figure 3.1). 
 
Figure 3-1: Campylobacter spp. Multiplex PCR. 
3% agarose gel showing PCR amplification fragments derived from a multiplex PCR including 
23S amplicons, hipO amplicons for identification of C. jejuni and glyA amplicon for identification 
of C. coli : Lane 1, 14, 15, 28, 29, 43: 1kb ladder (Promega); lanes 2-13: CJP01-CJP12 respectively; 
lanes 16-27: CJP13-CJP24, respectively; lanes 30-35: CJP25-CJP30, respectively; lane 36: C. jejuni  
NCTC 11168; lane 37: C. jejuni  81-176; lane 38: hyper-motile C. jejuni mutant NCTC 11168H; 
lane 39: C. jejuni NCTC 480; lane 40: C. coli NCTC 11366; lane 41: E. coli NEB-10; lane 42: negative 
control containing no DNA. The 650 base pair (bp) band represents the 23S PCR product, the 
323bp band represents the C. jejuni hipO gene amplification and the 126bp band represents 
the C. coli glyA gene amplification. 
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3.2.3 Biofilm Assay 
The crystal violet staining assay is widely used to quantify biofilm formation in  a variety of species 
biofilms including Staphylococcus spp, E. coli, Candida spp and Pseudomonas spp, to name just a few 
(Luo et al., 2017, Kao et al., 2017) as well as C. jejuni  (Joshua et al., 2006, Reuter et al., 2010).  
Preliminary experiments were performed in this study to assess biofilm assay duration and 
atmospheric conditions on a selection of broths (Mueller-Hinton, Brucella and Brain Heart Infusion) 
using crystal violet staining. Incubation for 72 hours in Brain heart infusion broth (BHI broth) in 
microaerophilic atmospheres on polystyrene provided the most successful biofilm, i.e. highest optical 
density (OD) reading using crystal violet staining (Appendix II). All subsequent biofilm assays were 
performed under these conditions.  
In order to select isolates for further characterisation, a panel containing five competent, and five poor 
biofilm isolates are required, which will enable comparisons between the extremes of the biofilm 
phenotype. All chicken isolates (CJP1-30) were therefore screened for their ability to form biofilms in 
the optimal conditions detailed above. The biofilm assays were incubated at 37ᵒC and 42ᵒC to mimic 
human and chicken body temperatures. The results are presented in Figure 3-2.  
Interestingly, the ability of the poultry C. jejuni isolates to form biofilms under the given conditions 
were varied, with the majority of isolates unable to produce biofilms. As shown in Figure 3-2 , there 
was also a large amount of variation between replicates. However, isolates CJP11, CJP12 and CJP27 
that were able to form biofilms, were significantly more prominent at 37ᵒC, compared to 42ᵒC 
(p<0.001, shown by ‘***’ in Figure 3-2). The crystal violet optical density (OD) values of ten biological 
replicates were subjected to a ranking analysis which identified isolates that were consistently 
‘competent’ or ‘poor’ biofilm formers between replicates. An average crystal violet OD greater than 
0.1 was considered a competent biofilm isolate. This is depicted by the horizontal grey dotted line 
across the x-axis in Figure 3-2. The isolates chosen for further study were as follows: Competent biofilm 
isolates: CJP11, CJP12, CJP13, CJP17, CJP27; Poor biofilm isolates: CJP01, CJP19, CJP21, CJP22, CJP28 
and represented by the blue dashed and red dotted boxes in Figure 3-2. These five competent, and 
five poor biofilm C. jejuni isolates were taken forward as representative panels of both extremes of the 
phenotype. It must be noted that no differences in growth after 72 hours of incubation at 37ᵒC were 
observed between the CJP isolates, and a low correlation between endpoint OD600 growth and biofilm 
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formation was obtained through Pearsons correlation coefficient (r=0.1134). This indicates that the 
growth endpoint is independent from biofilm formation. 
 
 
Figure 3-2: Biofilm formation of C. jejuni chicken isolates. 
C. jejuni poultry isolates CJP01-CJP30 with NCTC11168 grown in brain heart infusion broth in a 
96 well plate for 72 hours at 37°C and 42°C in microaerophilic conditions. After incubation, 
biofilm cells were washed and stained with crystal violet. The bound crystal violet was dissolved 
with methanol and optical density (OD) readings taken at Absorbance (A)540. Bars show the 
average of five technical and ten biological replicates, error bars represent the standard 
deviation. Asterisks indicate the significant difference in biofilm formation between 37°C and 
42°C using multiple T-tests (*, p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001). Blue dashed 
boxes indicate isolates that constantly generated the most competent biofilms and 
subsequently the highest crystal violet optical density value, referred to herein as competent 
biofilm formers. Red dotted boxes indicate isolates that consistently formed poor to no biofilm 
indicated with the lowest crystal violet optical density readings, referred to herein as poor 
biofilm formers. 
 
3.2.4 Antibiotic resistance profile 
To build up a phenotypic profile of the C. jejuni isolates, their antibiotic resistance profiles to four 
clinically and industrially relevant antibiotics, including nalidixic acid, ciprofloxacin, gentamicin, 
tetracycline and erythromycin, were screened. Antibiotic sensitivity was determined using either the 
EUCAST (EUCAST, 2017) or BSAC (BSAC, 2015) breakpoints for the disc diffusion assay. The antibiogram 
profiles are presented in Table 3-2 .  
The isolates tested demonstrated a range of resistance profiles which were representative of the strain 
diversity previously reported for Campylobacter isolated from poultry meat (Wimalarathna et al., 
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2013). Resistance to ciprofloxacin and tetracycline was most common with ≥50% of the isolates 
resistant in this study. Resistance to naladixic acid was moderate at 37.5% resistance. Isolates were 
also generally most sensitive to gentamycin with only 12.5% of isolates showing resistance. Isolates 
showed a 30% resistance to erythromycin, which is the antibiotic used most commonly to treat 
Campylobacter infections. In addition, there was no correlation between the resistance profile and the 
biofilm capability of the isolates (Pearson correlation coefficient r=-0.225).  
  
64 
 
 
Nalidixic Acid Ciprofloxacin Gentamicin Tetracycline Erythromycin 
(NA 30) (CIP 1) (CN 10) (TE 30) (E 15) 
Cut-off values 
(mm) 
R≤19  S≥20 R≤25  S≥26 R≤19  S≥20 R≤29  S≥30 R≤22  S≥23 
Isolates  
CJP01 R R S S S 
CJP02 S S S R R 
CJP03 R R S R R 
CJP04 S S S S S 
CJP05 S S S S S 
CJP06 R R S R S 
CJP07 S S S R S 
CJP08 S S R R R 
CJP09 S S S S S 
CJP10 R R R R S 
CJP11 S S S S S 
CJP12 S R S R R 
CJP13 S S S R S 
CJP14 S R R S S 
CJP15 R R S S S 
CJP16 S S S R R 
CJP17 R R S S S 
CJP18 R R S S S 
CJP19 R R S S S 
CJP20 R R R S S 
CJP21 R R S S S 
CJP22 S R S S S 
CJP23 S S S R R 
CJP24 S S S R S 
CJP25 S S S R S 
CJP26 S S S R R 
CJP27 S S S R R 
CJP28 R R S R S 
CJP29 S S S R R 
CJP30 R R S R S 
NCTC 11168 S S S R S 
% resistant 37.50% 50% 12.50% 59.40% 30% 
Table 3-2: Antibiotic sensitivity profiles of poultry C. jejuni isolates. 
Isolates determined as sensitive (S) or resistant (R, highlighted) to five antibiotics by the disc 
diffusion method using BSAC (nalidixic acid 20µg and ciprofloxacin 1µg) and EUCAST 
(gentamicin 10µg, tetracycline 30µg and erythromycin 15 µg) breakpoints. Isolate numbers 
highlighted blue or red represent the panel of five competent or poor biofilm isolates 
respectively. This experiment was repeated in triplicate, with three biological replicates 
preformed. 
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3.2.5 Multi-Locus Sequence Typing of C. jejuni isolates 
To confirm that the C. jejuni test isolates from chicken meat used in this study are genetically diverse, 
MLST typing was performed, which is the gold standard for Campylobacter typing (pubMLST, 2017). 
Seven housekeeping genes, including aspA, glnA, gltA, pgm, tkt and uncA, were amplified using 
specialised MLST primers, the amplicon purified and sequenced by Sanger sequencing.  
The sequence of each gene was submitted to pubMLST (pubMLST, 2017) to assign an allele number. 
Subsequently the identified allelic profile, consisting of seven allele numbers, was submitted to 
pubMLST to identify the sequence type and clonal complex (ST and CC, respectively). Allelic profiles 
and assigned ST and CC are shown in Table 3-3 and mapped in Figure 3-3.  
The chicken C. jejuni isolates (CJP01-CJP30) were assigned to 13 different ST’s and 10 CC’s, with the 
most common being ST-257 and ST-574. Three isolates had not been assigned a ST and/or a CC (CJP03, 
CJP22 and CJP26) meaning their allelic profile is novel and has not been entered into the pubMLST 
database. Some ST’s were clustered into supermarket retailer groups, for example ST-574 was 
prominent in supermarket 4 (Table 3-1 and Table 3-3).  
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Isolate aspA glnA gltA glyA pgm tkt uncA ST CC 
CJP01 2 1 5 3 2 1 5 19 ST-21 complex 
CJP02 2 4 1 2 5 1 5 846 ST-48 complex 
CJP03 24 2 2 48 10 3 3  -   -  
CJP04 1 2 3 4 6 9 3 2580 ST-42 complex 
CJP05 1 2 3 4 6 9 3 2580 ST-42 complex 
CJP06 24 2 2 2 10 3 3 5136 ST-464 complex 
CJP07 9 2 4 62 4 5 6 257 ST-257 complex 
CJP08 9 2 4 62 4 5 6 257 ST-257 complex 
CJP09 9 2 4 62 4 5 6 257 ST-257 complex 
CJP10 24 2 2 2 10 3 3 5136 ST-464 complex 
CJP11 2 4 1 2 7 1 5 48 ST-48 complex 
CJP12 24 2 2 2 10 3 3 5136 ST-464 complex 
CJP13 2 75 5 2 316 34 1 2185 ST-661 complex 
CJP14 9 2 4 62 4 5 6 257 ST-257 complex 
CJP15 2 4 2 4 19 3 6 658 ST-658 complex 
CJP16 7 28 4 28 17 34 12 573 ST-573 complex 
CJP17 2 1 12 3 2 1 5 50 ST-21 complex 
CJP18 2 1 12 3 2 1 5 50 ST-21 complex 
CJP19 2 1 12 3 2 1 5 50 ST-21 complex 
CJP20 2 4 2 4 19 3 6 658 ST-658 complex 
CJP21 2 4 2 4 19 3 6 658 ST-658 complex 
CJP22 1 2 42 4 98 58 34 586  -  
CJP23 7 53 2 10 11 3 3 574 ST-574 complex 
CJP24 7 53 2 10 11 3 3 574 ST-574 complex 
CJP25 7 53 2 10 11 3 3 574 ST-574 complex 
CJP26 7 53 2 10 17 3 3  -   -  
CJP27 7 53 2 10 11 3 3 574 ST-574 complex 
CJP28 8 10 2 2 11 12 6 354 ST-354 complex 
CJP29 7 28 4 28 17 34 12 573 ST-573 complex 
CJP30 7 28 4 28 17 34 12 573 ST-573 complex 
Table 3-3: C. jejuni Multi-Locus Sequence Typing (MLST) allelic profiles. 
C. jejuni isolates were assigned allele numbers for each of the seven housekeeping genes 
corresponding to a sequence type (ST) and clonal complex (CC) number according to pubMLST. 
CJP03 and CJP26 were not assigned a ST or CC and CJP22 was not assigned a CC, indicating these 
are unique combinations of alleles, which have not been reported to the pubMLST database and 
therefore have an unassigned lineage. Colours represent the four supermarket retailers from 
which the chicken meat was purchased. 
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Figure 3-3: Chicken C. jejuni isolates’ MLST phylogenetic dendrogram. 
MLST phylogenetic tree demonstrating the phylogenetic diversity between 30 C. jejuni ST 
isolated from fresh supermarket chicken meat. The diversity is determined by a Pearson 
correlation coefficient matrix (Garcia-Vallve et al., 1999). Dendrogam indicates clustering into 
10 different STs with isolates of unassigned lineage dispersed throughout. 
 
3.2.6 C. jejuni motility and diffusion 
The 30 chicken C. jejuni isolates (CJP01-CJP30) were subjected to a motility assay using semi-solid agar. 
The diameters of the halo of isolate diffusion across the agar was measured after 24 hours incubation 
at 37ᵒC, as shown in Figure 3-4A. All C. jejuni isolates were found to be motile, however, there was a 
large range of variance in motility (from 7.3mm - 33.3mm in diameter) between isolates. 
The association of motility and biofilm phenotype of each isolate was assessed using Pearson 
correlation, as shown in Figure 3-4B. Here, the biofilm data was transformed to log scale (log10) to 
reduce skewness in the data due to the biofilm values for CJP13 and NCTC11168 being considerably 
higher than average.   No correlation (Pearson correlation coefficient, r=-0.0683) was found between 
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the motility of the isolate and biofilm formation ability in the conditions used. However, as can be seen 
in Figure 3-4B, the panel of poor biofilm formers (displayed as open triangles in Figure 3-4B) cluster 
together and exhibit a strong motile phenotype, more so than three of the five most competent biofilm 
isolates (open circles in Figure 3-4B). Indeed, we find (Figure 3-4C) that the distribution of motility 
values appears to be bimodal, suggesting two distinct populations, where all ‘poor’ biofilm isolates are 
described by the right peak. It has to be noted that there are few samples, and the screening of a larger 
sample of isolates may converge the two distinct modes into a single distribution to reflect the 
population of C. jejuni. Nevertheless, treating the poor biofilm formers as a distinct population from 
all other isolates, we calculated the difference in the mean motility values of the two populations in 
standard deviation units i.e. the effect size, as this is a statistical measure independent of the number 
of samples collected. A large difference (Cohen’s d = 0.80) in motility between ‘poor’ biofilm producers 
compared to the general population was found. This goes against the general understanding that 
highly motile isolates are competent biofilm formers.  
A  
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Figure 3-4: C. jejuni motility and diffusion 
The ability of isolates CJP1-CJP30 to diffuse through semisolid media indicating isolate motility 
in mm (B) Motility vs Log10 Biofilm formation as assessed by crystal violet staining. Motility and 
biofilm formation show no correlation (Pearson correlation coefficient, r=-0.0683). Open circles 
represent the most competent biofilm formers, identified in section 3.2.3 (CJP11, CJP12, CJP13, 
CJP17 and CJP27), open triangles indicated poor biofilm formers (CJP01, CJP19, CJP21, CJP22 
and CJP28), closed circles represent the other chicken C. jejuni isolates and the closed square 
represents the NCTC11168 C. jejuni strain. (C) Histogram depicting the distribution of isolate 
motility in increments of 5 mm. Plot demonstrates two distinct populations. 
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3.2.7 C. jejuni autoagglutination  
Autoagglutination, which involves the clumping of bacteria, shares similar characteristics to biofilm 
formation in C. jejuni (Howard et al., 2009, Reuter et al., 2015). Cultures of C. jejuni isolates were grown 
and cell suspensions of cells were adjusted to an OD600 of 1 in PBS and incubated at 37ᵒC for 18 hours. 
After incubation the top millilitre (ml) was removed and OD600 readings taken. The results for the 
autoagglutination assay are presented in Figure 3-5A expressed as percentage agglutination compared 
to the starting OD. Isolates with a lower OD reading after incubation represented isolates with an 
increased ability to autoagglutinate.  
The isolates were varied in autoagglutination ability, with CJP11, a competent biofilm former, showing 
a strong autoagglutination phenotype. There was no significant difference in % autoagglutination 
between the group of competent and poor biofilm formers (unpaired t-test, p=0.8). Figure 3-5B shows 
a weak positive relationship between autoagglutination and log10 biofilm formation data (Pearson 
correlation coefficient, r=0. 233). 
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Figure 3-5: C. jejuni autoagglutination and correlation to biofilm formation 
2ml of C. jejuni isolate suspension were made to an OD of 1 (A600) in PBS and incubated at 37ᵒC 
for 18 hours. After incubation, the top ml was taken from the suspension and OD 
measurements taken at A600. (A) % autoagglutination compared to the starting OD. Blue bars 
indicate competent biofilm isolates, and red checkered bars represent poor biofilm isolates. 
Black bar represents NCTC11168. There was no significant difference in % autoagglutination 
between the group of competent and poor biofilm formers (unpaired t-test, p>0.05). Data 
represents the average OD readings of three biological replicates, error bars shows the 
standard deviation. (B) Correlation between % autoagglutination and log10 OD biofilm 
formation. Open circles represent the best biofilm formers, open triangles indicate poor biofilm 
formers and the closed square represents the NCTC11168 C. jejuni strain. Autoagglutination 
and biofilm formation have a weak positive correlation (Pearson correlation coefficient, 
r=0.233). 
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3.2.8 C. jejuni adhesion and invasion to Caco-2 human intestinal epithelial cells  
A number of virulence factors involved in C. jejuni pathogenesis have also been linked to the 
attachment of abiotic surfaces and initial stages of biofilm formation. These include, flagella, where 
the filament itself and motility have been reported as important, (Svensson et al., 2009, Joshua et al., 
2006) the fibronectin binding protein, CadF (Sulaeman et al., 2012), among others. To assess the 
correlation between biofilm formation capability and virulence, the panel of 10 isolates, five 
competent biofilm isolates and five poor biofilm isolates identified in section 3.2.3, along with 
NCTC11168 C. jejuni and SAP16, a highly invasive Salmonella Typhimurium, control strains were 
subjected to a series of adhesion and invasion assays. Data is shown in Figure 3-6A and B to show 
adhesion and invasion efficiencies respectively, and their correlation to biofilm formation in Figure 
3-6C and D. There was no significant difference in adhesion or invasion efficiency between the group 
of competent and poor biofilm formers (unpaired t-test, p>0.05). 
Adhesion efficiency was varied between isolates and between the panels of isolates and negatively 
correlated (Pearson correlation coefficient, r=-0.246, linear regression r2=0.0605) with biofilm 
formation capability. The invasion efficiency was also varied with CJP19 showing extreme invasion into 
Caco-2 cells, approximately six times more than the S. Typhimurium control. Again, a negative 
correlation was observed between biofilm formation capability and invasion efficiency (r=-0.289, linear 
regression r2=0.0837).  
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A B 
  
Figure 3-6: Adhesion and Invasion of poultry C. jejuni isolates to human Caco2 cells. 
(A) Adhesion efficiency shown as cells attached C. jejuni cells to Caco-2 cells, but not invaded, 
as a percentage of starting inoculum. (B) Invasion efficiency shown as the number of cells that 
crossed the Caco-2 cell membrane, as a percentage of starting inoculum. Blue bars indicate 
competent biofilm isolates, and red checkered bars represent poor biofilm isolates. Black bars 
represent NCTC11168 and S. Typhimurium (SAP16, hyper invasive) control strains. There was no 
significant difference in adhesion or invasion efficiency between the group of competent and 
poor biofilm formers (unpaired t-test, p>0.05). 
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3.2.9 Galleria mellonella infection model 
The Galleria mellonella (greater wax moth) larvae insect model has been previously used to assess C. 
jejuni infection and identify potential virulence determinants (Senior et al., 2011, Champion et al., 
2010). This model has a number of advantages since the G. mellonella larvae possess haemocytes 
which have been likened to mammalian neutrophils, which are likely to respond to C. jejuni infection 
in a similar way (Bergin et al., 2005). The G. mellonella larvae are readily available from live food shops 
and are considerably cheaper than other vertebrate models. Infection of G. mellonella is combined 
with melanisation of the larvae, and can also be incubated at 37ᵒC, which are useful properties for 
infection models. 
To further investigate the infection, and to some extent the virulence, of each of the poultry C. jejuni 
isolates showing both competent and poor biofilm phenotypes, each isolate was subjected to the G. 
mellonella infection model.  G. mellonella larvae were injected with the C. jejuni isolates at 
approximately 1×108 CFU ml −1 and incubated for 24 hours at 37ᵒC. The appearance of the G. mellonella 
larvae post incubation is depicted in Figure 3-7, which shows CJP17 and CJP19 caused the most 
melanisation. After incubation, the percentage survival and infection score consisting of the colour, 
ability to move and mortality was calculated (see Figure 3-8A and Figure 3-8B respectively). Data 
shown are averages of five biological replicates. 
Uninfected G. mellonella injected with PBS showed 100% survival as seen in Figure 3-8A. Each C. jejuni 
isolate reduced G. mellonella survival to varying degrees, with most significant reductions seen when 
infected with CJP17, CJP01 and CJP19 (p<0.01, one away ANOVA Figure 3-8A). There was no significant 
difference in G. mellonella survival between the two panels of competent and poor biofilm C. jejuni 
isolates (p>0.05, unpaired t-test). 
 The infection score (Figure 3-8B) which assesses melanisation, motility and mortality also identifies 
CJP17, CJP01 and CJP19 as having the highest infection score across the five biological replicates. 
However, similar to the survival data, no significant difference in infection scores between the 
competent and poor biofilm formers was found (p=0.945). A weak negative correlation was observed 
between the infection score and biofilm formation ability using crystal violet staining (Pearson 
correlation coefficient, r=-0.173). No correlation between the logged biofilm data and percentage G. 
mellonella survival was identified (r = 0.0825). 
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Figure 3-7: Galleria mellonella melanisation post infection. 
Example of melanisation and defecation of Galleria mellonella after being injected with C. jejuni 
and incubated for 24 hours. Columns from left to right, controls, (including PBS, un-injected 
control and NCTC 11168 C. jejuni strain), Competent biofilm formers (including CJP11, CJP12, 
CJP13, CJP17, CJP27) and poor biofilm isolates: (CJP01, CJP19, CJP21, CJP22, CJP28). Each plate 
contains 10 individual Galleria mellonella larvae which represents 10 technical replicates. Figure 
details one representative biological replicate. 
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Figure 3-8: Galleria mellonella percentage survival and infection value. 
(A) G. mellonella % survival after 24 hours post infection. Significant reductions of G. mellonella 
survival compared to the PBS control when infected with CJP17, CJP01 and CJP19 compared to 
the PBS control. Statistical analysis using one-way ANOVA followed by Tukey’s multiple 
comparisons test. *, p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001. (B) G. mellonella 
infection score representing larvae melanisation, movement and mortality 24 hours post 
infection with C. jejuni isolates. CJP17, CJP01 and CJP19 were identified as having the highest 
infections scores. Blue bars indicate competent biofilm isolates, and red checkered bars 
represent poor biofilm isolates. Black bar represents NCTC11168. 
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3.2.10 Scanning Electron Microscopy of CJP13 biofilms 
CJP13 was the chicken isolate that consistently formed the most competent biofilm across 10 biological 
replicates (section 3.2.3). This isolate was therefore used as a representative strain for a competent 
biofilm phenotype, and was taken forward for further study. Before any additional experiments were 
conducted, scanning electron microscopy (SEM) analysis was performed which allowed visualisation 
of the biofilm structure and composition.  
CJP13 biofilms were grown on polystyrene coupons, fixed and gold coated for analysis under the 
microscope (see methods 2.4.9). Images of the biofilm are shown in Figure 3-9. Figure 3-9A shows an 
image of the biofilm that has begun to come away from the glass slide creating a ridge exposing some 
spiral C. jejuni cells from underneath the top layer of coccid cells. This is shown at a higher 
magnification (x4,500) in Figure 3-9B. Figure 3-9C shows spiral and coccid cells directly on the plastic 
surface with evidence of extracellular polymeric substance (EPS) coating the cells and aiding the 
adhesion to the glass surface. Figure 3-9D shows areas of dense biofilm with complex architectural 
structure with evidence of coccid and spiral cells adhered together with EPS.  
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Figure 3-9: Scanning Electron Micrograph image of CJP13 biofilm on glass slide 
CJP13 C. jejuni biofilm grown in optimal conditions over 72 hours and fixed with glutaraldehyde. 
(A) C. jejuni biofilm at x1800 magnification, (B) a magnification of A, exposure of spiral C. jejuni 
biofilm cells at x4500 magnification, (C) presence of C. jejuni spiral and coccid cells with 
extracellular polymeric substance attached to glass surface at x12000 magnification, (D) 
complex structure of C. jejuni biofilm including coccid, spiral and EPS  at x17000 magnification. 
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3.3 Discussion 
This study focuses on biofilm formation with particular interest to its relevance in poultry processing 
plants. It was therefore essential to isolate strains currently circulating in the UK and present on 
chicken meat, (which would have survived poultry processing) in order to make the research more 
relevant. Selecting strains exhibiting competent or poor biofilm phenotypes allows isolate 
characterisation and direct comparisons to be made in a variety of different phenotypic assays 
including motility, autoagglutination, virulence, using in vitro tissue culture adhesion and invasion 
assays, and G. mellonella infection models. The C. jejuni NCTC11168 strain was incorporated into each 
of the assays as a reference, which is commonly used in the literature, and therefore provides a 
comparison to previously published works. 
Multiple C. jejuni strains were isolated from different cuts of fresh chicken meat from a variety of 
supermarket retailers. To ensure that an accurate indication of the current circulating strains on 
poultry meat was achieved, a variety of different cuts i.e. thigh and lower leg, from organic, free-range 
and regular quality meat were sampled. As expected, approximately 65% of the species isolated were 
C. jejuni, however the remaining 35% mainly consisted of C. coli, which is more common within pig 
meat products (Snelling et al., 2005). Since 80-85% of human Campylobacter infections are caused by 
C. jejuni (Moore et al., 2005), and C. jejuni is a predominant species on poultry meat, it was decided 
that the remainder of the study would specifically focus on C. jejuni biofilm formation. 
The isolates were discarded if they were not competent growers in BHI broth in microaerophilic 
conditions at 37ᵒC and 42ᵒC, as these are optimal conditions for Campylobacter growth and would be 
used as the basis of many of the subsequent characterisation assays. Although these conditions are 
optimal, it must be highlighted that they may not represent the conditions of the poultry processing 
plant. This will have to be taken into consideration when interpreting results, and deciding its relevance 
to poultry processing plant environments.  
The biofilm assay used in this study was a simple but effective method for screening the panel of 
chicken isolates for their ability to form biofilms in given conditions. This method is the most common 
assay used to quantify bacterial single and multispecies biofilms in the literature (Coffey and Anderson, 
2014, Woodward et al., 2000, Reuter et al., 2010).  
80 
 
Although the most common, this method does have limitations, and it has been suggested that crystal 
violet is not an accurate indicator of biofilm formation. The dye is not specific to bacterial cells and will 
bind to any surface molecule with a negative charge, including plastics, and other biological materials 
that are introduced to the assay (Li et al., 2003). Brown et al. (2014) reported that 2,3,5-
Triphenyltetrazolium chloride (TTC), a redox indicator producing a colour change to indicate cellular 
respiration, may be a more suitable alternative to crystal violet. However, the study incorporates 
chicken juice into C. jejuni cultures which contains precipitates that are heavily stained by crystal violet. 
Therefore, background crystal violet staining outweighs any staining representing changes in biofilm 
formation.  
Since the biofilm assays in this study only contained C. jejuni cells and basic culture media, the 
background crystal violet stain did not cause a problem when comparing biofilm formation between 
samples. Each assay included a negative control, containing no C. jejuni cells, which would provide the 
background staining OD values to which the data could be normalised. Furthermore, the nonspecific 
nature of crystal violet allows staining of not only bacterial cells, but also of the extracellular matrix 
which is a large and important component of the biofilm biomass (Turonova et al., 2016). Crystal violet 
staining therefore allows us to investigate and quantify ‘biofilm formation’, rather than focusing on 
quantifying ‘bacterial cells in a biofilm’ which the TTC would provide. To visualise what the crystal violet 
was staining, CJP13 C. jejuni biofilm samples, the most competent biofilm former, were analysed by 
scanning electron microscopy (Figure 3-9). This confirmed the presence of C. jejuni cells and 
extracellular matrix in the form of a biofilm, which validates the crystal violet OD values in representing 
biofilm formation. 
It should also be mentioned that C. jejuni forms different types of biofilm in liquid culture, including an 
attached biofilm, an unattached aggregate, known as a floc, and a pellicle, which forms at the liquid 
gas interface (Joshua et al., 2006). The crystal violet staining assay selects for biofilms that are attached 
to the wells of a 96-well plate that can withstand washing steps with PBS. Flocs or parts of the biofilm 
that are unattached are not able to be quantified using this method. 
The biofilm assay results presented in Figure 3-2 displays the varied ability for the isolates to generate 
biofilms at the conditions of the study. It should be noted that the majority of chicken isolates 
produced poor or no biofilms. Interestingly, a study by Pascoe et al. (2015) identified that the majority 
(64%, n=14) of chicken isolates were identified as poor biofilm formers, compared to the 71% (n=34) 
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of isolates that were competent biofilm formers from ‘host generalist’ (isolated from hosts of multiple 
species) C. jejuni isolates. This could suggest that, in general, the majority of chicken C. jejuni isolates 
are poor biofilm formers, but perhaps the few that are competent are able to persist in the 
environment.  
The purpose of a biofilm is to enable the survival of bacterial cells in suboptimal environments. This 
has been validated in studies showing increased C. jejuni biofilm formation in aerobic conditions 
(Reuter et al., 2010) and in media with lower nutrient availability (Reeser et al., 2007). However, this 
study reported more competent C. jejuni biofilms in BHI, which has a high nutrient content, and in 
microareophilic conditions (Appendix II). It must be noted that many of the isolates failed to grow in 
the assays performed aerobically and therefore were unable to form a biofilm. 
The biofilms in this study were assayed at two different temperatures, 42°C and 37°C to mimic both 
chicken and human body temperatures. Assays were also performed at 30ᵒC, however no growth or 
biofilm formation was observed (Appendix II). It was identified that biofilm formation was significantly 
better at 37ᵒC (Figure 3-2). A study looking into gene expression of C. jejuni at 37°C and 42°C reports 
that 20% of C. jejuni genes are either up- or downregulated in response to temperature increasing 
from 37°C to 42°C (Stintzi, 2003). Interestingly, many genes associated with motility and chemotaxis, 
which has a strong link to increased biofilm formation (Reeser et al., 2007, Dwivedi et al., 2016, 
Kalmokoff et al., 2006), were upregulated at 42ᵒC (compared to 37oC), which may appear contradicting 
to the results in this study. However, although expression of these genes in particular increased shortly 
after the temperature increase, the expression was found to return to baseline levels after 50 mins of 
incubation at 42ᵒC. 
Thus, as the assays performed in this study assess biofilm formation after 72 hours, the findings of 
Stintzi (2003) is unlikely to have an impact throughout the whole biofilm cycle, but may have influenced 
initial stages, ie attachment or colonisation of existing biofilms in the environment. Taken together, 
the fact that such a large percentage (20%) of genes in the C. jejuni genome had their expression 
altered (significantly up- or down-regulated) by a relatively small temperature change in the initial 
stages of incubation, it is not surprising this study was able to achieve significant differences in 
phenotype between the two temperatures. Biofilm formation has long been known to be a 
multifactorial process, and without further investigations it would be difficult to identify the factors 
responsible for the increased biofilm formation at 37ᵒC. The genetic association of C. jejuni biofilm 
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formation will be discussed in detail in Chapters 4 and 5. Consequent biofilm experiments were 
performed at 37ᵒC, as it was the temperature that generated the best biofilms. 
The biofilm data generated was highly variable, represented by the large error bars in Figure 3-2, which 
made statistical analysis difficult. A ranking analysis (see Methods section 2.4.2.1) identified the 
isolates which were consistently the most competent biofilm formers; CJP11, CJP12, CJP13, CJP17, 
CJP27, and the poorest; CJP01, CJP19, CJP21, CJP22, CJP28. One particular isolate, CJP13, was the most 
competent biofilm former, second only to the NCTC11168 strain at 37°C (Figure 3-2). Due to its 
particularly strong biofilm phenotype, it was used as an example of C. jejuni biofilm to be subjected to 
genetic manipulation, detailed in Chapter 4.  
As with many other bacterial pathogens, the emergence of antibiotic resistance in C. jejuni is 
increasing, particularly to fluoroquinolones (Luangtongkum et al., 2009) such as ciprofloxacin, and 
Macrolides such as erythromycin. Both of these antibiotics are used readily to treat Campylobacter 
infections in humans (Gibreel et al., 2005, Kovac et al., 2015). 
The antibiogram of poultry isolates in Table 3-1 shows a large variation in antibiotic resistance profiles, 
indicating diverse genomes. More than half (59.4%) of the isolates were resistant to tetracycline and 
50% were resistant to ciprofloxacin. Resistance was lower with naladixic acid (37.5%), erythromycin 
(30%) and gentamicin (12.5%).  
Antibiotic resistance trends in C. jejuni and C. coli isolated from UK chicken meat in 2001 and 2004-5 
were published in a recent study by Wimalarathna et al. (2013). The study, sampling 576 C. jejuni 
strains isolated between 2004 and 2005, reported the highest percentage resistance for tetracycline 
and quinolones, including naladixic acid and ciprofloxacin. Lower resistance was observed for 
erythromycin, and aminoglycosides, including gentamicin. These findings correlate with the results 
presented in this study, which indicates that the CJP isolates CJP1 - CJP30, despite the small sample 
size, show a good representation of resistance profiles to isolates on chicken meat throughout the UK.   
Many genes responsible for antibiotic resistance are carried on plasmids, for example tetO which is 
common in the pTet plasmid in C. jejuni (Taylor, 1986) and pCC31 on C. coli (Batchelor et al., 2004). In 
addition, much of Campylobacter aminoglycoside resistance is plasmid borne, and genes known to 
confer kanamycin resistance such as aphA-1 have also been detected in plasmids from C. jejuni 
(Ouellette et al., 1987). Plasmid mediated resistance transmission in a C. jejuni population is possible 
83 
 
via conjugation, and it is probably the most common transmission mechanism for tetracycline 
resistance (Luangtongkum et al., 2009). In contrast, natural transformation is more common for 
transmission of chromosomally encoded resistance including fluoroquinolones and macrolides. 
Campylobacter species are naturally competent; they are able to acquire free DNA from the 
environment, which may encode resistance genes, or genes that encode enzymes that can modify 
antibiotics making them ineffective, such as aph which inactivates gentamycin (Zhao et al., 2015).  
The multiple mechanisms of horizontal gene transfer and the natural competency of Campylobacter 
can be exacerbated, especially in densely populated environments such as biofilms, where the close 
proximity of cells can allow for easy transference of resistance. In fact, studies have shown that C. 
jejuni is able to transfer and acquire antibiotic resistance genes via natural transformation, such as 
kanamycin and chloramphenicol, more frequently when in a biofilm compared to planktonic 
counterparts (Bae et al., 2014). Biofilms in the environment are almost always composed of multiple 
species, which will allow resistance to pass from one species to another, although horizontal gene 
transfer is most successful between intraspecies populations (Gibreel et al., 2004). Moreover, 
Campylobacter strains harbouring additional resistance genes may not show a fitness burden, and in 
some cases can outcompete non-resistant wild type strains (Luo et al., 2005), enabling the resistant 
Campylobacter to survive in a biofilm, and proliferate in more favourable conditions. 
More specifically for Campylobacter, recent publications have shown that not only is extracellular DNA 
a large component of the C. jejuni biofilm, but exogenously added DNA is able to be utilised in the 
biofilm environment to adopt resistance (Brown et al., 2015b, Brown et al., 2015a). There is no 
correlation between the resistance profiles and the biofilm capability of the isolates in this study (r=-
0.225), however it could be argued that the more competent biofilm formers, for example CJP13, that 
is resistant to tetracycline, is more likely to transfer its resistance in a biofilm environment than other 
isolates. A multidrug resistant isolate with a strong biofilm phenotype may be more efficient at 
transferring antibiotic resistance through a population. Taken together, this study reports various 
levels of antibiotic resistance between isolates.  
MLST is the gold standard strain typing method for Campylobacter species. The sequencing of seven 
housekeeping genes has allowed easy comparisons to be made, and large online databases to 
accumulate, such as pubMLST, which can determine known sequence types or identify new ones. It is 
therefore possible to identify particular ST’s and CC’s to specific hosts, environments or niches. For 
84 
 
example, ST-42 and ST-61 has been attributed to ovine, ST-45 to poultry (Colles et al., 2003) and ST-
3704 to bank vole Campylobacter isolates (Williams et al., 2010). 
C. jejuni chicken isolates CJP03, CJP22 and CJP26 in this study had novel MLST allele combinations and 
therefore were not assigned to a lineage after submission to pubMLST. The remaining isolates were 
grouped into 13 different sequence types (STs) and 10 clonal complexes (CCs). Five out of the 10 CCs 
isolated (ST-21, ST- 464, ST574, ST-573 and ST-48) have also been identified in a 2016 study looking at 
the genetic diversity of C. jejuni and C. coli in broiler flocks in the UK (Vidal et al., 2016). ST-573 was 
identified as the most prevalent and ST-464 was the fourth most prevalent ST of 645 isolates, and were 
isolated repeatedly in this study. In addition, the study by Pascoe et al. (2015) investigating biofilm 
formation in genetically diverse lineages, use eight different ST chicken isolates, five of which have 
been isolated and incorporated into this study. This, once again, indicates that the panel of strains 
CJP1-CJP30 is a good representation of the numerous STs circulating in poultry. 
Interestingly, Pascoe et al. (2015) reports that biofilm formation was not equally distributed across 
Campylobacter lineages, implying that biofilm formation is not attributed to the ST of the isolate. 
Variation in biofilm formation is apparent between and within STs and a complex accessory genome is 
probably responsible for the phenotype (Pascoe et al., 2015). Taken together, the identification of the 
chicken isolate MLST profiles in this study has ensured we have a relevant and accurate representation 
of multiple circulating poultry STs, with large genetic diversity which will be discussed and further 
characterised in later chapters. 
Motility has been linked to biofilm formation in many different bacterial species (Lemon et al., 2007, 
O'Toole and Kolter, 1998, Gonzalez Barrios et al., 2006) including Campylobacter (Joshua et al., 2006, 
Reuter et al., 2010, Kalmokoff et al., 2006). In addition to motility, the lack of flagella structure using 
flaA and flaB aflagellate mutants show a decreased ability to form biofilms in C. jejuni NCTC11168 
(Reuter et al., 2010). 
All isolates in this study were motile, however the motility varied largely between isolates (Figure 
3-4A). A weak negative correlation between motility and biofilm formation was calculated (Pearson’s 
correlation coefficient r = -0.0683) (Figure 3-4B). These results imply that the observed biofilm 
phenotype is not attributed solely to motility. Studies have shown that aflagellate mutants are able to 
produce biofilms under aerobic conditions which supports the idea that flagella (and motility) are not 
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essential for biofilm production in C. jejuni, although may aid specific phases of biofilm formation such 
as initial attachment (Reuter et al., 2010). Moreover, Svensson et al. (2014) reported that flagella aid 
the initial attachment of C. jejuni to abiotic surfaces, whereas motility facilitates biofilm formation. 
CJP13, the most competent biofilm former, is not however the most motile, which again highlights the 
likelihood of motility- dependent and independent mechanisms of biofilm formation in C. jejuni. 
Autoagglutination, which can be described as clumping of cells, in C. jejuni has been linked to changes 
in flagella glycosylation (Guerry et al., 2006) and, similar to biofilm formation, is dependent on quorum 
sensing (Jeon et al., 2003). In addition, flagella glycosylation mutants have reduced autoagglutination 
and biofilm formation ability (Howard et al., 2009, Reuter et al., 2010). The attachment of bacteria by 
this agglutination mechanism may be an important process in the development of a biofilm (Reuter et 
al., 2015).  
Autoagglutination was investigated on the panel of 10 chicken isolates including five competent 
(CJP11, CJP12, CJP13, CJP17, CJP27) and five poor (CJP01, CJP19, CJP21, CJP22, CJP28) biofilm isolates. 
Autoagglutination was shown to vary largely between isolates. In addition, a weak correlation to 
biofilm formation was observed (Figure 3-5). There was no significant difference in autoagglutination 
between the panel of competent and poor biofilm isolates, or to the motility of each isolate (unpaired 
t-test, p>0.05). This goes against the findings by Reuter et al. (2010) where non motile mutants were 
linked with reduced biofilm formation and reduced autoagglutination. Results obtained in this study 
may not correlate with published literature due to the small sample size, but also the interpretation of 
competent and poor biofilm formation that is not consistent throughout the literature. It should also 
be noted that much of the literature investigating autoagglutination in C. jejuni compare phenotypes 
between mutant and wild type strains, and not between multiple wild type isolates (Golden and 
Acheson, 2002, Nguyen et al., 2013). The results here reinforce the concept of multiple mechanisms 
involved in biofilm formation. 
Competent biofilm isolates are able to adhere to abiotic surfaces, as seen by isolates CJP11, CJP12, 
CJP13, CJP17 and CJP27 identified in this chapter (Figure 3-2), which were able to withstand washing 
steps in the biofilm assay. These isolates may also use the same mechanisms for attachment to human 
intestinal epithelial cells. Moreover, known virulence factors such as flagella and other adhesins such 
as cadF have also been linked to biofilm formation in C. jejuni (Reuter et al., 2010, Sulaeman et al., 
2012).  The 10 C. jejuni isolates identified as the most competent and poorest biofilm formers were 
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therefore subjected to adhesion and invasion assays using Caco2 cells to investigate a possible link 
between biofilm formation capability and virulence. 
Similar to the other phenotypic experiments in this chapter, large variation was observed between 
isolates in their ability to adhere and invade Caco2 cells, with CJP19, a poor biofilm former, providing 
the most efficient adhesion and invasion results (Figure 3-6A and B). When compared to biofilm 
formation ability, both adhesion and invasion showed slight negative correlations (r= -0.246 for 
adhesion and r=-0.289 for invasion). There was also no significant difference between the two groups 
of isolates for either adhesion or invasion (p>0.05, unpaired t-test, Figure 3-6A and B). Lack of 
correlation and significance implies that, in this study, C. jejuni possess distinct mechanisms for both 
attachment and invasion of the epithelial cell, and attachment and biofilm formation on abiotic 
surfaces.  
Adhesion to intestinal epithelial cells is mediated by a number of adhesion proteins such as CadF 
(Konkel et al., 1997), CapA (Ashgar et al., 2007), the Peb binding proteins (Pei and Blaser, 1993, Kale et 
al., 2011) and FlpA (Flanagan et al., 2009). Invasion is mediated through flagella proteins including 
FlhA, FlhB, FliO, FliP, FliQ and FliR which are components of the type-3 secretion system (Carrillo et al., 
2004). CadF has been shown to be linked to adhesion to abiotic surfaces (Sulaeman et al., 2012), and 
Peb1 and Peb4 are overexpressed in biofilm cells indicating both these important adhesins have an 
involvement in the biofilm process. In addition, flagella and motility are responsible for biofilm 
formation and invasion into intestinal epithelial cells, which does not correlate to the data reported 
here. Given that many of the factors involved with adhesion and invasion of human intestinal epithelial 
cells are also involved with biofilm formation in C. jejuni, it would be logical to assume that more 
virulent isolates (determined virulent by their ability to adhere or invade to Caco-2 cells) would be 
more competent biofilm formers. It is not currently clear why the correlation between the Caco-2 
virulence assays and biofilm formation is not greater than that reported in this study. 
The G. mellonella infection model has been a useful tool in identifying virulence genes (Champion et 
al., 2010) and identifying virulence trends in C. jejuni (Champion et al., 2010). Since there was negative 
correlation between biofilm formation and virulence in adhesion and invasion assays (r=-0.245 for 
adhesion and r=-0.289 for invasion), the same panel of isolates were injected in the G. mellonella to 
further assess virulence trends. The G. mellonella was first assessed by percentage survival, as per the 
method published in the literature (Figure 3-8A). Here, CJP17, CJP01 and CJP19 caused the most 
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mortality showing significant reduction in G. mellonella survival compared to PBS controls. Secondly, 
G. mellonella were given an infection score which included the movement and colour change of the 
individual larvae as well at mortality (Figure 3-8B). Although some of the isolates did not kill the larvae, 
they were severely melanised and unable to move, which implies that the isolate is somewhat virulent. 
This was particularly evident for CJP12 which caused strong melanisation, but did not kill the larvae. 
Weak or negative correlation was observed between biofilm formation and G. mellonella percentage 
survival or infection score (r= 0.082 for percentage survival and r=-0.173 for infection score). 
Interestingly, there was a stronger positive correlation between G. mellonella infection score and 
isolate adhesion and invasion (Pearsons correlation coefficient r = 0.740 and 0.406, respectively). This 
gives confidence that the G. mellonella infection model, using the individual infection scores is 
comparable to conventional cell culture virulence assays.  
However, the ‘virulence’ determined by adhesion, invasion and G. mellonella assays did not correlate 
with the isolates’ ability to form biofilms. However, an isolates’ virulence does not dictate its 
importance to human health. Biofilm capability and therefore a strain’s ability to survive in the 
environment in large numbers poses a larger contamination risk in poultry processing plants, which 
can lead to increased incidence of human infection. 
As mentioned, CJP13, the chicken isolate that produced the best biofilm, was selected for Scanning 
Electron Microscopy analysis. This was to firstly verify that the crystal violet was staining a biofilm 
consisting of C. jejuni cells and extracellular matrix, but to also examine the structure of the biofilm, 
best seen in Figure 3-9D. The appearance and structure of the CJP13 biofilm is almost identical to the 
Scanning Electron Microscopy images of C. jejuni attached, or aggregate biofilms in Joshua et al. (2006) 
with flattened and extensive extracellular matrix. The Scanning Electron Microscopy revealed a 
complex structure of biofilm formation which may have been nearing dispersal phase. The C. jejuni 
cells are visibly well protected by layers of extra cellular matrix, which reminds us why biofilms are 
more resistant and persistent than planktonic counterparts.  
In summary, the CJP isolates 1-30 represent well the antibiotic resistance trends and STs of chicken 
isolates in circulation. Each isolate has been characterised in its ability to form a biofilm, and a panel 
of poor and competent biofilm formers were identified as representatives of each phenotype. Isolates 
were characterised by motility, autoagglutination and virulence, with the best biofilm former being 
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subjected to Scanning Electron Microscopy analysis. This study failed to find a strong correlation 
between biofilm formation and virulence by way of adhesion and invasion cell culture assays and G. 
mellonella infection models. However, the panel of 10 isolates (5 poor, 5 competent biofilm producers) 
were taken forward and form the basis of genomic analysis in Chapter 4. 
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4 Identification of genes influencing biofilm formation using a 
transposon mutagenesis approach  
4.1 Introduction 
The most common genetic association with biofilm formation in Campylobacter, and other bacterial 
pathogens, are the genes encoding proteins that make up the flagella and/or responsible for motility. 
This includes the two main flagellin proteins FlaA and FlaB, with FlaAB mutants showing a reduced 
ability to form C. jejuni biofilms on glass (Reeser et al., 2007). Correct flagella assembly involves 
numerous proteins, many of which have been linked to biofilm formation. Joshua et al. (2006) reported 
a lack of attachment and biofilm formation in mutants of Cj1337, involved with flagella modification, 
and fliS, for flagella assembly. Kalmokoff et al. (2006) investigated protein expression in C. jejuni biofilm 
cells compared to stationary phase planktonic cells, which revealed that a number of flagella and 
chemotaxis proteins showed higher levels of expression when in the biofilm phenotype.  
It is also suggested that genes such as peb1A and peb4 (Asakura et al., 2007), capA (Ashgar et al., 2007), 
jlpA (Jin et al., 2001), ciaC (Christensen et al., 2009) and cadF (Konkel et al., 1999a), which encode 
proteins involved in attachment and invasion to host cells, may also play a role in biofilm formation in 
Campylobacter. 
Transposon mutagenesis is a method for rapidly generating a large pool of mutants (often by 
interrupting every gene in the genome), which can be systematically screened for specific gene 
influencers on a particular phenotype. There are many examples of C. jejuni transposon mutant 
libraries that have been screened for motility and autoagglutination (Golden and Acheson, 2002), 
energy taxis system (Hendrixson et al., 2001), invasion (Javed et al., 2010), cell shape (Esson et al., 
2017), and gene essentiality (Stahl and Stintzi, 2015). However, until recently, there has not been an 
extensive screen of transposon mutant libraries in chicken strains for their ability in biofilm formation 
(Teh et al., 2017).  
As discussed in Chapter 3, CJP13 was the chicken isolate that displayed the best biofilm phenotype in 
this study. Many studies report the use of the NCTC11168 strain for phenotypic experiments and 
genetic manipulation. However the NCTC11168 strain may not represent strain specific factors or 
mechanisms utilised by isolates from chicken hosts. This is supported by the results presented in 
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Chapter 5, where NCTC11168 displays great genomic variation to poultry isolates (discussed in detail, 
Chapter 5). Since this study is focused on biofilm formation in poultry processing plants, CJP13, being 
the most competent biofilm former, was selected as the representative/reference strain for assessing 
mutations that influence biofilm production in chicken isolate strains. Thus, CJP13 was subjected to 
transposon mutagenesis, revealing novel genes associated with biofilm formation, which are detailed 
in this chapter. 
The aims of the work detailed in this chapter were: 
 To perform transposon mutagenesis on isolate CJP13 and generate a picked transposon 
mutant library. 
 To screen the CJP13 transposon mutant library through an in vitro biofilm assay. 
 To identify mutants that cause a significant reduction in biofilm formation compared to the 
wild type strain. 
 To construct individual knock out mutants and genetic complements for genes identified to be 
‘novel influencers’ of biofilm formation through literature searches, and to assess changes in 
biofilm phenotype. 
4.2 Results 
As discussed in Chapter 3, CJP13, the most competent biofilm former of the chicken isolates used in 
this study, was selected for further investigation. Here, using the methods developed by Andrew Grant 
at the University of Cambridge, a transposon mutant library of CJP13 was created (see Methods section 
2.5 and detailed in de Vries et al. (2017)). Briefly, a Himar1-C9 transposase was used to slice a mariner 
transposon element, containing the Himar1 mariner transposon and chloramphenicol resistance gene, 
into the genomic DNA of CJP13 at TA-dinucleotide sites. The transposon mutant DNA was naturally 
transformed into wild type CJP13, and mutants accepting the transposon insertions were selected for 
by media supplemented with chloramphenicol. Approximately 3,000 transposon mutant colonies were 
picked and stored separately in 96-well plates, with each well containing one transposon mutant. 
There are circa 337,998 TA-dinucleotide sites in the 1,726,966bp CJP13 genome, approximating to a 
transposon insertion site every 5.1 bp. Thus, in theory, transposons are able to insert into, and disrupt, 
every gene in the genome. Moreover, the CJP13 genome contains 1,814 coding regions (Table 5.1, 
Chapter 5, discussed in detail), therefore probability suggests that 3,000 individual transposon mutants 
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should account for transposon interruptions in all genes non-essential for survival in the given growth 
conditions.  Here, 3,000 individual picked mutants were screened for their ability to 1) grow, and 2) 
form biofilms with the aim of identifying novel genes associated with biofilm formation in CJP13.  
4.2.1 Screening of the CJP13 transposon mutant library to determine mutants displaying reduced 
biofilm phenotype. 
Transposon mutants were grown and screened in the biofilm assay as described in section 2.6. After 
incubation for 72 hours at 37ᵒC in microaerophilic conditions (optimal for biofilm formation, see Figure 
9-1, Appendix II), each mutant had an OD600 reading taken to represent the growth, and subsequently 
biofilm formation (OD540), post crystal violet staining. This was to determine the proportion of mutants 
which had successfully grown, and to eliminate the inclusion of false negatives in analysis, i.e. a 
reduction of biofilm formation due to lack of growth. The mutant library screen was repeated in 
duplicate; a heat map of two averaged biological replicates showing growth and biofilm OD values are 
represented in Figure 4-1. 
The heat map clearly defines the mutants which grew as opposed to the mutants that did not (growth 
OD<0.1), indicated by the first three columns of mutants labelled on the left of the heat map. 
Approximately 30.4% of the mutants did not grow across two replicates. This is well represented in the 
biofilm section of the heat map, with little purple staining visible (crystal violet OD< 0.5). 
Despite the lack of correlation between endpoint growth OD and biofilm OD with individual CJP isolates 
(section 613.2.3 and Figure 9-2 Appendix II), biofilm production of transposon mutants shows a gradual 
increase of colour intensity as growth endpoint OD increases, indicating that biofilm formation is 
somewhat dictated by the volume of cells present in the well which are available for incorporation into 
the biofilm. The Scatter graph depicted in Figure 4-2 illustrates the strong relationship between growth 
and biofilm formation (of mutants that show growth, i.e. OD600>0.1), with Pearsons correlation and 
linear regression (r=0.8428 and R2 =0.3319, respectively). Arrows in Figure 4-1 indicate individual 
transposon mutants that were competent growers, with reduced ability to form a biofilm. 
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Figure 4-1: Heat map of transposon mutant growth and corresponding biofilm 
formation. 
Approximately 3,000 transposon mutants grown in 96-well plates and assayed for their ability 
to form biofilms in duplicate. Averaged OD600 readings representing growth of each mutant, 
indicated by the brown colour and OD540 reading for biofilm formation) post crystal violet 
staining, indicated by the purple colour, are represented here. The intensity of the colours 
represent the OD values of each reading as indicated by the colour key, the darker shades 
indicating the highest OD values i.e. most competent growers (brown), or competent biofilm 
formers (purple). Mutant growth and biofilm data was ranked in order of growth OD, indicated 
by the gradual increase of brown intensity from left to right. A similar gradient was observed for 
crystal violet staining, but to a lesser degree. Arrows indicate transposon mutants which present 
competent growth, with reduced ability to form a biofilm. 
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Figure 4-2: Transposon mutant relationship between growth and biofilm formation. 
The growth of each mutant after 72 hours incubation at 37ᵒC in microaerophilic conditions 
(OD600) plotted against the individual mutant’s ability to form biofilms measured by crystal 
violet staining (OD540). Each graph data point represents the averaged values of two biological 
replicates. Linear regression and Pearson’s correlation coefficient analysis shows a strong 
positive relationship between growth and biofilm formation (R2 =0.3319, r=0.8428). Only 
mutants displaying growth (OD600>0.1) were included in this figure/analysis. 
 
4.2.2 Selection of transposon mutants for further study 
A positive relationship between growth and biofilm formation was observed. ‘Interesting’ transposon 
mutants that showed a significant increase/decrease in biofilm formation, could not be simply selected 
based on their ability to form biofilms (i.e. the Crystal violet assay). Thus, a data analysis approach that 
takes growth in to account was developed. Here, mutants were stratified by growth OD, ranging from 
0.1 to 0.25 OD in 0.01OD intervals. Once grouped, ‘interesting’ mutants, those that exhibit a 
significantly different biofilm OD than their peers (mutants with similar growth ODs), could be 
identified by calculating Z-values. A Z-value, was determined for each mutant by the equation below, 
where z= Z-value, x= the individual biofilm OD of a single mutant, µ = the mean biofilm OD across all 
mutants comprising the same growth OD stratification, and SEM = biofilm standard error of the mean 
(SEM). 
𝑧 =
𝑥 − 𝜇
𝑆𝐸𝑀
 
Essentially, the Z-value is a measure of how different a mutant’s biofilm OD is compared to the mean 
(expected) OD of the stratification, in units of standard deviations; the more extreme the positive or 
negative Z-value, the larger the difference in biofilm OD. Using the Z-value distribution, and the 
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degrees of freedom associated with the given growth OD stratification, each Z-value was transformed 
in to a p-value, representing the probability of the observed difference in biofilm OD under the null 
hypothesis that there is no difference between biofilm ODs of mutants in the same stratification. 
Subsequently, the mutants for both biological replicates of the library screen could be ranked in order 
of p-value. The mutants with the lowest p-value for both replicates were selected for further study. 
4.2.3 Confirmation of transposon mutant reduction of biofilm phenotype 
Twelve transposon mutants that showed reduced ability to form biofilms were selected. These were 
screened in the biofilm assay to confirm the reduced phenotype using adjusted starting inocula, rather 
than stab inoculation (used in the library screen). The results of this assay, as shown in Figure 4-3, 
confirmed that although biofilms were still formed by each mutant, all displayed a significantly reduced 
ability to form biofilms compared to the wild type strain CJP13 over three biological replicates. 
 
Figure 4-3: Biofilm assay of selected transposon mutants exhibiting reduced biofilm 
formation. 
Bar chart illustrating biofilm assay results for 12 transposon mutants showing significantly 
reduced biofilm formation, the wild type strain CJP13, NCTC11168 and CJP01, a chicken C. jejuni 
isolate displaying a poor biofilm phenotype used as a negative control. The biofilm assay was 
performed in triplicate, with each biological replicate consisting of five technical replicates. All 
transposon mutants showed a significantly reduced ability to form biofilms compared to the 
wild type CJP13 isolate using a one-way ANOVA followed by Tukey’s multiple comparisons test. 
(*, p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001).  
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4.2.4 Linker PCR to identify targets 
Following this successful validation of reduced biofilm phenotype, the genomic DNA of each of the 
selected transposon mutants was extracted, digested with RsaI and ligated with an oligo-pair linker. 
Linker PCR was performed using primers Cat15, complementary to the cat cassette (located in the 
transposable element), and the oligo 258, complementary to the linker. The amplified product, when 
sequenced by Sanger sequencing, revealed the location of the transposon. 
4.2.4.1 Results of linker PCR revealing the transposon insertion site in CJP13 
The genes disrupted by the transposon in each mutant are listed in Table 4-1. Figure 4-4 and Figure 
4-5 show the exact insertion site of each transposon. Two of the identified genes, trbJ, encoding a 
conjugative transfer protein, and rha, a phage gene, are not present in the NCTC11168 genome, but 
have been identified in a pCC42-like plasmid present in CJP13 (Figure 4-5). This will be discussed in 
detail in Chapter 5.  
Linker PCR also revealed genes associated with flagella and chemotaxis, which are established factors 
in biofilm formation across numerous bacterial species (Guttenplan and Kearns, 2013a, Dwivedi et al., 
2016). Putative membrane protein genes such as Cj0080 and Cj1623 (named herein ‘memP’ in this 
study) were also detected. These genes are uncharacterised in C. jejuni, therefore it is unknown if they 
are periplasmic or surface exposed, which may aid the initial attachment of CJP13 on abiotic surfaces 
in early stages of biofilm formation. 
The library screen also highlighted a number of genes involved in C. jejuni metabolism such as hydA, a 
nickel/iron hydrogenase subunit, hisF, an imidazole glycerol phosphate synthase subunit and nuoM, a 
NAD-H quinone oxidoreductase.  
The rpsB 30S ribosomal subunit gene was also identified as affecting biofilm formation. However, the 
inactivation of this protein subunit is more likely to affect the synthesis of numerous proteins linked 
to normal cell function, rather than specifically biofilm formation in CJP13.  
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No. 
mutant 
Transposon 
mutant ref no. 
(plate 
no._well) 
11168 
gene ID 
Gene 
name 
Function 
1 5_D3 
Cj0079c & 
Cj0080 
cdtA & 
Cj0080 
cytolethal distending toxin subunit A & 
putative membrane protein 
2 5_F6 
Cj1266c & 
Cj1267c 
hydB & 
hydA 
quinone-reactive Ni/Fe-hydrogenase large 
& small subunit 
3 11_C9 Cj0548 fliD flagellar hook-associated protein 
4 14_C8 - trbJ Conjugative transfer protein 
5 15_C12 Cj1310c Cj1310 hypothetical protein 
6 15_D11 Cj1314c hisF 
imidazole glycerol phosphate synthase 
subunit 
7 15_E11 Cj0448c Cj0448c MCP-type signal transduction protein 
8 18_C7 
Cj0064c  
&Cj0065c 
flhF & 
folK 
flagellar biosynthesis protein & 2-amino-4-
hydroxy-6-hydroxymethyldihydropteridine 
diphosphokinase 
9 18_D11 - rha Phage Rha protein 
10 23_F1 Cj1182c rpsB small subunit 30S ribosomal protein S2 
11 27_A4 Cj1567c nuoM NADH-quinone oxidoreductase subunit M 
12 27_D11 Cj1623 
Cj1623 
(memP) 
putative membrane protein 
 
Table 4-1: Identification of transposon mutants with reduced ability to form 
biofilms. 
Table listing the 12 genes that showed reduced biofilm formation when interrupted in CJP13 
mutant library screens, identified by linker PCR. Each mutant is given a corresponding 
NCTC11168 gene identification number (if applicable), the gene name, and function. trbJ and 
rha are not present in the NCTC11168 genome, therefore no gene number could be assigned. 
Identification and annotation of these genes were identified through BLASTn searches in the 
CJP13 genome, annotated by ‘Rapid Annotation using System Technology’ (RAST) server, 
(http://rast.nmpdr.org/), detailed in Chapter 5. 
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Figure 4-4: Transposon insertion sites in genes associated with biofilm formation in 
CJP13. 
Twelve transposon mutants with decreased ability to form biofilms were identified using linker 
PCR. The transposon insertion sites are depicted by red arrows. Genes in the clockwise 
orientation are coloured in light blue, counter clockwise in dark blue, pseudogenes in red, and 
RNA in purple. Images adapted from ecogene.org using the NCTC11168 genome as a template. 
NCTC11168 gene order in these examples match CJP13 sequence and orientation. 
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Figure 4-5: Transposon insertion sites in genes present on a pCC42-like plasmid 
present in CJP13. 
Two transposon insertion sites identified by linker PCR were not present in the NCTC11168 
strain, or in the genomic DNA of CJP13. These sites were located in genes trbJ and rha, found 
in a pCC42-like plasmid found to be present in the CJP13 isolate. Image generated by RAST, 
(http://rast.nmpdr.org/). 
 
4.2.5 Selected gene targets for knock out mutant construction 
The 12 transposon mutants identified by linker PCR are all candidates for further study. However 
putative membrane proteins Cj0080 and memP (Cj1623) have not been characterised in C. jejuni, and 
if surface exposed, could elucidate novel mechanisms utilised by CJP13, and indeed other C. jejuni 
strains, for biofilm formation. These two genes were therefore selected to be knocked out of the wild 
type CJP13 and NCTC11168 genome completely. 
The metabolic mechanisms involved in biofilm formation are not well characterised, and hydA has 
been previously linked with attachment and colonisation (Hong et al., 2014). hydA was therefore also 
chosen for further study.  
TrbJ, a conjugal transfer protein, is located in a plasmid present in the CJP13 genome. Trb genes are 
involved in type IV secretion systems (T4SS), but it is not clear what role these genes play in biofilm 
formation. trbJ was therefore also selected for further study.  
4.2.6 Individual mutant construction 
The selected genes memP, hydA, Cj0080 and trbJ were used as targets for individual gene knock out 
mutants using a series of cloning and overlapping extension PCR (OE-PCR) methods.  
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The nature of the transposon mutagenesis means that the transposon can be inserted at any TA-
dinucleotide site in the genome, and effects gene function by interruption. This suggests that a 
transposon could be inserted at the end of the gene, and that the expressed protein, albeit truncated, 
may still be functional. To properly monitor the effect of the gene of interest and its involvement with 
biofilm formation, individual knock out mutants were made to eliminate the gene (and possibility of 
functional protein) completely.  
4.2.7 Overlapping extension PCR (OE-PCR) for mutant construction 
OE-PCR is a powerful genetic method that can enable rapid construction of knock out mutants. 
(Heckman and Pease, 2007). 
The method of OE-PCR is summarised in Figure 4-6 and was used for the construction of ΔCj0080, 
ΔhydA and ΔtrbJ mutants. As explained in method section 2.8.1, three primer pairs are designed 
specifically to target the genes of interest, but also contain complementary regions allowing amplicons 
to anneal together, forming the mutant contract. Briefly, the P1 and P2 primers amplify the upstream, 
and P3 and P4 primers amplify the downstream regions of the gene of interest (i.e. Cj0080, hydA and 
trbJ), using wild type NCTC11168 or CJP13 DNA as template. C1 and C2 primers are used to amplify the 
chloramphenicol (cat) cassette from a pAV103 donor plasmid. The 5’ ends of P2 and P3 possess 
complementary regions to the 5’ ends of C1 and C2, respectively, which allow the three products to  
anneal. Short PCR cycles allow amplification of the whole mutant construct. This method allows 
replacement of the gene of interest with the cat cassette which can be used for selection. The stages 
of individual mutant construction using OE-PCR are detailed below. 
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Figure 4-6: OE-PCR methodology. 
Figure taken from Hansen et al. (2007) explaining the theory of the OE-PCR. Briefly, upstream and 
downstream flanks of the gene of interest (gene x) is amplified using P1, P2, P3 and P4 according 
to the figure. The 5’ region of the P2 primer and the 5’ region of the P3 primer are complementary 
to the C1 and C2 primers, respectively, which amplify a cat resistance cassette from a separate 
plasmid. Complementary regions, depicted by black regions, are allowed to anneal, and PCR 
extension using P5 and P6 amplifies the mutant construct. 
 
4.2.7.1 OE-PCR for ΔCj0080 construction 
Cj0080, encoding a putative membrane protein in C. jejuni, was the gene target for the first mutant 
using the OE-PCR method. Briefly, the upstream and downstream regions (labelled flanks one and two, 
or F1 and F2 in Figure 4-7 and beyond) were amplified from NCTC11168 and CJP13 genomic DNA, using 
Cj0090_P1 and Cj0080_P2 for F1, and Cj0080_P3 and Cj0080_P4 for F2. The cat cassette was amplified 
from pAV103 using C1 and C2 primers as depicted in Figure 4-7. These generated F1 of 489bp, F2 of 
302bp and cat of 798bp. 
The F1, F2 and cat products were annealed together and amplified using the Cj0080_P1 and Cj0080_P4 
primers generating a 1589bp product as shown in Figure 4-8. This product was purified and 
electroporated into either CJP13 or NCTC11168, depending on the template of the original 
amplification of flanks. The mutant construct was inserted into the C. jejuni genomes via homologous 
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recombination, and successful mutants were selected using bBHI media supplemented with 
chloramphenicol (10 µg/ml). 
Colonies of NCTC11168 and CJP13 that grew on selective media were screened by colony PCR using 
primers Cj0080_P1 and CC069, the latter being complementary to the chloramphenicol cassette. The 
PCR products from three colonies of each mutant strain are shown in Figure 4-9. Presence of a PCR 
product indicates that the cat cassette is present, and the 699bp size indicates that the cat cassette 
has been inserted into the correct location in the genome. Wild type CJP13 and NCTC11168 genomic 
DNA was used as a negative control showing no amplification since there is no cat cassette naturally 
occurring in the genomes.  
The mutants construct was amplified again using Cj0080_P1 and Cj0080_P4, which was sent for Sanger 
sequencing and which confirmed the correct location of insertion. The sequence of the mutant 
construct is presented in Appendix III. Finally, the genomic DNA was extracted from the 11168_ 
ΔCj0080 and CJP13_ΔCj0080 mutants and used in a natural transformation of the wild type NCTC11168 
and CJP13 cultures to produce mutants, and reduce the chance of secondary site mutations.  
 
Figure 4-7: Amplification of flanks 1, 2 and cat cassette for Δcj0080 construction. 
Agarose gel electrophoresis demonstrating amplification of flanks 1 and 2 (F1 and F2, upstream 
and downstream respectively) of Cj0080, and cat cassette. Lane 1, 1kb ladder (Promega). 
Amplification of F1 (489bp, lanes 2 and 3), using primers cj0080_P1 and cj0080_P2, and F2 
(302bp, lanes 4 and 5), using primers cj0080_P3 and cj0080_P4 as per method in Table 2-7. 
NCTC11168 and CJP13 genomic DNA was used as template for both amplifications as indicated. 
Amplification of cat using C1 and C2 primers using the pAV103 plasmid as template (lane 6). 
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Figure 4-8: OE-PCR for Δcj0080 construction. 
Agarose gel electrophoresis demonstrating amplification of OE-PCR products using annealed 
F1, F2 and Cat products from Figure 4-7 using primers cj0080_P1 and cj0080_P4 as described 
in section 2.8.1. Product shows size of 1589bp using flanks from NCTC11168 (lane 2) and CJP13 
(lane 3) genomic DNA. 
 
 
 
Figure 4-9: Colony PCR of Δcj0080 electroporation transformants. 
Agarose gel electrophoresis demonstrating amplification of mutant construct using 
transformant colonies from the NCTC11168 (lanes 2-4) and CJP13 (lanes 5-7) electroporation 
were used in colony PCR with primers cj0080_P1 and CC069 (internal cat primer). Amplification 
of a product determines successful mutant construct insertion into the genome. Products show 
the correct size of 699bp. Wild type genomic NCTC11168 DNA was used as a negative control, 
showing no product. 
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4.2.7.2 OE-PCR for ΔhydA construction 
The ΔhydA mutant was constructed using identical methods explained in Section 4.2.7.1 for ΔCj0080. 
Briefly, the F1 and F2 flanks were amplified using primers hydA_P1 and hydA_P2, and hydA_P3 and 
hydA_P4 respectively. C1 and C2 primers were used to amplify cat from pAC103, as shown in Figure 
4-10. The three products were annealed and amplified using hydA_P1 and hydA_P4 primers as shown 
in Figure 4-11. The purified product was electroporated into both NCTC11168 and CJP13 wild type 
strains. Three colonies of mutants in each strain were selected at random and used as template in 
colony PCR using hydA_P1 and CC069 primers. This generated products of 680bp, which indicated the 
correct size for the desired location. Wild type NCTC11168 genomic DNA was used as a negative control 
showing no product. The 11168_ΔhydA and CJP13_ΔhydA genomic DNA was extracted and used in a 
natural transformation. Resultant colonies were used in a similar PCR and performed as illustrated in 
Figure 4-12. The mutant construct was amplified by hydA_P1 and hydA_P4 and sent for Sanger 
sequencing for confirmation of insertion. The sequence can be found in Appendix III. 
 
Figure 4-10: Amplification of flanks 1, 2 and cat cassette for ΔhydA construction. 
Agarose gel electrophoresis demonstrating amplification of flanks 1 and 2 (F1 and F2, upstream 
and downstream respectively) of hydA, and cat cassette. Lane 1, 1kb ladder (Promega). 
Amplification of F1 (470bp, lanes 2 and 4), using primers hydA_P1 and hydA_P2, and F2 (424bp, 
lanes 3 and 5), using primers hydA_P3 and hydA_P4  as per method in Table 2-7. NCTC11168 
and CJP13 genomic DNA was used as template for both amplifications as indicated. 
Amplification of cat (798bp) using C1 and C2 primers using the pAV103 plasmid as template 
(lane 6). 
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Figure 4-11: OE-PCR for ΔhydA construction. 
Agarose gel electrophoresis demonstrating amplification of OE-PCR products using annealed 
F1, F2 and Cat products from Figure 4-10 using primers hydA_P1 and hydA_P4 as described in 
section 2.8.1. Product shows size of 1692bp using flanks from NCTC11168 (lane 2) and CJP13 
(lane 3) genomic DNA. 
 
 
 
Figure 4-12: Colony PCR of ΔhydA electroporation transformants. 
Agarose gel electrophoresis demonstrating amplification of partial mutant construct. 
NCTC11168 (lanes 2-4) and CJP13 (lanes 5-7) electroporation colonies were used as template, 
with primers hydA_P1 and CC069 (internal cat primer). Amplification of a product determines 
successful mutant construct insertion into the genome. Products show the correct size of 
680bp. Wild type genomic NCTC11168 DNA used as a negative control, showing no product 
(lane 8). 
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4.2.7.3 OE-PCR for ΔtrbJ construction 
The ΔtrbJ mutant was constructed in a similar way to the ΔCj0080 and ΔhydA mutants detailed in 
sections 4.2.7.1 and 4.2.7.2 respectively. Briefly, trbJ upstream and downstream flanks F1 and F2 were 
amplified from CJP13 only as NCTC11168 does not contain this gene. F1 was amplified by primers 
trbJ_P1 and trbJ_P2, and F2 amplified by primers trbJ_P3 and trbJ_P4 as shown in Figure 4-13. These 
were annealed with the cat product shown in Figure 4-10. The three products were annealed and 
amplified using trbJ_P1 and trbJ_P4 as shown in Figure 4-14. This was then amplified and 
electroporated into CJP13 wild type strain. The mutant construct was amplified using trbJ_P1 and 
trbJ_P4 and sent for Sanger sequencing to confirm insertion into the genome. The sequence can be 
found in Appendix III. 
 
Figure 4-13: Amplification of flanks 1 and 2 for ΔtrbJ construction. 
Agarose gel electrophoresis demonstrating amplification of flanks 1 and 2 (F1 and F2, upstream 
and downstream respectively) of trbJ. Lane 1, 1kb ladder (Promega). Amplification of F1 (366bp, 
lane 2) using primers trbJ_P1 and trbJ_P2, and F2 (306bp, lane 3) using primers trbJ_P3 and 
trbJ_P4 as per method in Table 2-7. CJP13 DNA was used as template.  
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Figure 4-14: Annealing of flanks with cat cassette and OE-PCR for ΔtrbJ 
construction.  
Agarose gel electrophoresis demonstrating amplification of OE-PCR product using annealed F1, 
F2 and Cat products from Figure 4-13 using primers trbJ_P1 and trbJ_P4 as described in section 
2.8.1 (lane 2). Product shows size of 14702bp using flanks from CJP13 (lane 2) genomic DNA. 
 
4.2.8 Cloning ΔmemP construction 
Following several failed attempts to construct the ΔmemP mutant using OE-PCR methods, it was 
decided that a ΔmemP mutant would be constructed using restriction cloning. The overall strategy of 
obtaining the ΔmemP mutant is displayed in Figure 4-15. 
Firstly, the memP gene along with upstream and downstream flanks (F1 and F2 respectively) was 
amplified with primers memP_P1 and memP_P2 for F1 and memP_P3 and memP_P4 for F2 using 
CJP13 and NCTC11168 genomic DNA, generating a 1182bp product (Figure 4-16). These products were 
ligated into pGEM®-T Easy by TA cloning forming plasmid pRC001 (plasmid map depicted in Figure 
4-17). pRC001 was transformed into JM109 E. coli competent cells for storage.  Colony PCR was 
performed on E. coli colonies containing the plasmid, using primer memP_P1 and memP_P4 which 
generated bands, of the correct size, as seen in Figure 4-18. NCTC11168 and CJP13 genomic DNA were 
used as positive controls. It must be noted that lanes four and five show multiple bands of incorrect 
size, and were therefore eliminated from further experimentation.  
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Purified pRC001 was digested and linearised by BglII which had its only restriction site in the centre of 
the memP gene. Meanwhile, the cat cassette flanked by BamHI restriction sites, was digested out of 
plasmid pCAS036F by BamHI, where the fragment was gel extracted and purified. Both digestions are 
depicted in Figure 4-19. The linearised digested pRC001 vector (4198bp) and the cat cassette with 
BamHI restriction sites (809bp) were ligated together to form pRC002.  The plasmid map for pRC002 
is depicted in Figure 4-20 which includes the memP gene disrupted by the cat cassette. 
The memP mutant construct was amplified by memP_P1 and memP_P4 to generate a 1991bp product, 
compared to a 1182bp product without the cat cassette, shown in Figure 4-21. The mutant construct 
for both CJP13 and NCTC11168 was electroporated into CJP13 or NCTC11168 wild type strains, and 
colonies subjected to the same PCR. The genomic DNA was extracted from successful mutants and 
used in a natural transformation generating the ΔmemP mutants in both CJP13 and NCTC11168. The 
mutant construct was amplified and sent for Sanger sequencing for confirmation of correct insertion 
(Appendix III). It should be noted that although both the transposon and cloning mutant of memP 
involve gene interruption, the gene was interrupted at different sites of the open reading frame (Figure 
4-22). 
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Figure 4-15: ΔmemP cloning strategy. 
MemP amplified with primers memP_P1 and memP_P4 generating a 1182bp product inserted 
into pGEM®-T Easy vector by TA cloning. The chloramphenicol cassette, amplified by the C1 and 
C2 primers from pCAS036F plasmid generating a 809bp product was then digested with BamHI 
and the vector digested with BglII. The cat cassette was then ligated into the cut vector, 
disrupting the memP gene. 
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Figure 4-16: Amplification of memP with upstream and downstream regions. 
Agarose gel electrophoresis demonstrating amplification of memP with upstream and 
downstream regions using primers memP_P1 and memP_P2 and Go-taq DNA polymerase 
generating a 1182bp product. NCTC11168 (lane 2) and CJP13 (lane3) genomic DNA was used as 
template. Lane 1 containing 1kb ladder (Promega). 
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Figure 4-17: pRC001 plasmid map. 
Plasmid map of pRC001 consisting of the pGEM®-T Easy vector backbone with inserted memP 
and upstream and downstream flank. Inserted region indicated in red. pRC001 contains an 
ampicillin resistance gene (AmpR) which can be used for selection during transformation in E. 
coli competent cells. 
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Figure 4-18: pRC001 Colony PCR from E. coli ΔmemP transformants. 
Agarose gel electrophoresis demonstrating amplification of memP using E. coli transformant 
colony (containing the pRC001 plasmid) as template. Amplification using primers memP_P1 and 
memP_P4. Wild type CJP13 and 11168 genomic DNA were used as positive controls. 
 
 
Figure 4-19:pRC001 and PCAS036F digests. 
Agarose gel electrophoresis demonstrating BglII digestion of pRC001, generating a 4198bp 
linear product (lane 2) and undigested pRC001 (lane 3). BamHI digestion of pCAS036F plasmid 
containing the cat cassette with BamHI restriction sites, generating a 3393bp, 809bp linear 
fragments (lane4) and undigested pCAS036 (lane 5). 
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Figure 4-20: pRC002 plasmid map. 
pRC002 with the PGEM®-T Easy vector backbone with inserted memP mutant construct, the cat 
cassette inserted into the memP gene. 
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Figure 4-21: Colony PCR of memP transformants E. coli pRC002. 
Agarose gel electrophoresis demonstrating amplification of memP mutant construct with 
inserted cat cassette; using E. coli transformant colony (containing the pRC002 plasmid) as 
template. Amplification using primers memP_P1 and memP_P4. E. coli containing pRC001 
(without cat cassette) plasmid DNA was used as a negative control. 
 
 
Figure 4-22: Location of BglII restriction site and transposon (Tn) insertion site in 
the nucleotide sequence of CJP13 memP. 
Two insertional mutants in the memP gene have been constructed in this study, one by the 
transposon mutant library, and the other by insertion of the cat cassette in the BgIll site, both 
indicated by the arrows.  
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4.2.9 Mutant biofilm formation 
To assess how important the selected mutations are to biofilm formation, the mutants and wild type 
strains were screened in the biofilm assay using crystal violet staining. The results are displayed in 
Figure 4-23. Here, a reduction in biofilm formation was observed for all mutants compared to their 
respective wild type controls. However, only one mutant, 11168_ΔmemP, showed significant 
reductions in biofilm formation (p<0.0001). The crystal violet assay data showed varied results 
between replicates which may account for the lack of significance for the other mutants. No 
significance was observed in the CJP13 chicken isolate. It must also be noted that there was no 
significant difference in endpoint (72 hours) growth OD600 between the wild type and mutant strains 
(Figure 9-8, Appendix III). 
 
Figure 4-23: Biofilm formation of NCTC11168 and CJP13 wild type and ΔmemP, 
ΔCj0080, ΔhydA and ΔtrbJ mutant strains. 
Biofilm formation of NCTC11168 and three individual knock out mutants including ΔmemP, 
ΔCj0080, ΔhydA, and wild type CJP13 C. jejuni chicken isolate along with ΔmemP, ΔCj0080, ΔhydA 
and ΔtrbJ, assayed using crystal violet staining at OD540. Statistical comparisons by one-way analysis 
of variance (ANOVA) comparing the mutants to their representative wild type revealed significance 
between NCTC11168 wild type and 11168_ΔmemP. (*, p<0.05; **, p<0.01; ***, p<0.001, ****, 
p<0.0001). No significance was observed between wild type and mutants in the CJP13 chicken 
strain. 
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4.2.10 Complementation 
Despite a lack of significant reductions in biofilm formation, all mutants did consistently show 
reduction in biofilm formation to some degree. In order to confirm that any change in biofilm 
phenotype compared to the wild type strains is attributed to the lack of the gene of interest, it is 
necessary to complement the mutant, or simply, reinsert the gene, to ideally observe a restoration of 
wild type phenotype. 
Complementation in Campylobacter has been historically changing, with many recent papers not 
having been able to complement mutants to confirm results (Brown et al., 2015b). However, we were 
able to obtain a newly formed C. jejuni complementation plasmid, pSV009, (Dr Andrew Grant, 
University of Cambridge).  The pSV009 vector plasmid map is displayed in Figure 4-24. 
The pSV009 plasmid contains a genetic complementation region which is flanked by two 
recombination regions that are suitable for homologous recombination in the CJM1_0055–0057 
pseudogene region in strain M1, but is also compatible in NCTC11168 and CJP13. The region also 
contains a cat promoter, for expression of the gene of interest, or alternatively, the cat promoter can 
be sliced out and the gene of interest inserted in the multiple cloning site (MCS) along with its native 
promoter. The complementation region also contains a kanamycin resistance gene which can be used 
for selection of successful complemented transformants. The primers presented in Figure 4-24 show 
pSV009GCamplif_FW1 and pSV009GCamplif_RV1, which can be used to amplify the complementation 
region to be electroplated into C. jejuni, and primers pSV009_Seq_FW1 and pSV009_Seq_RV1, used to 
amplify the area to which the gene of interested is inserted, which can be sent for sequencing to 
confirm correct insertion. 
The complementation of ΔmemP, ΔhydA, ΔCj0080 and ΔtrbJ are outlined in the following sections. 
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4.2.10.1 ΔmemP, ΔCj0080 and ΔtrbJ complementation strategies 
The strategy for ΔmemP, ΔCj0080 and ΔtrbJ complementation, and the full plasmid maps for pRC003, 
pRC005 and pRC006 is shown in Figure 4-25, Figure 4-27 and Figure 4-28. The genes of interest were 
amplified from NCTC11168 and CJP13 wild type DNA using primers _GC_cat_XbaI_P1 and 
_GC_/cat_BamHI_P2 (as listed for each gene in table 2-7) which contain XbaI and BamHI restriction 
sites respectively. The PCR product and pSV009 complementation plasmid was digested with XbaI and 
BamHI, and ligated together. Alkaline phosphatase was used during pSV009 digestion to prevent 
recircularisation. Genes memP, Cj0080 and trbJ were inserted under the cat promoter. 
4.2.10.2 ΔhydA complementation 
The strategy for ΔhydA complementation, and the full plasmid map for pRC004 is shown in Figure 4-26. 
The genes of interest were amplified from NCTC11168 and CJP13 wild type DNA using primers 
hydA_GC_native_Xhol_P1 and hydA_GC_cat_SalI_P1 (as listed in table 2-7) which contain XhoI and SalI 
restriction sites respectively. The PCR product and pSV009 complementation plasmid was digested 
with XhoI and SalI, and ligated together. Alkaline phosphatase was used during pSV009 digestion to 
prevent recircularisation. The hydA gene was inserted under its native promoter.  
4.2.10.3 Electroporation and natural transformation 
All complemented constructs were amplified using the pSV009_GCamplif_FW1 and 
pSV009_GCamplif_RV1 primers, the product purified and electroporated into NCTC11168 and CJP13 
strains. The resultant mutants were then screened and the genomic DNA extracted and used in a 
natural transformation of NCTC11168 and NCTC knockout mutants. 
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Figure 4-24: pSV009 complementation plasmid. 
Plasmid pSV009 plasmid used for complementation of C. jejuni (de Vries et al., 2015). The 
genetic complementation region contains two recombination regions, a cat promoter, multiple 
cloning site (MCS) and kanamycin resistance gene for selection. The primers presented show 
pSV009GCamplif_FW1 and pSV009GCamplif_RV1 which can be used to amplify the 
complementation region which can be electroplated into C. jejuni. The primers 
pSV009_Seq_FW1 and pSV009_Seq_RV1 are used to amplify the area to which the gene of 
interested is inserted, which can then be sent for sequencing to confirm correct sequence. 
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A  
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Figure 4-25: pRC003 ΔmemP complementation strategy. 
(A) The complementation strategy for complementing ΔmemP. MemP was amplified from wild 
type CJP13 and NCTC11168 genomic DNA, digested with XbaI and BamHI and ligated into 
pSV009 also digested with XbaI and BamHI. MemP is expressed under the cat promoter. (B) The 
full pRC003 plasmid map containing the complementation region consisting of two 
recombination regions, memP expressed under the cat promoter, and the kanamycin resistance 
gene for selection. 
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Figure 4-26: pRC004 ΔhydA complementation strategy. 
(A) The complementation strategy for complementing ΔhydA. HydA was amplified from wild 
type CJP13 and NCTC11168 genomic DNA, digested with XhoI and SalI and ligated into pSV009 
also digested with XhoI and SalI. HydA is expressed under its native promoter. (B) The full 
pRC004 plasmid map containing the complementation region consisting of two recombination 
regions, hydA expressed under its native promoter, and the kanamycin resistance gene for 
selection. 
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Figure 4-27: pRC005 ΔCj0080 complementation strategy. 
(A) The complementation strategy for ΔCj0080. Cj0080 was amplified from wild type CJP13 and 
NCTC11168 genomic DNA, digested with XbaI and BamHI and ligated into pSV009 also digested 
with XbaI and BamHI. Cj0080 is expressed under the cat promoter. (B) The full pRC005 plasmid 
containing the complementation region consisting of two recombination regions, Cj0080 
expressed under the cat promoter, and the kanamycin resistance gene for selection. 
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Figure 4-28: pRC006 ΔtrbJ complementation strategy. 
(A) The complementation strategy for ΔtrbJ. trbJ was amplified from wild type CJP13 genomic 
DNA, digested with XbaI and BamHI and ligated into pSV009 also digested with XbaI and BamHI. 
trbJ is expressed under the cat promoter. (B) The full pRC006 plasmid map containing the 
complementation region consisting of two recombination regions, trbJ under the cat promoter, 
and the kanamycin resistance gene for selection. 
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4.2.11 Mutant and isogenic complement; biofilm formation assays 
The wild type NCTC11168 and CJP13 strains, along with the ΔmemP ΔCj0080, ΔhydA and ΔtrbJ mutants 
and respective complemented strains were assayed in the biofilm assay. Results are illustrated in 
Figure 4-29 and Figure 4-30. No significant difference in the endpoint growth OD600 readings between 
wild type, mutant and complement strains was observed (Figure 9-8, Appendix III) 
Mutants and complemented mutants showed the most significant results in the NCTC11168 strain 
(Figure 4-29). The 11168_ΔmemP mutant shows the greatest reduction in biofilm formation (p<0.0001) 
compared to the wild type phenotype. However, the complemented mutant, 11168_ΔmemP_comp, 
also showed a significant reduction in biofilm formation (p<0.0001), although the average was slightly 
higher than the mutant. This indicates that the reinsertion of the memP membrane protein gene into 
the genome has not significantly increased the strain’s ability to form biofilms. 
The 11168_ΔCj0080 mutant’s ability to form biofilms was not significantly reduced (p=0.754), although 
the complemented mutant was (p<0.0373). In addition, the 11168_ΔhydA mutant had a significantly 
reduced ability to form biofilms (p=0.0036), however the complemented mutant had a similar 
significantly reduced phenotype (p=0.0024). In fact, all three complemented mutants in the 
NCTC11168 strain failed to raise the biofilm phenotype levels up to wild type levels. 
Little significance was observed in mutants and complement mutants in the CJP13 chicken isolate 
(Figure 4-30). No significance was observed between mutants, complemented mutants and wild type 
strains of memP (p values >0.9) and hydA (p values> 0.245). Significant reductions in biofilm formation 
were observed between CJP13_wt and CJP13_ΔCj0080 (p=0.0455), and CJP13_ΔCj0080_complement 
had partially restored wild type biofilm phenotype, with no significant reduction to the wild type 
observed (p=0.2453).  
Significance was also observed between CJP13_wt and CJP13_ΔtrbJ mutant (p=0.0128), and CJP13_WT 
and CJP13_ΔtrbJ_complement (p<0.0370). Similar to NCTC11168, all CJP13 complemented mutants 
failed to restore biofilm formation to wild type levels. 
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Figure 4-29: Biofilm formation of NCTC11168 wild type and ΔmemP, ΔCj0080 and 
ΔhydA mutant and complemented strains. 
Biofilm formation of wild type NCTC11168 and three individual knock out mutants and 
complement strains including ΔmemP (A), ΔCj0080 (B) and ΔhydA (C), assayed using crystal 
violet staining at OD540. Bars show average of three biological replicates, each consisting of three 
technical replicates. Error bars indicate standard deviation. Statistical comparisons by one-way 
analysis of variance (ANOVA) followed by Tukey’s multiple comparisons test. (*, p<0.05; **, 
p<0.01; ***, p<0.001, ****, p<0.0001). 
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Figure 4-30: Biofilm formation of CJP13 wild type and ΔmemP, ΔCj0080, ΔhydA and 
ΔtrbJ mutant and complemented strains. 
Biofilm formation of wild type NCTC11168 and three individual knock out mutants and 
complement strains including ΔmemP (A), ΔCj0080 (B) ΔhydA (C) and trbJ (D), assayed using 
crystal violet staining at OD540. The biofilm assay was performed in triplicate, with each biological 
replicate consisting of five technical replicates. Statistical comparisons by one-way analysis of 
variance (ANOVA) followed by Tukey’s multiple comparisons test. (*, p<0.05; **, p<0.01; ***, 
p<0.001, ****, p<0.0001). 
 
  
126 
 
4.2.12 Motility assay 
Mutant and complement memP strains in NCTC11168 showed significant reductions in motility 
compared to the wild type strain (Figure 4-31) (p=0.0346 and p=0.0478, respectively). This result 
indicates that the reduction in biofilm formation could be due to changes in the strains’ motility. The 
11168_ΔmemP_complement strain shows a significantly reduced motility which may be responsible 
for the lack of wild type biofilm formation as seen in Figure 4-29. 
 
Figure 4-31: NCTC11168 wild type, 11168_ΔmemP and 
11168_ΔmemP_complemented mutant. 
The ability of NCTC11168 wild type, 11168_ΔmemP and 11168_ΔmemP_complemented 
mutant diffuse through semisolid media indicating isolate motility in mm. Statistical analysis 
using one-way ANOVA followed by Tukey’s multiple comparisons test identified significance 
between NCTC11168 wild type and mutant and NCTC11168 and complement strains. (*, 
p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001). 
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4.3 Discussion 
Following extensive characterisation studies, detailed in Chapter 3, one isolate was selected for further 
study.  Therefore, this chapter focuses on one chicken strain, the CJP13 chicken isolate, which was 
determined as the most competent biofilm former (see Chapter 3). CJP13 was a prime candidate for 
further study due to its ability to form dense and complex biofilms and the strain was obtained from 
poultry meat making it relevant to the current UK poultry industry. Investigating the genetic 
associations to biofilm formation in the CJP13 isolate rather than a lab or type strain enables us to 
identify potentially novel genes involved in biofilm formation in the environment, and highlight factors 
that may be causing the increased survival of C. jejuni in poultry processing plants today.  
One way to assess each individual gene in the CJP13 genome, with its relevance to biofilm formation, 
is to construct a transposon mutant library. The principle is to insert transposons into a genome of 
choice and screen for a change in phenotype. The gene to which the transposon is inserted in mutants 
displaying the desired phenotypic change can then be identified, and used for further experimentation. 
In this study, Himar1 transposons were inserted into TA-dinucleotide sites in the CJP13 genome. It was 
calculated from next generation sequencing (discussed in detail in Chapter 5) that the number of TA-
dinucleotide sites allowing transposon insertion occur every 5.1bp in the CJP genome. The transposon 
insertion will interrupt the gene expression, resulting in the failure of, or translation of truncated 
proteins which may affect protein function. This does however depend on the location of insertion. If 
the transposon is inserted towards the end of the open reading frame, the expressed protein may still 
be functional. The transposon mutagenesis protocol generated approximately 3,000 CJP13 transposon 
colonies, with each colony consisting of a single transposon mutant. It is possible for more than one 
transposon to be inserted into one CJP13 mutant, however the concentration of transposon DNA to 
CFU/ml used in the natural transformation ensured that this was highly improbable. Once the colonies 
were picked into 96-well plates for storage, the individual mutants could be screened in a high-
throughput biofilm assay, also in 96 well plates. 
Preliminary experiments comparing stab inoculation and OD adjusted inoculation of CJP13 starter 
cultures were conducted prior to the transposon mutant library screens to justify stab inoculation as a 
robust method for assay inoculation (Figure 9-7, Appendix III). Over 12,000 OD values were obtained 
during mutant library screens across two biological replicates.  It was necessary to firstly measure the 
growth of each mutant, before staining with crystal violet for biofilm formation analysis. Without this 
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growth measurement, mutants could be selected that displayed a false negative phenotype, i.e. no 
biofilm formation due to lack of growth, rather than as a result of transposon insertion. The average 
of growth and biofilm OD values for the two biological replicates of 3,000 mutants are displayed in a 
heat map in Figure 4-1. The OD values for growth and biofilm were ordered by growth OD value, where 
it became clear that mutants with growth OD<0.1 were non-growers (or extreme poor growers), and 
subsequently no biofilm was formed. Lack of growth is indicated by the light shaded brown (for growth) 
and purple (for biofilm) areas to the left of the heat map. Of the 3,000 mutants, 30.4% did not grow in 
the library screen across two replicates. This could be attributed to the location of the transposon, 
meaning the mutants are severely compromised, and its survival reduced under these conditions. It 
should be noted that all mutants in the library will contain transposons in non-essential genes, or in 
essential genes where the protein function is not inhibited. 
The heat map was able to identify trends in biofilm formation when correlated to growth. Since growth 
and related biofilm OD were ranked in ascending order of growth OD (explained above), this allowed 
visualisation of an increase of biofilm or crystal violet OD (light to darker shades of purple) which 
corresponds to the increasing growth OD (from left to right of the heat map, Figure 4-1). Figure 4-2 
supported the ‘growth-biofilm’ trends by showing a strong positive relationship between mutant’s 
growth and biofilm formation using linear regression and Pearson’s correlation coefficient analysis 
(R2=0.3319 and r=0. 8428 respectively). This implies that the growth of each mutant in this library 
screen, or simply the number of cells in the well (represented by the endpoint growth OD), is related 
to the biofilm phenotype. This growth-biofilm relationship was not observed between individual CJP 
isolates (Figure 9-2, Appendix II), however it is clear that introducing mutations into the genome will 
affect key phenotypes such as growth and biofilm formation. 
Individual transposon mutants were carefully selected by ranking mutants in order of growth, and 
grouping them in 0.05OD600 intervals. Each mutant was given a Z-value, which indicated whether the 
mutant had an increased or decreased biofilm OD compared to the average for that particular growth 
interval. P-values were obtained from the Z-values, and mutants showing significance between two 
library screens were selected. These 12 mutants, listed in Table 4-1, were screened again in the biofilm 
assay with adjusted starting inoculums to confirm the phenotype (Figure 4-3). It should be noted that 
this study has focused on mutants that possess a reduced biofilm phenotype, rather than increased. A 
comparatively small proportion of the isolates that showed significance were due to increased biofilm 
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formation, however, since the CJP13 isolate already produces a strong biofilm, it was difficult to collect 
data showing increased biofilm ability. This would be more effective on an isolate with moderate 
biofilm capability, where an increase in biofilm formation could easily be detected and analysed. 
The transposon insertion sites for the selected mutants were revealed by linker PCR and Sanger 
sequencing (Figure 4-4 and Figure 4-5). Transposons were inserted in genes listed in Table 4-1. To find 
the transposon insertion sites, BLASTn searches were performed using the NCTC11168 as a reference 
genome. Two of the insertion sites were not identified in the NCTC11168 genome, meaning that the 
CJP13 genome contained novel genes (to the reference) linked to biofilm formation. These were later 
identified as trbJ, a conjugal transfer protein, and Rha a bacteriophage protein, which can inhibit phage 
growth when expressed in E. coli (Henthorn and Friedman, 1995). 
Linker PCR revealed 12 genes which, when impaired, reduced CJP13’s ability to form biofilms. Three of 
the mutants were involved with flagella or chemotaxis genes (fliD, intragenic region between flhF and 
folk, and Cj0448C, and MCP-type signal transduction protein). Motility, flagella and chemotaxis are 
already well established factors in biofilm formation and, in particular, C. jejuni (Joshua et al., 2006, 
Kalmokoff et al., 2006, Reuter et al., 2010, Kim et al., 2015, Svensson et al., 2014, Dwivedi et al., 2016). 
These genetic factors have been reported extensively in the literature, which although validates the 
results of the mutant library screen presented in this study, was the reason why these genes were not 
taken forward for future study. 
Two of the identified mutants were linked to putative membrane proteins, Cj1623, and the predicted 
promoter region of Cj0080. It is not clear if these membrane proteins are surface exposed or 
periplasmic as they are not well characterised in C. jejuni. Many proteins expressed on the outer 
membrane of C. jejuni are linked to colonisation, and the major outer membrane protein has been 
linked to reduced biofilm formation when O-glycans were removed (Mahdavi et al., 2014). It was 
hypothesised that membrane proteins, whether surface exposed or periplasmic, are likely to be 
involved with initial attachment of biofilm formation in C. jejuni. Moreover, Kalmokoff et al. (2006) 
identified a number of putative periplasmic or outer membrane proteins that were linked to biofilm 
formation. in addition, a recent transposon mutant library study investigating biofilm formation in C. 
jejuni identified one of three genes significantly reducing biofilm formation as a probable 
transmembrane protein (Cj0268c) (Teh et al., 2017). This gene was not identified in the library screen 
presented in this study, however the repeated identification of membrane proteins here and in the 
130 
 
literature implies that membrane proteins are important for C. jejuni biofilm formation. It was for this 
reason that the Cj1623 (named memP in this study), and Cj0080 were taken for further study. 
Metabolic genes such as Cj1310, a carbonic anhydrase, hisF, a phosphate synthase subunit, and nuoM, 
NADH-quinone oxidoreductase subunit were identified from the transposon mutant library screen. 
However, hydA, which encodes a nickel/iron hydrogenase small subunit in C. jejuni and has been linked 
to bacterial attachment and colonisation (Hong et al., 2014), was therefore selected for further study.  
Hydrogenases catalyse the reversible reaction H2 ⇔ 2H+ + 2e-. The uptake hydrogenase describes the 
forward reaction, i.e. oxidising hydrogen by liberating electrons that can enter the electric transport 
chain, generating ATP. The genes that are responsible for hydrogenase activity in C. jejuni are hydA, 
hydB, hydC and hydD or Cj1267c, Cj1266c, Cj1265c and Cj1264c and are clustered in the NCTC11168 
genome (Parkhill et al., 2000). hydA, the gene detected in this screen as reducing biofilm formation 
when disrupted, encodes a 41.4 kDa small subunit protein, which has been shown to be non-essential 
(Metris et al., 2011). hydB, a larger subunit, contains the nickel/iron (Ni/Fe) active site; hydC encodes 
the Ni/Fe-hydrogenase cytochrome subunit, indicating an uptake type hydrogenase, which is attached 
to the membrane, and hydD encodes a protease which has been linked to enzyme maturation (Parkhill 
et al., 2000, Weerakoon et al., 2009). 
HydA has been linked to host colonisation and was found to be upregulated when exposed to porcine 
mucin (Hong et al., 2014). Interestingly, Weerakoon et al. (2009) reported that a mutant in the hydB 
gene demonstrated a reduced ability to colonise the chicken ceca. However a more reduced 
colonisation was reported in a hydB/fdh double mutant. fdh genes encode a formate dehydrogenase. 
This double mutant eliminates ability for the strain to oxidise hydrogen and formate therefore unable 
to liberate electrons. Weerakoon et al. (2009) suggest that this may weaken the strain which can be 
easily out-competed by other gut microorganisms (Weerakoon et al., 2009). In this study, growth was 
taken into consideration, negating the idea that growth was responsible for the reduction of the 
biofilm phenotype. Part of the hyd complex, namely HydC, is attached to the cell membrane, and 
disruption of the complex itself due to transposon insertion, may disrupt the surface of the C. jejuni 
mutant’s cell membrane which express essential adhesions effecting the attachment to abiotic 
surfaces. It was for this reason that the hydA gene was taken forward for further investigation. 
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In addition to this, a recent study by Hitchcock et al. (2010) investigated the roles of twin-arginine 
translocase (TAT) in the biogenesis of the electron transport chains of C. jejuni, and reported that a 
tatC translocase mutant possessed protein subunits such as HydB in the periplasm. However, HydB 
does not contain the TAT motif required for translocation from the cytoplasm into the periplasm 
(Hitchcock et al., 2010). It is suggested that the presence of HydB in the periplasm is mediated by a 
‘piggy-backing’ mechanism with HydA which contains the necessary TAT motif for translocation 
(Rodrigue et al., 1999).  Both the hydA transposon and knockout mutants constructed in this study 
show a reduction in biofilm phenotype. This could be due to the fact that certain other subunits or 
proteins were not able to be expressed on the surface of the cell due to its inability to translocate the 
cytoplasmic membrane. In addition to this, Parrish et al. (2007) identified 23 C. jejuni proteins which 
interact with HydA, (listed in Appendix III), including a number of hypothetical, transport, chaperone, 
membrane and periplasmic proteins which may affect C. jejuni’s ability to adhere to surfaces. 
trbJ has been identified as a conjugal transfer protein, which is involved with the T4SS in Gram negative 
bacteria (Lawley et al., 2003, Souza et al., 2012). T4SS in Gram negative bacteria are similar to 
conjugational processing in bacteria in that they exchange genetic material, translocate proteins and 
can be attributed to the virulence of the bacteria. For example, all of the essential genes for 
conjugation of the pTiC58 plasmid in Agrobacterium tumefaciens is present in the tra and trb gene sets 
(Li et al., 1999). 
Graaf-van Bloois et al. (2016) investigated the conservation of T4SS in Campylobacter fetus subspecies. 
They discovered that subspecies had different versions of the T4SS encoding regions, either located in 
both the chromosome and in extra-chromosomal plasmids, exclusively in the chromosome or 
exclusively in extra-chromosomal plasmids.  
Interestingly T4SS genes, including trb genes that were attributed only to plasmids, had the highest 
homology to a C. coli plasmid, similar to the trbJ gene isolated in this study. The trbJ sequence of CJP13 
shows 83% identity (E value=0.0) homology with the trbJ gene located in the pCC42 C. coli plasmid. 
Graaf-van Bloois et al. (2016) suggests C. fetus acquired the T4SS from other Campylobacter species, 
which is probably how CJP13, a C. jejuni isolate, acquired the pCC42 C. coli plasmid (discussed in 
Chapter 5). 
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trbJ transposon and knock out mutants displayed a reduced ability to form biofilms. It is currently 
unclear how this may affect biofilm formation, however the phenotype must have been affected by 
the inability for the strain to acquire, or transfer genetic material horizontally. 
Other genes highlighted from the library screen included Rha, a phage protein, and RpsB, a 30S subunit 
protein. These were not selected for further study due to the lack of published literature on Rha in C. 
jejuni, and the RpsB mutation is more likely to effect the synthesis of a number of proteins, rather than 
being an individual biofilm factor.  
As explained in section 4.2.6 and in Figure 4-6, transposon mutants disrupt the gene target, resulting 
in synthesis of truncated proteins which may remain functional. To ensure that the reduction in biofilm 
formation is attributed to the function of the gene containing the transposon, the gene must be 
knocked out completely. This was performed by OE-PCR, a powerful molecular tool for rapidly 
constructing bacterial mutants (Hansen et al., 2007). The complementary regions of the primers used 
to amplify the upstream and downstream flanks to the regions on the primers amplifying the 
chloramphenicol (cat) cassette, mean that the gene of interest can be completely replaced by the 
antibiotic selection gene. Mutants ΔCj0080, ΔhydA and ΔtrbJ were constructed using this method, 
described in Figure 4-7 to Figure 4-14. However, some difficulty in the OE-PCR method occurred in the 
construction to the ΔmemP mutant, which was finally constructed using restriction cloning methods, 
detailed in Figure 4-15 to Figure 4-21. The cloning method however, does mean that the mutant, 
similar to the transposon mutant, interrupts the gene by insertion, rather than complete gene deletion. 
Figure 4-22 indicates the two insertion sites i) by the transposon, and ii) the BglII restriction site where 
the cat cassette was inserted. The gene was interrupted in two locations and each mutant showed a 
reduction in biofilm phenotype. This gene is uncharacterised in C. jejuni and there are no putative 
conserved domains from BLASTn and BLASTp searches, therefore it is difficult to determine if the 
memP protein is still functional. 
Mutants of the genes of interest were constructed in both the NCTC11168 lab strain, originally a 
human isolate, and the CJP13 chicken isolate to observe phenotypic effects the genes may cause in 
strains from different hosts. Of course, two strains from two hosts may not be representative of the 
larger pool of isolates, but these findings can be extrapolated and trends into the presence and 
absence of these genes of interest can be investigated in a number of isolates and MLST types, as 
discussed in Chapter 5.  
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All mutants in both NCTC1168 and CJP13 showed a reduction in biofilm formation compared to the 
wild type strains, however, only the 11168_ΔmemP mutant showed a significant reduction over five 
biological replicates (Figure 4-23). Of particular interest was the reduction in biofilm in the Cj0080 and 
hydA mutants since the transposon was inserted upstream of the open reading frame. This implied 
that the transposon reduced the expression of the two genes by interrupting the gene promoters. 
Despite the lack of significance (through variation between replicates), all mutants were 
complemented to observe the effect on the biofilm phenotype. 
Complementation has become a routine and important process in molecular biology, since knocking 
out a gene and observing a phenotype is not adequate for determining gene function. 
Complementation is a useful tool to confirm that the gene of interest is showing the change in 
phenotype, by reinserting the gene elsewhere in the genome. Here, the gene will still be expressed, 
however it may not be expressed under its native promoter. This study used the pSV009 C. jejuni 
complementation plasmid, possible though a collaboration between the University of Surrey and 
Andrew Grant’s group at the University of Cambridge. The complementation plasmid enables rapid 
complementation of knock out mutants as it contains two recombination regions of a C. jejuni 
pseudogene, with a MCS for cloning the gene of interest, either under its native promoter, or under 
the cat promoter which is located between two XhoI sites (for easy removal if not required). Mutants 
were complemented by expressing the gene under the cat promoter, as it can be challenging to express 
certain genes under its native promoter, especially if the gene is in the middle of an operon. It is also, 
on occasion, difficult to identify individual promoter regions for specific genes, and expression under 
the cat promoter would be more likely. However, due to presence of restriction sites in the hydA gene, 
complementation of ΔhydA mutants used the native promoter region for expression of hydA. 
As seen in Figure 4-29 and Figure 4-30, the complemented mutants were mixed in their ability to form 
biofilms, however complemented 11168_memP, CJP13_Cj0080, CJP13_hydA and CJP13_trbJ mutants 
showed an average increase in biofilm formation compared to their mutant counterparts. None of the 
complemented mutants, except the CJP13_memP complement, matched or exceeded wild type levels 
of biofilm formation which could be attributed to the choice of promoter used for this study. The 
pSV009 plasmid gave the option to use the cat promoter which was used instead of the gene’s native 
promoter. This could mean that the levels of gene expression are still vastly reduced compared to wild 
type levels. To further investigate this, real time-PCR, amplifying the genes of interest should be 
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performed on wild type, mutant and complemented mutants to verify that; i) the gene has truly been 
knocked out of each mutant, and ii) that the complemented mutant is expressing similar gene 
expression levels to the wild type. Any differences here could be seen in the phenotype. Another 
option would be to over-express each gene using a hyperactive promoter such as T7. This is commonly 
used in molecular biology and may increase the biofilm phenotype compared to the wild type strain, 
or indeed complemented mutants expressed under the cat promoter. In addition, an enzyme-linked 
immunosorbent assay (ELISA) would quantify the levels of protein in each wild type, mutant and 
complement. 
Since the 11168_ΔmemP mutant exhibited significantly reduced biofilm formation, its motility was 
screened using the semisolid agar method (Figure 4-31). Interestingly, the motility of the mutant and 
complement strain was significantly reduced compared to the wild type. It must be noted that all other 
mutant and complemented mutant strains showed no difference in motility to the wild type. This 
implies that the membrane protein (memP), when unable to be expressed, may have disrupted the 
construction or regulation of the flagella complex. However, the re-insertion of memP into the genome 
did not increase biofilm formation to wild type levels, although this could be attributed to the 
differential expression of memP under the cat promoter compared to its native promoter.  
Interestingly a recent paper highlighted the importance of second site mutations effecting phenotypic 
variation with regard to motility in C. jejuni (de Vries et al., 2015). In this study, a deletion of the flaB 
gene resulted in second site mutations in fliW and flgD which caused variation in observed motility. 
This highlights a few important factors when considering the interpretation of the results in this 
chapter; i) the deletion mutants may have incurred second site mutations in other genes which effect 
biofilm formation, and ii) the reduction in biofilm phenotype in the memP example may be attributed 
to its reduction in motility rather than the membrane protein being a true factor in biofilm formation. 
It must be noted that all other mutants and complemented mutants showed wild type motility. To 
confirm the results of this chapter, all mutants and complements would ideally be whole genome 
sequenced to screen for other mutations that could affect the phenotype. 
In summary, this chapter describes the work undertaken to extensively screen over 3,000 transposon 
mutants in the CJP13 strain, to identify 12 genes which, when disrupted, reduce biofilm formation. 
This study presents four genes, Cj0080, memP, hydA and trbJ, which when knocked out of the CJP13 
genome, showed reduced biofilm formation, although 11168_ΔmemP was the only mutant to show a 
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significant reduction when individual knock out mutants were constructed (p=0.0001). 
Complementation of mutants resulted in mixed levels of biofilm formation, but generally did not 
provide wild type levels of biofilm. To confirm these results, experiments should be performed to check 
the expression of the genes of interest in all wild type, mutant and complemented mutant strains. The 
possibility of secondary site mutations and their effect on motility should also be considered when 
concluding how important these novel factors are to biofilm formation in C. jejuni. 
  
136 
 
5 Genome wide association study for C. jejuni biofilm traits using a 
comparative genomics approach 
5.1 Introduction 
Biofilm formation in bacterial species is influenced by a number of genetic and environmental factors. 
The genetic associations to biofilm formation in C. jejuni, to date, include genes involved in motility 
(Joshua et al., 2006), chemotaxis (Chandrashekhar et al., 2015) and adhesion (Chandrashekhar et al., 
2015), among others. C. jejuni can display a large amount of genetic variation, both within core and 
accessory genomes (Meric et al., 2014). The latter can be described as genes that are not present in all 
strains within a species, and are often transferred horizontally or laterally. The growing availability of 
C. jejuni genomes, through the advances of high-throughput sequencing, has enabled large 
comparative genomic studies to be conducted to better understand the link between genotype and 
phenotype. 
Previous investigations into genomic content of Campylobacter with focus on biofilm formation have 
been conducted on a wide scale by Pascoe et al. (2015). Here, they report that 13 genes involved in 
adhesion, motility, glycosylation, capsule production and oxidative stress showed statistically robust 
associations to biofilm formation in Campylobacter. They also report additional genes which only show 
association to biofilm formation in ‘host generalist’ clonal complexes (ST-21 and ST-45), which they 
suggest indicates the evolution of enhanced biofilm from different genetic backgrounds.  
Previously in Chapter 4, individual genes were identified in the CJP13 genome which presented a 
reduction in biofilm formation when inactivated. Some of the genes of interest were revealed to be 
genes absent from the NCTC11168 reference strain, indicating strain specific mechanisms for biofilm 
formation. In order to further investigate the genetic associations to biofilm formation, the genotypic 
content of the 10 CJP isolates were analysed in a genome wide association study comparing competent 
and poor biofilm isolates. 
The aims of the work discussed in this chapter were to:  
 Sequence 10 CJP isolate genomes, of which five are competent biofilm formers, and five are 
poor biofilm formers. 
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 Perform comparative genomics using i) alignment to the NCTC11168 reference genome and ii) 
pangenome comparison. 
 Perform distribution analysis on biofilm related genes in a wider panel of C. jejuni reference 
genomes. 
5.2 Results 
5.2.1 De novo assembly and annotation  
The 10 CJP isolates, five that displayed a competent biofilm phenotype (CJP11, CJP12, CJP13, CJP17 
and CJP27), and five that displayed a poor biofilm phenotype (CJP01, CJP19, CJP21, CJP22 and CJP28) 
discussed in Chapter 3, had their DNA extracted and sent for next generation sequencing. An overview 
of the data processing and analysis is presented in Figure 5-1. 
The raw reads were assembled de novo using SPAdes (version 3.9.0) (Bankevich et al., 2012). The 
collection of assembled contigs for a genome was submitted to the Rapid Annotation using Subsystem 
Technology (RAST) server (Aziz et al., 2008) (http://rast.nmpdr.org/rast.cgi) for gene annotation 
(calling of open reading frames and functional annotation, based on sequence homology). An overview 
of the 10 genomes is displayed in Table 5-1. The genomes ranged from 1.61-1.76 Mbp in size and 
contained between 1,671 and 1,892 coding sequences. The number of subsystems, RNAs and GC% 
content present in the 10 genomes are consistent. The DNA assembly is of a high quality as indicated 
by the N50, L50 and number of contigs values, explained in Table 5-1. No differences in size, GC 
content, number of coding sequences, subsystems or RNAs were identified between the two panels of 
competent and poor biofilm isolates. 
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Figure 5-1: Overview of sequence data processing and analysis. 
Raw reads in .fastq format were assembled de novo using SPAdes. (1) The generated contigs 
from this assembly were subjected to phylogenetic analysis, comparing >5,000 C. jejuni 
genomes to observe distribution of CJP isolates and selected genes of interest across C. jejuni 
lineages. (2) Contigs were subjected to BRIG analysis which aligned CJP genomes to the 
NCTC11168 reference genome. (3) Annotated protein sequences were also analysed by Roary, 
which compared the 10 CJP genomes at 90%, 95% and 99% identity, and compared CJP17 and 
CJP19 genomes with 99% identity. 
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Table 5-1: Overview of 10 CJP isolate genomes. 
The size of the genomes in base pairs (bp), GC% content, N50 and L50 values, number of contigs 
(including protein encoding genes), number of subsystems, number of coding sequences and 
number of RNAs detected in each of the 10 CJP C. jejuni genomes. Genomes are grouped as 
follows: competent (CJP11, CJP12, CJP13, CJP17 and CJP27, coloured blue) and poor (CJP01, 
CJP19, CJP21, CJP22 and CJP28, coloured red) biofilm formers. Data generated from RAST 
annotation. 
*N50 value represents the contig size in bp at which at least 50% of the assembly is contained 
in contigs of this size or larger. A higher value is preferred, e.g. associated with a higher quality 
assembly. 
**L50 value represents the smallest number of contigs whose length sum produces the size of 
N50. A lower value is preferred, e.g. associated with a higher quality assembly. 
 
5.2.2 Comparative genomics using NCTC11168 as a reference genome 
5.2.2.1 BLAST Ring Image Generator (BRIG) 
The alignment of the 10 CJP genomes to the NCTC11168 reference genome revealed large variation i) 
between the CJP isolates, and ii) compared to the reference. This is depicted by BLAST Ring Image 
generator software, or BRIG (see Figure 5-2). BRIG software uses BLASTn analysis (using 100%, 70%, 
and 50% identity) and to align identified open reading frames of the 10 isolate genomes to the 
annotated reference genome of NCTC11168. Each genome is represented by a different coloured ring, 
where the five inner most rings represent the competent biofilm former isolates, and the five outer 
rings represent the poor. The lighter shaded and grey areas of each ring represent percentage identity 
lower than 70% and 50% respectively compared to the reference genome.  
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Large regions of the CJP01, CJP11 and CJP28 genomes are indicated as being either absent or having 
less than 50% homology to the reference strain NCTC11168. Many of the genes shown to be involved 
in biofilm formation and adhesion to abiotic surfaces, such as  flagella genes (Svensson et al., 2014), 
luxS (Reeser et al., 2007), involved in quorum sensing, and adhesins such as cadF (Sulaeman et al., 
2012), are located in the regions that show increased variation in the reference genome (highlighted 
with red boxes, Figure 5-2). 
Large proportions of the CJP genomes were not aligned to the reference genome as they contain novel 
(to the reference strain) genes that are not present in NCTC11168. One example is the identification 
of genes known to reside in the pCC42-like plasmid found to be in the genome of isolate CJP13. As 
NCTC11168 lacks extra-chromosomal plasmids (Parkhill et al., 2000) these genes of CJP13 have not 
been included in the BRIG representation. The selection of a reference genome is therefore critical in 
comparative genomics and, if not considered, can produce misleading results. Pangenome approaches 
based on annotated features allows for more flexible thresholds than DNA-DNA alignments only, since 
alterations in DNA sequence do not necessarily result in changes in amino acid sequence, depending 
on the position in the codon. Hence, this allows a whole genome comparison and identification of 
specific genes, so delivering more accurate comparisons between genomes. 
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Figure 5-2: 10 CJP isolate genomes aligned to NCTC11168 reference genome. 
The CJP chicken C. jejuni isolate genbank files, annotated by RAST were used as input to the BRIG 
software that performs BLASTn analysis against the NCTC11168 reference genome. Each ring 
represents a CJP genome as indicated by the key. Lighter shaded areas show a reduced percentage 
identity to the reference genome. Gene names are listed in order of the NCTC11168 genome 
annotation. Image generated by BRIG software. Genomes CJP11, CJP12, CJP13, CJP17 and CJP27 
(inner rings 1-5) represent competent biofilm former isolates, and genomes CJP01, CJP19, CJP21, 
CJP22 and CJP28 (outer rings 6-10) represent poor biofilm former isolates. 
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5.2.2.2 A pangenome approach to assess differential gene content between competent and poor 
biofilm isolates  
The 10 CJP genome BRIG alignment to the NCTC11168 reference genome identified regions of low 
sequence identity (<50%), implying considerable variation between the reference and the chicken 
isolates. It was also unclear from BRIG analysis how the CJP genomes vary between them. For this 
reason, a pangenome (comprising all genes in the 10 CJP isolates) approach was used, where 
assembled and annotated CJP genomes were subjected to Roary analysis. Roary, a pangenome pipeline 
(Page et al., 2015), allows the comparison of the annotated genomes using a BLASTp cut-off of 90%, 
95% and 99% sequence identity. This analysis generated a gene presence/absence database for each 
annotated gene in the 10 CJP genomes. Roary analysis with BLASTp cut-off of 90% identity with paralog 
clustering enabled (i.e. where paralogous genes are not split into separate groups, to correct for high 
levels of allelic variation (van Vliet, 2017)) generated 2476 unique genes within the 10 genomes. In 
addition, Roary with 95% sequence identity with paralog clustering generated 2671 genes, and 99% 
(paralog clustering disabled) generated 4125 genes to be analysed.  
Here, it must be noted that the higher percentage identity will detect more genes due to stringent 
nature of the BLASTp cut off, i.e. one single nucleotide polymorphism (SNP) that results in one amino 
acid change will be presented as a new gene using 99% sequence identity. The genomes were grouped 
into the two panels of five competent and five poor biofilm isolates, and the gene content for each 
panel assessed. The individual genes showing the greatest differential presence or absence between 
the competent and poor biofilm genomes at three different percentage identities were selected and 
listed in Table 5-2.  
No single gene identified in this screen was either exclusively present or exclusively absent in the 
competent or poor biofilm genome panels. Those genes that were present in all of the genomes in one 
panel (i.e. competent or poor) also showed some presence in the other. Similarly, despite some genes 
being absent in all of the genomes in one panel, they were present, in varying quantities, in the other.   
The generated gene results imply CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-
sialyltransferase (highlighted in grey, Table 5-2) has the greatest differential gene content between the 
competent and poor isolates, independent of the chosen BLASTp thresholds of 90%, 95% and 99%. 
This gene was present in 80% of the competent biofilm genomes, and none of the poor.  
143 
 
A hypothetical protein, namely ‘FIG00638667’ (highlighted in green, Table 5-2), was present in 80% of 
the poor, and 20% of the competent biofilm former genomes at 95% and 99% identity threshold 
analysis. BLASTp searches revealed that ‘FIG00638667’ had a weak homology (39%, BLASTp E-
value=6e-08) to YqjC, a periplasmic protein in Yersinia enterocolitica. 
Furthermore, comparison strains using the 99% sequence identity threshold identified two additional 
genes as differentially present between the competent and poor biofilm isolates; the first, neuB1, a 
gene encoding sialic acid synthase, and the second, a gene encoding a DsbA-like protein. Interestingly, 
DsbA (thiol:disulfide interchange protein) has been linked to C. jejuni motility and autoagglutination 
(Grabowska et al., 2014).  
Gene 
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0
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1
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2
1 
C
JP
2
2 
C
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2
8 
% com-
petent 
biofilm 
isolates 
containing 
gene (A) 
% poor 
biofilm 
isolates 
cont-aining 
gene  (B) 
A-B 
% identity 
threshold 
CMP-N-
acetylneuraminate-beta-
galactosamide-alpha-2,3-
sialyltransferase (EC 
2.4.99.-) cstIII (Cj1140) 
Y Y Y N Y N N N N N 80 0 80 90/95/99 
FIG00638667: hypothetical 
protein 
N N N Y N Y Y Y Y Y 20 100 -80 95/99 
N-acetylneuraminate 
synthase (EC 2.5.1.56) 
neuB1, sialic acid synthase 
(Cj1141) 
Y Y Y N Y N N N N N 80 0 80 99 
Periplasmic thiol:disulfide 
interchange protein, DsbA-
like 
N N N Y N Y Y Y Y Y 20 100 -80 99 
 Table 5-2: Genes showing differential presence and absence between competent 
and poor biofilm former isolates. 
Four genes showing the greatest trends in differential gene presence and absence between 
competent (blue) and poor (red) biofilm isolates. Data generated using 90% identity with 
paralog clustering. 
 
5.2.3 Presence of biofilm related genes in CJP genomes 
The genes identified as being associated with the biofilm phenotype in CJP13, from the transposon 
mutant library screen (see Chapter 4), were used as targets for gene content analysis in the 10 CJP 
genomes (Table 5-3). Roary analysis (90%, 95% and 99% sequence identity) revealed that all but two 
of the genes were present in all 10 CJP genomes. trbJ and rha were only present in CJP13, and found 
to be located on a pCC42-like plasmid (Pearson et al., 2013). None of the other CJP isolates contain this 
plasmid (or plasmid genes), represented by the absence of trbJ and rha in the screen.   
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Gene CJP01 CJP11 CJP12 CJP13 CJP17 CJP19 CJP21 CJP22 CJP27 CJP28 
memP Y Y Y Y Y Y Y Y Y Y 
trbJ N N N Y N N N N N N 
hydA Y Y Y Y Y Y Y Y Y Y 
fliD Y Y Y Y Y Y Y Y Y Y 
mcp Y Y Y Y Y Y Y Y Y Y 
rbsp Y Y Y Y Y Y Y Y Y Y 
flhF Y Y Y Y Y Y Y Y Y Y 
folK Y Y Y Y Y Y Y Y Y Y 
nuoM Y Y Y Y Y Y Y Y Y Y 
hisF Y Y Y Y Y Y Y Y Y Y 
rha N N N Y N N N N N N 
Table 5-3: Presence and absence of genes associated with biofilm formation in CJP 
genomes. 
Presence and absence of biofilm related genes (identified from the transposon mutant library 
screen) analysed by Roary at 90%, 95% and 99% identity with paralog clustering. Genomes 
containing the gene are labelled with a “Y”, and “N” if the gene is absent. Competent biofilm 
formers are coloured in blue and poor are coloured in red. 
 
5.2.4 Distribution of biofilm related genes over C. jejuni lineages  
A total of 5,829 C. jejuni genomes were used to analyse the distribution of strains possessing the full 
length or truncated genes found to be associated with biofilm formation in Chapter 4 (Figure 5-3 and 
Table 5-4). The distribution of absent/truncated genes was mostly sparse and sporadic across C. jejuni 
phylogeny, except rha, which is only present in 24.14% of the 5,829 C. jejuni genomes (Table 5-4).  
Figure 5-4 represents the distribution of strains possessing hydA, memP, Cj0080 and trbJ, the genes 
selected for construction of gene knock outs and mutant complements (sections 4.8-4.10). Gene 
absence is indicated with blue, and truncation is indicated with red lines, apart from trbJ in Figure 5-4, 
where red lines indicate gene presence. Genomes are linked with their isolation source and MLST 
clonal complex. Details of the number of genomes containing the gene, or truncated gene are 
presented in Table 5-4.  
The majority of the C. jejuni genomes (>99%) were shown to possess the highlighted (Chapter 4) genes 
associated with biofilm production (Table 5-4), indicating that the genes are part of the C. jejuni core 
genome. Gene absence or truncation is sporadic throughout MLST types and isolation sources (Figure 
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5-3 and Figure 5-4). However, a small cluster of strains, showing mcp truncation, cluster around 
environmental isolates, (red arrow, Figure 5-3). In addition, strains containing trbJ cluster with 
agricultural isolates and ST-464 (indicated by red arrow, Figure 5-4). 
Gene 
# full-length 
genes 
# truncated 
genes 
# absent 
genes 
% full 
length 
% truncated % absent 
hydA 5821 5 3 99.86 0.09 0.05 
fliD 5823 6 0 99.89 0.10 0.00 
mcp 5803 26 0 99.55 0.45 0.00 
rbsp 5821 6 2 99.86 0.10 0.03 
memP 5809 19 1 99.65 0.33 0.02 
Cj0080 5819 0 10 99.82 0.00 0.17 
flhF 5821 8 0 99.86 0.14 0.00 
folk 5823 6 0 99.89 0.10 0.00 
nuoM 5819 7 3 99.82 0.12 0.05 
trbJ 234 0 5595 4.01 0.00 95.99 
rha 1406 0 4423 24.12 
0.00 
75.88 
hisF 5828 0 1 99.98 0.00 0.02 
Total = 5829 C. jejuni genomes 
Table 5-4: Absent or truncated biofilm related genes in C. jejuni genomes. 
The numbers of genomes (total 5829) containing either full-length, truncated, or absent biofilm 
related genes. Genes selected due to their association with C. jejuni biofilm formation from 
Chapter 4. 
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Figure 5-3: Phylogenetic tree with distribution of biofilm related genes (from Chapter 4). 
Phylogenetic tree containing 5,829 C. jejuni genomes, with their isolation source and MLST clonal complex, showing the distribution of strains where fliD, 
mcp, rpsB, flhF, folK, nuoM and hisF are absent (blue) or truncated (red). The presence of rha is indicated in red. The tree was constructed from 52 
concatenated ribosomal gene sequences per genome (Jolley et al., 2012). 
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Figure 5-4: Distribution of hydA, memP, Cj0080 and trbJ across C. jejuni lineages. 
Phylogenetic tree containing 5,829 C. jejuni genomes, with their isolation source and MLST clonal complex, showing the distribution of strains where hydA, 
memP and Cj0080 are absent (blue) or truncated (red). Distribution of trbJ presence is also indicated (red). These genes were selected for further analysis, 
detailed in Chapter 4. The tree was constructed from 52 concatenated ribosomal gene sequences per genome (Jolley et al., 2012). 
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5.2.5 Distribution of pCC42 over C. jejuni lineages 
Genes known to be present within a C. coli plasmid pCC42 (listed in Appendix V), were identified by 
BLASTn analysis and shown to be assembled into one single contig (contig 15) of the CJP13 genome by 
Spades. BLASTn analysis identified a 90% identity (87% query cover, E value=0.0) to the C. coli plasmid, 
pCC42. The alignment of the pCC42 plasmid and CJP13_contig_15 using the software Mauve, is 
depicted in Figure 5-5, where coloured blocks indicate gene homology between the sequences. In 
addition, trbJ, the conjugal transfer gene identified to be associated with biofilm formation in Chapter 
4, was found to be located on the pCC42 plasmid. It must be noted that although all the genes present 
in the pCC42 plasmid are assigned to one contig, there is a remote possibility that some of the plasmid 
genes have been integrated into the genome. 
Further phylogenetic analysis revealed that the distribution of trbJ and pCC42 are similar (Figure 5-6), 
suggesting that the trbJ gene is often present on pCC42. The pCC42 plasmid is well distributed across 
C. jejuni linages, and present in a variety of clinical isolates. As indicated in Figure 5-4, trbJ, and 
therefore pCC42, cluster around a number of agricultural isolates, identified as ST-464 (red arrow, 
Figure 5-6). In addition, the rha gene (another gene associated with CJP13 biofilm formation, Chapter 
4) was also identified on the pCC42 plasmid present in CJP13, however it is also present in pTet, a 
common plasmid in C. jejuni. The distribution of rha and pTet is sporadic through C. jejuni phylogeny, 
although tend to be present in ST-574 clonal complexes (blue arrow, Figure 5-6). 
 
Figure 5-5: Comparative analysis of pCC42 and CJP13 plasmid sequence 
Comparative Mauve analysis between the scaffolds of pCC42 from Campylobacter coli FB1 (top) 
aligned to contig 15 of CJP13 chicken C. jejuni isolate. Red lines show contig boundaries, sequence 
homology between the two plasmid sequences is represented by colour matching regions. 
Sequence alignment performed by Mauve.  
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Figure 5-6: Phylogenetic tree comparing distribution of pCC42, trbJ, rha and pTet. 
Phylogenetic tree containing 5,829 C. jejuni genomes, with their isolation source and MLST clonal complex, showing distribution of the pCC42 plasmid found in isolate 
CJP13, trbJ and rha genes found to influence biofilm formation in the CJP13, selected for further study in Chapter 4, and pTet. The tree was constructed from 52 
concatenated ribosomal gene sequences per genome (Jolley et al., 2012). 
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5.2.6 Phylogenetic clustering of CJP genomes with 320 C. jejuni genomes 
The sequencing of seven housekeeping genes to determine the MLST of the CJP isolates (Chapter 3, 
Table 3-3) revealed isolates were assigned to a number of different sequence types and clonal 
complexes. To observe the genetic diversity on a whole genome scale, phylogenetic analysis using 
parSNP, revealed wide distribution of the CJP isolates across 320 C. jejuni reference genomes as 
depicted by the red isolates in the SNP tree (Figure 5-7). CJP isolates range over a number of different 
MLST types and CC, with the exception of CJP17 and CJP19, which were closely related.  
Interestingly, CJP17 and CJP19 display opposite biofilm phenotypes, provoking more in depth analysis 
between these two genomes.  
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Figure 5-7: Phylogenetic analysis of CJP isolates and C. jejuni reference genomes. 
Phylogenetic tree based on core genome single nucleotide polymorphisms (SNPs) of 320 
reference genomes and 10 CJP chicken isolates from this study (red). SNPs were identified using 
ParSNP (Treangen et al., 2014), and ParSNP also generated the phylogenetic tree. The genomes 
included shared ~60% of the C. jejuni genome, and the tree was rooted using C. jejuni subsp. 
doylei genomes. 
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5.2.7 Comparative analysis between CJP17 and CJP19 genomes 
Phylogeny clustering using SNP tree analysis (section 5.2.6) revealed that isolates CJP17 and CJP19 are 
closely related (Figure 5-7). However, CJP17 displays a competent biofilm phenotype, and CJP19 is 
unable to form biofilms (see Chapter 3). The genomes of CJP17 and CJP19 were aligned and reordered 
using Mauve (Figure 5-8) where the different coloured blocks indicate homology between strains. 
Figure 5-8 demonstrates that the genomes are almost identical, suggesting more detailed, stringent 
analysis of the genomes is required to assess genomic variation.  
 
Figure 5-8: Comparative analysis of CJP17 and CJP19 genomes. 
Comparative Mauve analysis between the scaffolds of CJP17 and CJP19 genomes. Red lines show 
contig boundaries; sequence homology between the two plasmid sequences is represented by 
colour matching regions. Sequence alignment performed by Mauve. 
 
The CJP17 and CJP19 genomes were analysed using Roary at a 99% sequence identity which identified 
proteins with at least one amino acid difference between strains. In total 14 genes were identified as 
differentially present between the two genomes. Of these genes, 11 were attributed to errors in RAST 
annotation due to the gene being located on a contig boundary. However, three genes, pflA, cheA and 
aas were identified as having different amino acid sequences between CJP17 and CJP19.  
CJP17 was found to have an adenine residue deletion which caused a frame shift mutation in pflA, the 
paralysed flagellum protein (Cj1565c in NCTC11168) with insertional mutations in this gene casing full 
length paralysed flagella (Yao et al., 1994) (Figure 5-9A). The translated protein is truncated as a result 
of the base deletion, shown in Figure 5-9B, which is likely to affect protein function possibly causing 
paralysed flagella. Interestingly, it is the CJP17 competent biofilm former which contains the sequence 
for the truncated protein, and further investigation revealed that motility using the diffusion method 
(see section 2.4.5) was significantly reduced (p=0.0009) in the competent biofilm former CJP17 (Figure 
5-10), indicating that the truncation of the PflA protein may be responsible for the reduction of motility 
in CJP17 compared to CJP19. This supports the findings by Svensson et al. (2014) which indicate that 
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the presence of the flagella filament structure is more fundamental in C. jejuni attachment and 
initiation of biofilm formation than motility. Moreover, Reuter et al. (2015) reported that inactivation 
of the pflA gene reduced autoagglutination ability (which has been linked to biofilm formation 
(Moreira et al., 2006)) similar to the wild type strain, which suggests this mutation in CJP17 may effect 
motility, but not effect biofilm formation as observed in the phenotype (Figure 5-9). 
cheA was found to include a 2 base pair insertion in CJP17, also causing a frame shift mutation (Figure 
5-11A). This again caused a premature stop codon resulting in a truncated protein (Figure 5-11B). 
Similar to the pflA gene, the mutation is present in the competent biofilm former, which conflicts with 
reports that chemotaxis genes have been linked to biofilm formation in C. jejuni (Chandrashekhar et 
al., 2015). 
The third gene, aas (Cj0938c in NCTC11168), which encodes a 2-acylglycerophosphoethanolamine 
acyltransferase / acyl-acyl carrier protein synthetase, possesses a frame shift deletion of one adenine 
in a poly-A tract in CJP17. This also resulted in a truncated inactive enzyme in the competent biofilm 
formers. 
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Figure 5-9: PflA comparisons between CJP17 and CJP19. 
(A) Nucleotide sequence of the pflA gene in CJP17 and CJP19 genomes, aligned using Clustal 
Omega. Asterisks indicate base homology. CJP17 possesses a base deletion in a poly-A tract. (B) 
The translated protein sequences show the correct translation of CJP19, the competent biofilm 
former, whereas PflA is truncated in CJP17, the competent biofilm former, due to base deletion. 
Red colour represents successful translation of protein, dashes (-) represent stop codons. 
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Figure 5-10: Comparison of CJP17 and CJP19 motility. 
The ability of isolates CJP17 and CJP19 to diffuse through semisolid media indicating isolate motility 
in mm. Results show the average of three biological and three technical replicated and significance 
determined by an unpaired t-test between CJP17 and CJP19 isolates. *, p<0.05; **, p<0.01; ***, 
p<0.001, ****, p<0.0001. 
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Figure 5-11: CheA comparisons between CJP17 and CJP19. 
A) Nucleotide sequence of the cheA gene in CJP17 and CJP19 genomes, aligned using Clustal 
Omega. Asterisks indicate base homology. CJP17 possesses a 2-base insertion. (B) The 
translated protein sequences show the correct translation of CJP19, the competent biofilm 
former, whereas CheA is truncated in CJP17, the competent biofilm former, due to base 
insertions. Red colour represents successful translation of protein, dashes (-) represent stop 
codons. 
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Figure 5-12: Aas comparisons between CJP17 and CJP19. 
A) Nucleotide sequence of the aas gene in CJP17 and CJP19 genomes, aligned using Clustal 
Omega. Asterisks indicate base homology. CJP17 possesses a base deletion. (B) The translated 
protein sequences show the correct translation of CJP19, the competent biofilm former, 
whereas aas is truncated in CJP17, the competent biofilm former, due to base insertions. Red 
colour represents successful translation of protein, dashes (-) represent stop codons. 
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5.2.8 Distribution of pflA, cheA and aas genes across C. jejuni lineages 
The distribution of the genes found to possess frame shift mutations in CJP17, namely pflA, cheA and 
aas (section 0) was identified in a panel of 5,829 C. jejuni genomes (Figure 5-13). The genes were found 
to be widely present in the C. jejuni genomes and mostly intact (Table 5-5). There was no clear 
clustering of strains that lacked the pflA, cheA and aas genes, or possessed a truncated version (Figure 
5-13).  
Gene 
# full-length 
genes 
# truncated 
genes 
# absent 
genes % truncated  % absent 
pflA 5813 12 4 0.21 0.07 
cheA 5810 18 1 0.31 0.02 
aas 5707 112 1 1.92 0.02 
Total = 5829 C. jejuni genomes 
Table 5-5: Absent or truncated pflA, cheA and aas genes in C. jejuni genomes. 
The numbers of genomes (total 5,829) containing either full length, truncated, or absent pflA, 
cheA and aas genes. Genes selected due to mutations in the CJP17 genome compared to CJP19.  
 
159 
 
 
 
Figure 5-13: Phylogenetic tree with distribution of differential genes between CJP17 and CJP19. 
Phylogenetic tree containing 5,829 C. jejuni genomes, with their isolation source and MLST clonal complex, showing the distribution of strains where pFlA, 
cheA and aas are absent (blue) or truncated (red). Genes selected through comparisons between two closely related genomes; CJP17, a competent biofilm 
former and CJP19 a poor biofilm former. The tree was constructed from 52 concatenated ribosomal gene sequences per genome (Jolley et al., 2012). 
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5.3 Discussion 
The overall aim of the work described in this chapter was to perform comparative genomic analysis on 
10 chicken CJP isolates and identify differences in gene content between competent and poor biofilm 
isolates. Two approaches to sequence alignment/comparison methods were taken; use of the 
reference genome NCTC11168, and a pangenome comprising the entire gene set of the 10 CJP isolates. 
The 10 genomes’ raw reads were assembled de novo using SPAdes. SPAdes was chosen due to a 
relatively recent paper comparing eight of the leading open source genome assemblers revealing that 
SPAdes produced some of the best assemblies, comprising the largest contigs and scaffolds (Magoc et 
al., 2013). The contigs produced from the assemblies in this work were submitted to RAST server for 
annotation, which identifies protein coding genes, tRNAs and rRNAs, and, through sequence 
homology, assigns function and predicts the subsystems that the identified/predicted genes are 
assigned to (Aziz et al., 2008). The assembled and annotated genomes varied in size and number of 
coding sequences (Figure 5-1). Both the smallest (CJP21) and the largest (CJP28) genomes were present 
in the poor biofilm panel. It was identified that CJP13, the most competent biofilm former, is thought 
to contain a 27.7kbp plasmid (due to its assembly to a single contig), which had a 90% nucleotide 
sequence identity (87% query cover, E value=0.0, Figure 5-5) to pCC42, a C. coli plasmid. No other 
isolates contained pCC42, or multiple genes assigned to pCC42.  
The BRIG software was used to align the assembled CJP genomes to the NCTC11168 reference genome 
(see Figure 5-2). This approach highlighted an important issue which we face in comparative genomics; 
the choice of reference genome is crucial for effective comparative genomic analysis, as novel genes 
present in the query genomes, but absent in the reference, are not accounted for. This is particularly 
evident in the genome of CJP13, which was shown to contain genes that typically reside in the plasmid 
pCC42, and is thus not present in the reference genome. In addition to this, Campylobacter is naturally 
competent, and readily takes up extracellular DNA which can result in great genomic diversity, which 
presents a problem when aligning to one reference genome. 
Large portions of the CJP genomes, particularly CJP01, CJP11 and CJP28, represented by the rings in 
Figure 5-2, contain low percentage identity to the reference genome, as seen by the grey/lighter 
regions of the rings. This is consistent with the knowledge that the CJP isolates are part of distinct CC’s 
which would display genetic variation attributed to the CC themselves. In addition, BRIG analysis uses 
DNA/DNA comparisons rather than amino acid, which by nature would highlight a greater diversity 
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between genomes (since not all SNP results in a change in amino acid). Areas of genome variability 
from BRIG analysis include flagella (Joshua et al., 2006), chemotaxis (Chandrashekhar et al., 2015), and 
adhesion genes (Sulaeman et al., 2012), which have all been linked to biofilm formation in C. jejuni. 
Here, the BRIG analysis is able to identify trends when comparing all query (CJP) genomes to one 
reference. However an approach that exclusively compares all query genomes to each other is 
preferable, particularly for identifying trends between the competent and poor biofilm genomes. It 
was for this reason that a pangenome approach, where the union of multiple genomes is used as a 
reference, was adopted.  
Roary, a pangenome pipeline, extracts the coding regions as defined by RAST annotation, converts 
them into protein sequences and pre-clusters them with ‘Cluster Database at High Identity with 
Tolerance’ (CD-HIT), which vastly reduces the volume of data (Page et al., 2015). BLASTp analysis 
compares all protein sequences against each other with a defined sequence identity. In this study, 
90%, 95% and 99% sequence identity was used depending on the type of analysis. Using 99% sequence 
identity thresholds are more stringent, and can identity genes with one amino acid difference. 
Sequences were clustered with the ‘Markov Cluster Algorithm’ (Enright et al., 2002) , and then merged 
with the CD-HIT clustering. The analysis was performed with "paralog clustering" enabled, which does 
not split potential paralogs into separate clusters: an important parameter, particularly when Roary 
uses high percentage identity thresholds. A recent paper from van Vliet (2017), which investigated 
Helicobacter pylori, a bacterium related to C. jejuni but with even higher levels of sequence variation, 
reported that paralog clustering had a significant effect on the size of the core genome, and the 
disabling of paralog clustering generated a number of allelic variants, or false positives. This is observed 
because paralog clustering groups duplicated genes. Ungrouped genes results in independent features 
which may disguise trends in gene content between genomes. 
Genomes were compared at different percentage identities to maximise the potential of the analysis. 
The lower percentage identity, i.e. 90% used in this study with paralog clustering, resulted in 2,476 
genes identified in the pangenome, whereas 95% (with paralog clustering) generated 2,671, and 99% 
(without paralog clustering) generated 4,125 genes. Indeed, lowering the percentage identity 
threshold results in the identification of fewer genes, due to a larger tolerance for divergence within a 
particular sequence and therefore larger and/or greater number of paralog clusters. Alternatively, 
increasing the percentage identity threshold, making the settings more stringent, highlights more 
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subtle differences between sequences, i.e. single nucleotide polymorphisms (SNPs) which can result 
in one amino acid change.  
As discussed in section 5.6, and presented in table 5.2, no genes were exclusively present or absent in 
either of the competent and poor biofilm former genomes. The genes which were found to be most 
differentially present between the panels, were most numerous at the 99% identity threshold, which 
is logical since it is the most stringent.  
Interestingly, one gene encoding a sialyltransferase (enzyme code EC 2.4.99, Table 5-2), was identified 
at each percentage identity threshold as present in 80% of the competent biofilm isolates.  
Sialyltransferase transfers sialic acid residues to surface exposed lipooligosaccharide (LOS) which may 
affect the surface protein function, such as adhesion. It is unclear how the sialyltransferase may affect 
biofilm formation by the function of the enzyme, however Louwen et al. (2008) reported that sialyation 
mutants (Δcst-II) showed significantly reduced invasion to Caco-2 and T-84 cells, yet only one mutant 
showed reduced adhesion. They suggest that adhesion to these cell lines involve JlpA, CadF etc, but 
invasion is more likely to be mediated by LOS sialylation. Interestingly however, Naito et al. (2010) 
reported that mutants lacking the LOS outer core (such as ΔwaaF and ΔlgtF) exhibited enhanced 
biofilm formation but ΔgalT or ΔcstII did not, suggesting the LOS outer core is linked with planktonic 
growth and/or biofilm dispersal. In this study, neuB1 homologs for sialic acid synthase were also 
present in the same 80% of competent biofilm genomes (and absent from 80% of the poor), further 
indicating an association between sialylation and biofilm formation, although the links between LOS 
and biofilm formation are unclear at this time. 
A hypothetical protein, thought to be a membrane protein due to a weak homology with a periplasmic 
membrane protein in Yersinia enterocolitica, was also present in 100% of poor biofilm isolates and in 
20% of the competent isolates. Its presence in predominantly poor biofilm isolates goes against the 
results presented in Chapter 4, which indicates that multiple uncharacterised membrane proteins 
(Cj0080 and memP) are involved in biofilm formation in C. jejuni, with mutations in showing a 
significant reduction in biofilm formation (Figure 4-23, Figure 4-29 and Figure 4-30). In addition, 
Kalmokoff et al. (2006) identified a number of uncharacterised periplasmic or membrane proteins 
expressed in the biofilm phenotype. It is unclear what role the putative periplasmic protein (identified 
from Roary analysis) has in biofilm formation, but they may be factors specific to the strains used in 
this study, rather than associated with the biofilm phenotype. 
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A dsbA-like gene was also presented in the Roary analysis at 99% sequence identity as present in 80% 
of the poor biofilm isolates. Interestingly dsbA has been linked to wild type motility and 
autoagglutination in C. jejuni (Grabowska et al., 2014, Reuter et al., 2015), both factors which are linked 
to C. jejuni biofilm formation. However, the genes are also present in the poor biofilm isolates, which 
is counter intuitive. It is possible that a defective dsbA gene which as a result reduces cell motility, may 
lead to the sinking of cells in broth culture. This could allow efficient attachment of cells to a surface, 
which would correspond to competent biofilm formation in the crystal violet staining assay. This 
implies that biofilms can be formed as a result of a failure of a mechanism, rather than a direct 
response. It must be noted at this time that caution must be taken when interpreting Roary results 
using 99% sequence identity, as these settings may be too stringent for such diverse genomes, 
generating allelic variants. 99% sequence identity is much more useful when comparing closely related 
sequences, as discussed for CJP17 and CJP19. 
Given the high levels of sequence diversity of C. jejuni genomes, and the small number of genomes 
sequenced in this study, it is not surprising that the Roary analysis was unable to identify a number of 
gene targets that were significantly present or absent between competent and poor biofilm isolates. 
Larger screens comprising hundreds of C. jejuni isolates with defined biofilm phenotypes would enable 
more effective identification of genes linked to biofilm formation in C. jejuni. Nevertheless, Roary 
analysis was able to generate four genes differentially present or absent between competent and poor 
biofilm isolates. 
The presence of genes associated with biofilm formation from the transposon mutant library screen, 
were subjected to Roary analysis (at 90%, 95% and 99% identity). Interestingly, all CJP genomes 
contained all but two genes of interest, trbJ and rha, which are located on the CJP13 pCC42 plasmid, 
only present in CJP13. Although genes memP, hydA, Cj0080 and trbJ were shown to reduce the biofilm 
phenotype in CJP13 (see Chapter 4), it is clear that their presence in a genome alone does not dictate 
the biofilm phenotype. In addition to this, distribution analysis revealed that >99% of 5,829 C. jejuni 
genomes possess a full length version of each of these biofilm related genes (Table 5-4, Figure 5-3 and 
Figure 5-4). The wide distribution of these genes across C. jejuni strains indicates their importance in 
the C. jejuni core genome, therefore inactivation of these genes, as seen in earlier chapters, is likely to 
influence key phenotypes involved with their survival, such as biofilm formation. 
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A small cluster of agricultural isolates, predominately ST-464, possess trbJ and pCC42 (red arrow, 
Figure 5-6). These particular agricultural samples were isolated from a variety of hosts, including 
chicken. However, there was no strong correlation between pCC42 or trbJ presence and agricultural 
strains per se. Further analysis is required to determine a possible link between presence of the pCC42 
plasmid and chicken C. jejuni isolates, and indeed biofilm formation. 
SNP analysis, using 60% of the core genome as the reference, assessed the phylogenetic relationship 
of the CJP isolates against 320 C. jejuni genomes (Figure 5-3). The SNP tree revealed (along with the 
MLST results in Chapter 3, Figure 3.3) the distribution of CJP isolates over a wide spectrum of STs and 
CCs. Comparisons between such diverse genomes can be challenging as discussed by Falush and 
Bowden (2006): within an expanding lineage, the progeny of a clonal population will share genes 
associated with a phenotype, as well as genes that are not. This can confuse the association between 
gene content and phenotype, and reduce statistical significance. It is therefore difficult to attribute the 
genes identified from Roary analysis as being related to biofilm formation. Analysis of poor and 
competent biofilm formers within the same clonal population would be preferable as this would 
reduce the ‘background noise’ of genes present due to the clonal population, and reveal genuine 
trends in gene content related to biofilm formation. This approach was adopted by a recent study 
investigating the genetic backgrounds of biofilm and non-biofilm isolates (Pascoe et al., 2015). Much 
of their comparative genomics comprised the analysis within two clonal complexes, ST-21 and ST-45, 
and compared poor and competent biofilm genomes within these groups. 
The finding that CJP17 and CJP19 had almost identical genomes (Figure 5-8) but displayed opposite 
biofilm phenotypes, presented a new focus for investigation. Genomic comparisons between CJP17 
and CJP19 using Roary at 99% sequence identity revealed three genes of interest which contained 
variations in amino acid sequence. Mutations in the pflA, cheA and aas CJP17 genes which caused 
frame shift mutations lead to the truncation of the respective proteins. Interestingly, the mutations 
are present in the CJP17 competent biofilm former, rather than the poor (CJP19) and further 
investigation revealed a significant reduction (p=0.0009) in motility of CJP17 compared to CJP19 
(Figure 5-10). The findings therefore imply that; i) the reduction in motility may be attributed to the 
mutations in the pflA gene, and ii) the motility of an isolate does not dictate the biofilm phenotype. 
This agrees with the earlier findings in Chapter 3, (Figure 3.4B) which identified a weak correlation 
between motility and biofilm formation. This also complies with the general consensus that flagella 
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structure is more important for initial attachment (key in the early stages of biofilm formation), 
whereas motility facilitates the kinetics of biofilm formation (Svensson et al., 2014). A similar analogy 
to the dsbA gene can be made by hypothesising that lack of motility will allow the sinking of cells, 
which will result in increased attachment of cells to the bottom of the wells in the biofilm assay. Strains 
with these gene defects and protein truncations may not be seen as strong biofilm formers in the less 
controlled environment of a poultry processing plant. The distribution of pflA, cheA and aas genes 
were also found to be widespread, with no obvious trends in gene absence or truncation across strains. 
Interestingly, the isolates identified as possessing a truncated version of the MCP chemotaxis protein 
(Figure 5-3) were clustered within the same sub-branch in the phylogenetic tree as the cheA truncated 
proteins (Figure 5-13) as indicated by arrows. These strains, isolated from environmental samples, 
show an increased likelihood of truncated chemotaxis proteins which are well known to affect biofilm 
formation in C. jejuni (Chandrashekhar et al., 2015). Given that this cluster of strains have been isolated 
from the environment, it is likely that these strains form biofilms, but not by chemotaxis driven 
mechanisms. 
Biofilm formation can be influenced by a number of factors, and this study proposes that the 
phenotype cannot be attributed to the presence or absence of any one gene. In addition to this, the 
same biofilm phenotype can be achieved through diverse genetic changes (Pascoe et al., 2015). Thus 
transcriptional and post-transcriptional regulatory events are more likely to play a pivotal role in the 
phenotype. Indeed, transcriptional and phase variation caused by the presence of poly-nucleotide 
tracts resulting in slipped-strand mispairing has been reported to highly influence biofilm formation in 
Staphylococcus sp. (Wu et al., 2015, Brooks and Jefferson, 2014). Genes, such as maf4 (which can alter 
flagella glycosylation affecting autoagglutination), and flgR (regulating motility) are both phase 
variable genes in C. jejuni with the potential to affect biofilm formation (van Alphen et al., 2008, 
Hendrixson, 2006). 
Biofilm formation is known to be a complex multifactorial process, and the results presented in this 
chapter support this. Of the four genes that were most differentially present between competent and 
poor biofilm isolates, two were involved with sialylation of surface structures in C. jejuni. Distribution 
analysis of previously described biofilm-related genes was identified as likely part of the C. jejuni core 
genome. More detailed comparisons between genomes CJP17 and CJP19 saw a number of frame shift 
mutations in CJP17, one of which is believed to be responsible for the reduction in motility. Genome-
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wide association studies on a larger scale, comprising strains of similar clonal populations, would 
provide more reliable trends in gene content for biofilm formation.  
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6 Metabolic phenotype profiling of C. jejuni  
6.1 Introduction 
C. jejuni is able to colonise the gastrointestinal tracts of numerous hosts and survive for long periods 
in the environment despite its fastidious nature. For the pathogen to successfully grow, survive and/or 
establish itself in a niche comprising multiple other bacterial species, it is essential for C. jejuni to utilise 
a diverse range of nutrients freely available in the given environment. 
The metabolic pathways of nutrient acquisition in C. jejuni are poorly understood (Stahl et al., 2012, 
Wagley et al., 2014). However, C. jejuni is known to lack 6-phosphofructokinase (Velayudhan and Kelly, 
2002, Parkhill et al., 2000), a key enzyme in the glycolytic pathway, which therefore prevents the 
metabolism of glucose, galactose and other carbohydrates. Therefore, Campylobacter relies on amino 
acids and organic acids as the main source of carbon. C. jejuni has been shown to metabolise amino 
acids in a preferential sequential order; with serine utilised first, then aspartate, glutamate and proline, 
when grown in a complex media (Wright et al., 2009). C. jejuni is also able to metabolise key organic 
acids such as pyruvate, fumarate and lactate and other by-products of fermentative utilisation of 
carbohydrates, such as lactate. 
To date, there has been a lack of information regarding a metabolic link to biofilm formation. 
Kalmokoff et al. (2006) investigated the protein expression profiles of C. jejuni biofilm and planktonic 
cells, which revealed a number of proteins involved in ‘energy generation’ upregulated when in a 
biofilm. This implies that biofilm cells are in a metabolically active state, and the individual metabolic 
profile of a particular strain may influence its ability to survive in a biofilm, even its ability to form a 
biofilm initially. In addition, it has recently been reported that C. jejuni isolates are able metabolise L-
fucose (Muraoka and Zhang, 2011). The capability of these strains to metabolise L-fucose seems to 
provide a competitive advantage (Stahl et al., 2011), and evidence in a reduction of biofilm phenotype 
when exposed to L-fucose has been reported (Dwivedi et al., 2016). In addition to L-fucose, the 
presence of environmental phosphate has been found to influence biofilm formation. phoX, encoding 
an alkaline phosphatase used in the TAT system of protein export, when disrupted increases biofilm 
formation in C. jejuni (Drozd et al., 2011). Therefore, it is proposed that low levels of phosphate induce 
C. jejuni to form biofilms as a survival mechanism, until increased levels of nutrients are available. 
Indeed, reversal of the biofilm phenotype has been observed when cultures were supplemented with 
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inorganic phosphate. Surfaces in poultry processing plants will provide surfaces with low levels of 
phosphate, which could induce the biofilm phenotype (Drozd et al., 2011). 
The Biolog phenotypic microarray system is a high-throughput method of assessing substrate 
utilisation, and has widespread use in bacteriology. The Biolog system comprises several 96-well plates 
with different substrates and a tetrazolium dye, an electron acceptor from the microbial 
oxidation/reduction reactions, present in each well. The cells are inoculated into the plate with a 
minimal medium, which forces the organism to utilise the carbon substrate provided, if metabolically 
capable. Respiration in the presence of a substrate stimulates a flow of electrons from the carbon 
source to NADH, through the electron transport chain of the organism, reducing the tetrazolium which 
results in the production of a purple precipitate (Bochner et al., 2001). The level of precipitate within 
a well acts as a marker of respiration and therefore metabolically active cells (Bhupathiraju et al., 
1999). The level of purple within a well can be detected and quantified using an OmniLog plate reader 
(http://www.biolog.com/) which reads the plates every 15 minutes, with a data output in OmniLog 
units. Repeated measurements of the purple pigment ultimately produces quantitative, kinetic curves 
of cells’ respiration in a given well from which further understanding of an organism/cells metabolic 
capacity can be obtained. The Biolog system provides a variety of phenotypic microarray (PM) plates 
for assessing utilisation of carbon, nitrogen, phosphorus and sulphur substrates. However, this study 
exclusively investigates C. jejuni utilisation of carbon sources, since carbon catabolism is central to 
energy production via reducing equivalents, ATP and biosynthetic precursors (Munoz-Elias and 
McKinney, 2006). In addition this system is being used increasingly as a high-throughput method of 
rapidly screening and comparing metabolism of different strains (Lee et al., 2017), species (Wagley et 
al., 2014) and between mutant and wild type strains (Pletzer et al., 2014, Rasmussen et al., 2013). 
Analysing the metabolic profiles of the competent and poor biofilm isolates may elucidate unique 
metabolic pathways which could be attributed to the biofilm phenotype in C. jejuni. With this in mind, 
the aims of the work that this chapter describes were as follows: 
 To screen 10 CJP isolates (five competent, and five poor biofilm formers) and NCTC11168 
through the Biolog phenotypic array system using phenotypic arrays PM1 plates to assess 
carbon source utilisation. 
 To determine carbon sources that are differentially utilised between individual strains, and 
between grouped competent and poor biofilm formers using four parameters of a kinetic 
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curve, namely: log phase, area under the curve (AUC), maximum (max) slope, and max 
utilisation. 
 To determine the effect of particular carbon sources on biofilm formation, using the crystal 
violet staining assay. 
6.2 Results 
6.2.1 Overview of carbon metabolism of CJP isolates 
The capacity of the panel of five competent and five poor biofilm former CJP isolates and NCTC11168 
strain to metabolise 95 different carbon sources was investigated. An overview of the utilisation of 
carbon sources (listed in the Biolog ‘PM1’ 96-well plate layout in Figure 2.1), corresponding to the 
respiration captured by the reduction of tetrazolium dye included in each Biolog well, is detailed in 
Table 6-1, and represented by the clustered heat map shown in Figure 6-1. All data was normalised to 
the A0 control well, which contains no carbon source i.e. used to assess baseline respiration of cells 
when no carbon source is available. Data comprising the endpoint data (96 hours) for each isolate and 
carbon source can be found in Appendix V. 
 Approximately 59% (56/95) of carbon sources were not utilised (OmniLog units=0) by the 10 chicken 
CJP isolates or indeed the NCTC11168 strain (Table 6-1). The heat map comprising the end-point (96 
hours) metabolism reading in Omnilog units, which detect colour change of the reduced tetrazolium 
when in the presence of metabolically active cells, generated from the Biolog shows that all C. jejuni 
strains were able to metabolise five of the carbon sources; L-Arabinose (well A02), D-Xylose (well B08), 
D-Psicose (well H05), L-Lyxose (well H06) and Pyruvic Acid (well H08) (OmniLog units>0, Appendix V). 
NCTC11168, CJP12 and CJP17 demonstrated strong utilisation of a number of substrates, indicated by 
the red colour of the heat map. These isolates along with CJP21 also utilise the highest number of 
carbon sources (37.5%-41.6% Table 6-1 and Appendix V). It must be noted that the NCTC11168 
metabolic profile largely matched previously published studies using this strain (Line et al., 2010). 
The ability to metabolise, and the level of utilisation of different carbon sources, varied largely 
between strains. Clustering of isolates, using the Euclidean distance metric, did not group competent 
and poor biofilm formers, indicating distinct metabolism traits between strains. CJP17 and CJP19 
isolates, identified as being almost genetically identical, show diverse carbon metabolism profiles (do 
not appear clustered together in the heat map of Figure 6-1). Further analysis of the CJP17 and CJP19 
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carbon utilisation profiles revealed a strong positive correlation between them (Pearson’s correlation 
coefficient r=0.64). However, generally CJP17, the competent biofilm former, utilised each carbon 
source more readily than CJP19, the poor biofilm former. This was consistent over three biological 
replicates. 
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Number of carbon sources 
Total 
utilised 
showing 
high 
utilisation 
(>100 
OmniLog 
units) 
showing moderate 
utilisation (50 – 100 
OmniLog units) 
showing low 
utilisation (<50 
OmniLog units) 
not 
utilised 
(0 
OmniLog 
units) 
NCTC11168 36 14 9 13 60 
CJP11 31 30 1 0 65 
CJP12 38 13 13 12 58 
CJP13 14 9 5 0 82 
CJP17 38 11 11 16 58 
CJP27 27 27 0 0 69 
CJP01 33 24 8 1 63 
CJP19 27 20 7 0 69 
CJP21 40 30 10 0 56 
CJP22 7 7 0 0 89 
CJP28 34 21 11 2 62 
Table 6-1: Carbon sources utilised by each CJP isolate. 
Table indicates the total number of carbon sources utilised by each of the 10 CJP isolates and 
NCTC11168 strain and the level of the reported utilisation. Data represents endpoint (t=96 
hours) utilisation readings at 37ᵒC measured in OmiLog units, which detect colour change of the 
reduced tetrazolium when in the presence of metabolically active cells. Data is normalised 
against the A0 control well data containing no additional carbon source. Isolates highlighted in 
blue indicate competent biofilm formers (CJP11, CJP12, CJP13, CJP17 and CJP27 respectively), 
and those highlighted in red indicate poor biofilm formers (CJP01, CJP19, CJP21, CJP22 and 
CJP28). High utilisation is represented by the endpoint OmniLog units >100, moderate utilisation 
indicates Omnilog units between 50 and 100, and low utilisation represents OmniLog units <50. 
No utilisation is represented by an OmniLog reading of 0. Data averaged over three biological 
replicates. 
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Figure 6-1: Clustered heat map showing end-point utilisation values of 95 carbon sources for 10 CJP isolates and NCTC11168. 
Clustered heat map showing respiratory activity (indicating carbon source utilisation) of CJP isolates. C. jejuni isolates were incubated for 96 hours in Biolog™ 
PM1 96 well-plates with each well containing a different carbon source. The end-point levels of respiration are colour-coded; blue indicates no utilisation of 
carbon source, yellow-green indicates low levels, and red indicates high levels of carbon source utilisation. The well positions listed below the heat map 
correspond to the Biolog plate layout illustrated in Figure 2.1 in materials and methods. Blue and red blocks next to the isolate labels on the y-axis indicate 
competent (CJP11, CJP12, CJP13, CJP17 and CJP27) and poor (CJP01, CJP19, CJP21, CJP22 and CJP28) biofilm former isolates, respectively. 
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6.2.2 Differential carbon utilisation between CJP isolates, and between competent and poor 
biofilm formers. 
Data analysis was performed as described (see materials and methods section 2.11.1). Any significant 
differences in strain utilisation of carbon sources (post-hoc p-value< 0.05) detected by the analysis is 
listed in Table 6-2 and Table 6-3. The data was analysed by taking two approaches: i) comparing each 
individual strain to identify strains that are significantly different in substrate utilisation compared to 
others (see Table 6-2); ii) comparing the groups of competent and poor biofilm CJP isolates to highlight 
significant differences between the two groups (see Table 6-3). 
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Six carbon sources were highlighted as being significantly differentially utilised when comparing the 
carbon metabolism of the chicken isolates (Table 6-2): five when using the lag phase to define 
substrate utilisation (namely L-glutamic acid, α-hydroxy butyric acid, D-malic acid, L-malic acid and 
Pyruvic Acid), and one carbon source, L-lactic acid, when using the AUC and maximum (max) utilisation 
parameters to define substrate utilisation. The strain CJP13, the most competent biofilm former, was 
shown to utilise L-glutamic acid, L-malic acid and pyruvic acid significantly differently to other strains 
when using lag phase, AUC and max utilisation to define substrate utilisation. For these substrates, 
CJP13 is associated with a longer lag phase or slower initial metabolism of the chosen substrate 
(compared to other strains), as indicated by the mean difference value. 
When the data was grouped into competent and poor biofilm panels (Table 6-3), three different carbon 
sources were shown to be significant; D-ribose and L-lyxose when using lag phase to define utilisation, 
and L-lactic acid when using max utilisation and max slope to represent substrate utilisation.  
Differential L-lactic acid utilisation kinetic curves between groups of competent and poor biofilm 
isolates are illustrated in Figure 6-2, with competent biofilm formers showing increased initial 
utilisation (indicated by max slope) and total utilisation (max utilisation). Significance is illustrated as 
described in Table 6-3.  
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Carbon Source Well Parameter 
Strains compared 
(strain1-strain2) 
Mean 
difference  
(strain1-strain2) 
P-value 
L-Glutamic Acid B12 Lag phase 
CJP13-CJP01 91.52 0.004 
CJP13-CJP17 88.714 0.005 
CJP12-CJP13 -84.065 0.007 
CJP11-CJP13 -82.327 0.008 
CJP13-CJP22 80.825 0.009 
CJP13-CJP28 80.56 0.009 
CJP13-CJP21 75.044 0.014 
CJP27-CJP13 -66.853 0.027 
CJP13-CJP19 61.195 0.088 
α-Hydroxy Butyric Acid E07 Lag phase CJP12-CJP22 -19.068 0.049 
D-Malic Acid G11 Lag phase 
CJP12-CJP22 -69.396 0.035 
CJP01-CJP22 -68.61 0.037 
CJP27-CJP22 -67.484 0.04 
CJP28-CJP22 -64.416 0.05 
L-Malic Acid G12 Lag phase 
CJP12-CJP13 -67.919 0.009 
CJP13-CJP17 64.431 0.012 
CJP13-CJP01 63.637 0.013 
CJP13-CJP28 60.52 0.018 
CJP13-CJP22 59.206 0.02 
CJP27-CJP13 -55.295 0.03 
CJP11-CJP13 -54.728 0.032 
Pyruvic Acid H08  Lag phase 
CJP12-CJP13 -81.108 0.018 
CJP13-CJP01 78.312 0.022 
CJP13-CJP28 74.802 0.028 
CJP27-CJP13 -73.962 0.03 
CJP11-CJP13 -71.464 0.035 
L-Lactic Acid B09 
AUC CJP12-CJP22 12836.027 0.02 
Max utilisation 
CJP17-CJP22 127.38 0.029 
CJP12-CJP22 126.165 0.031 
Table 6-2: Significantly different utilisation of carbon substrates between CJP 
isolates. 
CJP isolates ability to utilise carbon sources were screened in the Biolog phenotypic array, 
generating utilisation kinetic curves that were compared between strains using four parameters 
(Lag phase, max slope, max utilisation and AUC). Significant differences (p<0.05) in the lag phase 
parameter were detected in L-Glutamic Acid, α-Hydroxy Butyric Acid, D-Malic Acid, L-Malic Acid 
and Pyruvic Acid between the isolates indicated. Significant differences in L-lactic acid AUC and 
max utilisation parameters were observed in the highlighted isolates. The isolates highlighted 
in blue represent the competent biofilm formers, and the red, the poor biofilm formers. CJP13 
in bold represent the most competent biofilm CJP isolate. The mean difference indicates the 
value of the parameter of strain 1, minus the value of strain2. A negative number indicates a 
higher value for strain 2, i.e. a longer lag phase, higher max utalisation etc.  
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Carbon 
Source 
Well Parameter 
Groups compared 
(competent-poor) 
Mean difference 
(competent-poor) 
P-
value 
D-Ribose C04 Lag Phase Competent-Poor -1.863 0.0462 
L-Lyxose H06 Lag Phase Competent-Poor -3.225 0.001 
L-Lactic Acid B09 
Max utilisation Competent-Poor 42.842 0.017 
Max slope Competent-Poor 32.561 0.048 
Table 6-3: Significantly different utilisation of carbon substrates between 
competent and poor biofilm former CJP isolates.  
CJP isolates ability to utilise carbon sources were screened in the Biolog phenotypic array, 
generating utilisation kinetic curves that were compared between strains using four parameters 
(Lag phase, max slope, max utilisation and AUC). The data for the competent and poor biofilm 
isolates were averaged and compared. Significant differences (p<0.05) in the lag phase 
parameter were detected in D-ribose and L-lyxose between competent and poor isolates. 
Significant differences in L-lactic acid max utilisation and max slope parameters were observed 
between competent and poor biofilm isolates. The isolates highlighted in blue represent the 
competent biofilm formers, and the red, the poor biofilm formers. The mean difference 
indicates value of the parameter of grouped competent value, minus the value of the grouped 
poor biofilm isolates. A negative number indicates a higher value for grouped poor, i.e. longer 
lag phase in poor biofilm isolates. 
 
 
Figure 6-2: Differential metabolism of L-lactic acid between competent and poor 
biofilm isolates. 
Differences in L-lactic acid metabolism between grouped competent and poor biofilm isolates 
using biofilm data measured in Omnilog units.  Averaged respiration of competent biofilm 
formers shown in blue, and poor biofilm formers in red. The shaded areas represent the 
standard deviation. Statistical significance in max slope, and max utilisation listed Table 6-3. *, 
p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001. 
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6.2.3 L-lactic acid metabolism and biofilm formation 
L-lactic acid was shown to be differentially metabolised between competent and poor biofilm isolates 
when substrate utilisation was defined using max utilisation and max slope parameters. Thus the 
possible links between L-lactic acid and biofilm formation were further investigated. Increasing 
concentrations of L-lactic acid (0, 10 µM and 20 µM), were used in a biofilm assay using BHI broth to 
assess the effect on biofilm formation of the 10 CJP isolates and the NCTC11168 strain. The results in 
Figure 6-3 indicate no significant difference between biofilm formation of chicken isolates when 10 µM 
or 20 µM of L-lactic acid is available. At these concentrations of L-lactic acid no increase in biofilm 
formation was observed in competent isolates, or poor biofilm isolates. However, biofilms were 
significantly reduced in NCTC11168 when incubated with 20 µM of L-lactic acid compared to 0 or 10 
µM. 
 
Figure 6-3: The effect of L-lactic acid on biofilm formation of CJP isolates. 
Competent and poor biofilm isolates and NCTC11168 grown in brain heart infusion broth in a 
96 well plate for 72 hours at 37°C in BHI broth containing 0, 10 µM and 20 µM of L-lactic acid. 
After incubation, biofilm cells were washed and stained with crystal violet. The bound crystal 
violet was dissolved with methanol and optical density (OD) readings taken (OD540). Bars show 
the average of three technical and three biological replicates, error bars represent the standard 
deviation. Asterisks indicate the significant difference in biofilm formation between varying 
concentrations of L-lactic acid within isolates using a one-way ANOVA followed by Tukey’s 
multiple comparisons test (*, p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001). Black bars 
represent biofilm formation in media containing no L-lactic acid, dark grey bars with media 
containing 10 µM, and light grey bars with 20 µM of L-lactic acid. 
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6.3 Discussion 
The aim of the work described in this chapter was to investigate the utilisation of 95 carbon substrates 
by NCTC11168 and 10 CJP competent and poor biofilm C. jejuni isolates, and identify trends in 
utilisation between the two biofilm phenotypic panels. The Biolog phenotypic microarray system is a 
high throughput method enabling rapid screening of metabolic capabilities which are measured by the 
reduction of tetrazolium dye which acts as an electron acceptor to metabolising cells, and produces a 
purple precipitate when reduced (Bhupathiraju et al., 1999). 
In this study, reproducibility between replicates was poor, showing variation in the ability of a strain 
to utilise a substrate, and the level of utilisation. Variation between strains is likely due to genetic 
variation, with strains lacking relevant genes unable to metabolise some substrates. However, the 
variation between replicates may be attributed to gene regulation. Although conditions were the same 
in all biological replicates, slight changes in gene regulation may correspond to increases/decreases in 
levels of substrate utilisation. This in turn will affect the parameters used for analysis and reduce 
statistical significance. All data was normalised to the A0 control well in order to obtain a clearer 
distinction between substrate utilisation. Despite variation, statistical analysis generated significant 
differences in utilisation between; i) specific isolates (Table 6-2) and ii) grouped competent and poor 
biofilm isolates (Table 6-3). However, significance tended to be observed for only one parameter at 
any one time. In addition, many of the substrates showing significant differences in a particular 
parameter was not represented in the wider panels of competent and poor biofilm formers. 
Unfortunately, much of the significance was observed between strains in the same panel, i.e. both 
competent biofilm formers. It is clear that there is much variation in metabolic profiles between 
strains, which will affect statistical significance when comparing panels.  
The results of this study indicate that not all C. jejuni isolates utilise the amino acids that are reported 
to be essential carbon sources for C. jejuni (Figure 6-1 and Appendix V). Due to C. jejuni lacking the 
ability to utilise carbohydrates, Campylobacter rely on amino acid utilisation and the intermediates of 
the citric acid cycle for energy (Epps et al., 2013). More specifically to this study, CJP13 did not utilise 
aspartate, proline, glutamate or serine; CJP01 did not utilise serine; CJP19 did not utilise aspartate; and 
CJP22 did not utilise aspartate, proline, glutamate, asparagine or serine (Figure 6-1 and Appendix V). 
Interestingly, CJP22, a poor biofilm former, was the only strain to not possess a L-asparaginase enzyme 
(EC 3.5.1.1) within its genome (as defined by Roary analysis at 95% sequence identity), which 
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corresponds to the lack of CJP22 L- asparagine utilisation in Biolog data (Figure 6-1). Line et al. (2010) 
reported a strong chemotactic response of C. jejuni to L-asparagine using disc and capillary methods 
at 37ᵒC. Moreover, L-serine and L-fucose have been shown to induce the movement of C. jejuni cells 
towards the mucus layer of human intestinal tracts. This chemotactic response to particular amino 
acids allows bacteria to accumulate where a particular chemoattractant is present in high 
concentrations. Accumulation of bacteria in high density may allow the autoagglutination of cells and 
attachment to surfaces in the form of a biofilm. Alternatively, the inability of a strain to metabolise an 
amino acid may affect its chemotactic influences, and therefore is less likely to form a biofilm. Amino 
acids  serine, aspartate, glutamate, and proline are the most common amino acids in chicken excreta 
(Parsons, 1984) and contamination of surfaces in a poultry processing plant may provide ideal 
conditions for attracting and attaching C. jejuni cells. However, CJP13 was found not to metabolise key 
amino acids such as serine, aspartate, glutamate and proline. This result is confusing since the genome 
possesses the relevant genes for the metabolism of these amino acids, and is key in Campylobacter’s 
source of energy. If this result is correct, it is clear that the ability of the strain to metabolise certain 
amino acids alone is not responsible for the biofilm phenotype, since CJP13 forms complex biofilms. 
In terms of utilisation of organic acids, Line et al. (2010) reported the successful utilisation of pyruvate, 
L-lactate, fumarate, bromosuccinate, methyl pyruvate, succinate, D- and L-malate, α-hydroxybutyrate, 
α-ketoglutarate and citrate by NCTC11168 in Biolog PM1 Biolog plates. The results reported in this 
study agree with the findings of Line et al. (2010) as that the majority of CJP strains (6-10 of the total 
10) were able to metabolise these carbon sources, with NCTC11168 metabolising all mentioned 
organic acids. 
One carbon source, L-lactic acid, showed significance when using the AUC and max utilisation 
parameters to represent different substrate utilisation between isolates (Table 6-2) and when using 
the max slope and max utilisation parameters between competent and poor biofilm formers (Table 
6-3). Interestingly Stintzi (2003) proposes that an increase in temperature (i.e. from 37ᵒC to 42ᵒC) 
reduces the oxygen present in culture media, since gas solubility deceases. Therefore, a temperature 
increase could influence C. jejuni cells in liquid culture to switch from aerobic to anaerobic metabolism, 
and therefore increase the likelihood of L-lactic acid metabolism, given that it is a by-product of 
fermentation. This could be particularly relevant in poultry processing plants where part of the 
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processing involves the dipping of chicken carcasses into a hot water tank to facilitate feather removal. 
This could provide an ideal environment for anaerobic metabolism.  
A recent study reported that although C. jejuni NCTC11168 contains a fermentative lactate 
dehydrogenase gene (cj1167), no lactate excretion was observed (Thomas et al., 2011). In addition, 
cj1167 mutants did not reduce growth in minimal media supplemented with lactate. Thomas et al. 
(2011) propose that NCTC11168 use two novel NAD-independent L-LDHs, (a non-flavin iron–sulphur 
containing three subunit membrane-associated enzyme (Cj0075c-73c), and a flavin and iron–sulphur 
containing membrane-associated oxidoreductase (Cj1585c)) for utilisation of L-lactate. Other bacteria 
that readily colonise the avian gut produce L-lactate as a by-product of fermentative growth, which 
provides an ideal environment for C. jejuni to colonise as it can use L-lactate as an electron donor and 
a carbon source. This implies that the presence of other bacteria in the environment, such as in a 
poultry processing plant, may aid the growth and survival of C. jejuni. 
Interestingly, all isolates screened in this study were able to metabolise L-lactic acid (Figure 6-1), with 
the exception of CJP22. With further analysis, it was discovered that this isolate lacked a lactate 
dehydrogenase which was present in all other CJP genomes (Roary analysis at 95% sequence identity). 
Lactic acid treatments during poultry processing have been used with the aim of reducing bacterial 
load on the chicken carcasses. There have been multiple studies which have reported a significant 
reduction in Campylobacter populations after treatment (Rasschaert et al., 2013, Rajkovic et al., 2010, 
Lecompte et al., 2009), however chemical treatments are not authorised in the EU (EFSA, 2011). This 
study shows that competent biofilm formers more readily metabolise L-lactic acid suggesting that sub 
inhibitory concentrations of lactic acid used for treatment could potentially aid growth and select for 
C. jejuni strains which are competent biofilm formers.  
The competent biofilm former isolates metabolised D-ribose and L-lyxose with a shorter lag phase in 
the kinetic curve compared to poor biofilm isolates (Table 6-3). This is an interesting result as it is 
thought that C. jejuni has a limited metabolism of sugars, given that large parts of the glycolysis 
pathway are missing from the genome (Velayudhan and Kelly, 2002). This could perhaps be 
highlighting a key advantage of C. jejuni biofilm forming isolates, in that they are more able to 
metabolise a larger variety of carbon sources compared to non-biofilm forming isolates. However, a 
more likely scenario is that these are false positive results.  
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However, recent studies have identified subsets of C. jejuni strains that are able to metabolise hexose 
sugars such as L- fucose (Muraoka and Zhang, 2011, Stahl et al., 2011) and glucose (Vegge et al., 2016) 
as a carbon source through the Entner-Doudoroff pathway. Vegge et al. (2016) hypothesise that the 
conversion from glucose to glucose-6-phosphate and/or fructose-6-phosphate could be used for the 
production of surface structures such as capsule or free polysaccharide which could aid bacterial cell 
attachment and biofilm formation. However, L-fucose transport and metabolism has been shown to 
reduce biofilm formation in NCTC11168, suggesting L-fucose may be an intestinal signal to maintain 
cells in a planktonic state (Dwivedi et al., 2016). 
Interestingly false positive results have already been reported when using Biolog PM1 plates, especially 
surrounding utilisation of L-lyxose and D-ribose (Line et al., 2010). Biolog false positives in the lag phase 
parameter could be obtained by the cells introduced into the assay being in a high metabolically active 
state. The tetrazolium based dye will result in a colour change regardless of the cells metabolising at 
time 0, or as a result of the carbon source in the Biolog plate, although normalisation to the negative 
control well should eliminate this issue. A potential solution would be to ‘starve’ the C. jejuni cells in a 
minimal medium with no carbon source, before they are introduced into the assay. The risk with this 
method is due to Campylobacter’s fastidious nature; starving the cells may be detrimental to C. jejuni 
survival, and it runs the risk of introducing dead cells into the assay and generating false negatives. In 
addition, further evidence of false positives has been reported with the reduction of tetrazolium ‘Dye 
D’ (used in this study), without exposure to bacterial cells (Line et al., 2010). Results should therefore 
be interpreted with caution, and confirmed with individual growth curves using minimal media. 
L-lactic acid, which generated significant increased utilisation by competent biofilm isolates (see Table 
6-3 and Figure 6-2), was used in the biofilm assay using crystal violet staining (Figure 6-3). No significant 
differences in biofilm formation was seen between CJP isolates supplemented with 0, 10 µM or 20 µM 
of L-lactic acid. The supplementation neither increased biofilm formation in competent isolates, nor 
caused poor isolates to produce biofilms. However biofilm formation was significantly reduced in 
NCTC11168 when supplemented with 20 µM of L-lactic acid. This observed reduction could be due to 
the inhibitory effect of the reduced pH, therefore affecting growth rather than biofilm formation. 
Biofilms are formed in sub optimal environments, therefore it would be expected that C. jejuni cells 
would form biofilms under sub-inhibitory L-lactic acid concentrations. It should be noted that the max 
slope parameter in the initial stages of incubation (indicating quicker utilisation in competent isolates) 
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would not be accounted for in a biofilm assay lasting 72 hours. However, the maximum utilisation of 
L-lactic acid would be accounted for, which produced the lowest p-value when comparing competent 
and poor biofilm isolates (p=0.017), and therefore the most significant. Taken together, the fact that 
L-lactic acid had no effect on the majority of C. jejuni biofilms in this study implies no link between L-
lactic acid metabolism and biofilm formation in C. jejuni.  
The variation within Biolog data made analysis and drawing conclusions particularly difficult. Despite 
this, the data analysis software was able to identify significant differences in carbon metabolism, both 
between strains, and between the two panels of biofilm formers. The data of most importance in terms 
of understanding biofilm formation, are the three carbon sources, D-ribose, L-lyxose and L-lactic acid, 
which were significant between the two panels, although the utilisation of pentose sugars are thought 
to be false positive results. The negative results for utilisation of key amino acids in CJP13 poses further 
questions on the reliability of the Biolog data. As seen in Chapter 5, the CJP isolates are genetically very 
diverse, which implies that their metabolism profiles could show similar diversity. A set of more 
genetically related isolates may be able to highlight more significant trends in carbon metabolism 
between competent and poor biofilm isolates. In addition the gene regulation likely plays a large part 
in levels of metabolism observed.  Transcriptomic approaches investigating gene regulation and 
expression when exposed to varying carbon sources and varying environments may enable a better 
understanding of the substrate utilisation pathways relevant to C. jejuni environmental survival. 
The results of this study show that there is great diversity in the carbon metabolism of C. jejuni isolates, 
and highlight that there is still much to learn about the intricate metabolic pathways used by 
Campylobacter when in different environments. A better understanding of central carbon metabolism 
could lead to the development of novel control mechanisms as summarised by the following bullet 
points: 
• C. jejuni and host interactions. As mentioned previously, C. jejuni utilise amino acids as carbon 
sources which are common in the chicken faecal matter (Parsons, 1984). Moreover, mutants in sdaA 
gene (encoding a serine dehydratase), aspA, (aspartase enzyme), and ggt (glutamyltranspeptidase, 
which hydrolyses glutamine to glutamate) have all shown reduced ability to colonise in chick models 
(Velayudhan et al., 2004, Guccione et al., 2008, Barnes et al., 2007) . In addition, a putP mutant (proline 
symporter that facilitates the binding and uptake of proline in the cytoplasm), has also shown reduced 
colonisation in a mouse model (Hofreuter et al., 2012). It is clear that the increased understanding of 
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carbon metabolism will elucidate gut colonisation mechanisms. Thus, it may be possible to control C. 
jejuni by adjusting the composition of chicken gut contents through alterations to chicken feed. This 
may limit particular nutrient sources which could compromise the colonisation and survival of 
Campylobacter, or indeed other poultry pathogens. 
• Mixed species microbial communities. Many gut microorganisms can ferment carbohydrates 
to a variety of organic acids, including acetate, propionate, butyrate, formate, succinate and lactate 
which can be utilised by other bacterial pathogens such as C. jejuni (Louis et al., 2007). Therefore, the 
composition of mixed species microbial communities may aid the survival C. jejuni; particularly 
important since Campylobacter lacks key enzymes in sugar metabolism. Further research into the 
general and strain specific metabolic pathways that are present or absent from C. jejuni will enable 
better understanding of the dynamics of microbial populations and biofilms. The identification of 
specific species or combinations of multi-species strains that display synergistic survival mechanisms 
may direct control mechanisms to other pathogens which could reduce survival of C. jejuni as a result.   
• In poultry processing plant environments. This study highlighted the increased utilisation of 
L-lactic acid by competent biofilm CJP isolates. Lactic acid has been used for bacterial decontamination 
of poultry carcasses (Lecompte et al., 2009, Rasschaert et al., 2013). Although many studies report the 
effective reduction of C. jejuni bacterial load on chicken post poultry processing, we suggest that sub-
inhibitory concentrations may select for the growth and survival of competent biofilm formers. This 
indicates that lactic acid may not result in the reduction of human infection since the process can select 
for strains which are more resistant to chemical decontaminants and other environmental stresses 
which may in turn possess increased survival and virulence mechanisms in the host. It should also be 
noted that bacterial pathogens in a biofilm show increased resistance to chemical substances and 
antimicrobials compared to their planktonic counterparts. Taken together, understanding the 
utilisation of multiple carbon sources by strains with particular virulent or survival phenotypes, such 
as biofilm, could enable the adaption of decontamination protocols used by the poultry industry. 
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7 Final discussion and future perspectives 
7.1 Summary of findings, limitations and discussion 
It is thought that Campylobacter spp. form biofilms to aid survival in the environment. However, the 
molecular mechanisms and metabolic pathways that influence biofilm formation in Campylobacter are 
not well characterised. Thus, the aim of the work described in this thesis was to increase our 
knowledge of the genetic and metabolic associations/factors that influence biofilm formation in C. 
jejuni. To achieve this aim, several objectives were identified: 1) To phenotypically characterise a 
number of chicken C. jejuni isolates using biofilm, motility, autoagglutinaion assays (as discussed in 
Chapter 3). 2) To assess the correlation between biofilm formation and virulence by selecting a panel 
of representative poor and competent biofilm isolates, and screening for their ability to adhere and 
invade human epithelial intestinal cells, and to produce an infection Galleria mellonella virulence 
model (Chapter 3). 3) To identify genes associated with biofilm formation by the construction and 
screening of a transposon mutant library in a strong biofilm-producing chicken C. jejuni isolate (Chapter 
4). 4) To compare the gene content of panels of competent and poor biofilm chicken C. jejuni isolates 
through comparative pangenome approaches (Chapter 5). 4) To determine the metabolic profile of C. 
jejuni poor and competent biofilm isolates in order to investigate a link between biofilm formation and 
bacterial metabolism (Chapter 6). 
Many studies investigating C. jejuni biofilm formation use the NCTC11168 lab strain (Reuter et al., 
2010, Dwivedi et al., 2016, Hanning et al., 2009, Kalmokoff et al., 2006). However, NCTC11168, 
originally isolated from a human, may lack mechanisms used by circulating poutry isolates. It was 
therefore important for this study to isolate Campylobacter strains that were currently circulating in 
the UK to ensure the investigations were more relevant to present day contamination issues in poultry 
processing plants. Isolates were recovered from raw chicken meat on the basis that all isolates would 
have survived poultry processing and refrigeration and thus more likely to possess effective survival 
mechanisms such as biofilm formation. Initially, the aim of isolation was to collect genetically diverse 
strains to identify a variety of molecular mechanisms related to biofilm formation. This was achieved 
by sampling from a number of supermarket retailers, meat quality and cuts in the South East of 
England.  
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Subsequent to isolation, 30 isolates were screened for their biofilm forming ability which was assessed 
using crystal violet staining, a simple and effective method which selects for biofilms that attach to 
surfaces in liquid culture. For this reason it is the most common methodology for quantifying bacterial 
biofilms. Employing this method in this work therefore allows comparisons with the current literature 
(Reuter et al., 2010, Brown et al., 2015a, Turonova et al., 2015). However, C. jejuni forms multiple types 
of biofilm that are not necessarily attached to surfaces (Joshua et al., 2006), therefore cannot be 
assessed using this method and, as a result, are not accounted for in this study. However, unattached 
aggregate biofilms forming on liquid surfaces perhaps do not pose such a contamination issue in 
poultry processing plants due to regular compulsory water changes in hot water dipping tanks. 
Conversely, attached biofilms are more likely to remain on surfaces and equipment in processing 
plants, and cause persistent contamination between slaughter batches. It was for this reason that the 
biofilm formation assay selected for the isolates forming attached biofilms was used throughout this 
study. 
More detailed biofilm models incorporating live/dead staining, quantitative real time PCR (qRT-PCR), 
SEM, and urea-NaCl fluorescence in situ hybridization (urea-NaCl-FISH) (Kommerein et al., 2017) have 
been developed for mixed species biofilms in order to quantify, and identify different species 
localisation. Other studies have used a simpler method by using 2,3,5 triphenyltetrazolium chloride 
(TTC) staining which stains metabolically active cells only (Brown et al., 2013) rather than extracellular 
matrix staining. Scanning Electron Microscopy was used to observe the structure of CJP13 biofilms 
allowing visualisation of the extracellular matrix. Scanning Electron Microscopy does not allow 
quantification, but provided confirmation of complex biofilm structures which are comparable to 
NCTC11168 biofilm Scanning Electron Microscopy analysis by Joshua et al. (2006). 
Using the crystal violet assay the C. jejuni isolates in this study displayed mixed ability to form biofilms, 
with the majority not able to form biofilms at all. This finding is comparable with the literature as 
Pascoe et al. (2015) reported that 64% (n=14) of chicken C. jejuni isolates were identified as poor 
biofilm formers, compared to the 29% (n=34) of isolates that were poor biofilm formers that were 
‘host generalist’ (i.e. C. jejuni strains isolated from multiple hosts). Despite the overall inability of most 
strains isolated in this project to form biofilms, 10 isolates were selected from a panel of 30, five of 
which displayed competent, and five that displayed poor biofilm formation ability (Chapter 3). Genome 
sequencing revealed that this panel of 10 isolates displayed great genetic diversity (Chapter 5).  This 
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panel of 10 isolates was analysed/characterised further using phenotypic, metabolic and genetic 
approaches.  
7.1.1 Phenotypic characterisation 
Despite the known links between motility (Reuter et al., 2010), autoagglutination (Reuter et al., 2015) 
and biofilm formation, a weak correlation between these phenotypes was detected (r=0.226, R² = 
0.0481, Figure 3-4 and Figure 3-5). All the isolates were motile, however their motility alone did not 
dictate the biofilm ability of the isolate, indicating motility is not the sole factor in biofilm formation. 
This complies with the findings of Svensson et al. (2014) where the flagella structure, but not motility 
is required for biofilm formation. 
Biofilm formation and isolate virulence, determined by adhesion and invasion of Caco-2 human 
intestinal epithelial cells, did not display a strong correlation in this study (Figure 3-6). It is therefore 
likely that the mechanisms exploited by C. jejuni to attach to intestinal cells are distinct from those 
used to attach to the abiotic surfaces in our experimental conditions. Moreover, Hanning et al. (2009) 
reported that C. jejuni strains in biofilm and planktonic states displayed varying abilities to adhere and 
invade human epithlial cells. This implies a difference in key mechanisms for survival and persistence 
in- and outside of a host, and suggests strain-specific mechanisms that display variation in 
environmental survival and host virulence. Moreover, strain phenotypic variation, including biofilm 
formation, may prove to be advantageous to the survival and establishment of the species as a whole. 
For example, C. jejuni strains displaying a strong biofilm phenotype can provide environments suitable 
for strains less adapted to environmental survival. These isolates can then be released from the biofilm 
in dispersal phase, or when environments are more hospitable. It should be noted that the biofilm can 
encompass multiple bacterial species to which it can provide the same protection (Teh et al., 2010). 
Taken together, it would be reasonable to assume that strong biofilm former isolates may not be 
causing the majority of the reported infections in humans. However, strong biofilm formers may 
enable the survival, and persistence, and host colonisation of virulent strains.  
Galleria mellonella, greater wax moth larvae, have been used increasingly in the literature to assess 
the virulence determinates of bacterial pathogens including Campylobacter (Senior et al., 2011, 
Champion et al., 2010, Reuter et al., 2015). This model provides a number of advantages over 
mammalian models; injecting G. mellonella with bacterial pathogens is ethically more acceptable, they 
are inexpensive to purchase, can be incubated at 37ᵒC to mimic human body temperature, and they 
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possess cellular immune responses including hemocytes, which are able to phagacytose bacteria 
similar to macrophages (Champion et al., 2010). Similar to adhesion and invasion assays, G. mellonella 
infection model data failed to correlate to biofilm formation in this study. However, correlation was 
observed between adhesion and invasion assays and Galleria infection scores (r = 0.740 and 0.406, 
respectively), indicating the G. mellonella is likely to be an accurate model for human virulence in this 
case. 
7.1.2 Genetic characterisation 
It was identified from the biofilm assays that one isolate, CJP13, was found to be the most competent 
biofilm former out of the panel of 30 isolates. A way of rapidly screening the genome of bacterial 
pathogen (such as C. jejuni) for genes linked to a particular phenotype is to construct a picked 
transposon mutant library. Here, 3,000 individual transposon mutants in the CJP13 strain were picked 
and screened in the biofilm assay to identify mutants that display a change in biofilm phenotype. 
Transposon mutagenesis experiments identified a number of genes that, when disrupted in CJP13, 
produce strains that display reduced (compared to wild-type CJP13) biofilm formation (Table 4.1). 
Many of the genes identified were linked with motility, chemotaxis and flagella, which are already well 
established factors that influence biofilm formation for multiple bacterial species (Joshua et al., 2006, 
Dwivedi et al., 2016, Svensson et al., 2014). As the aim of this project was to further understanding 
and provide novel insights in to biofilm formation in C. jejuni, the genes selected for further study were 
non-characterised membrane proteins, or genes with a less obvious link to biofilm formation (see 
Chapter 4). 
Mutations in Cj0080 and memP (Cj1623), encoding small putative membrane proteins, produced 
strains exhibiting reduced biofilm formation compared to the wild type. A memP mutation in reference 
strain NCTC11168 produced a strain with significantly reduced biofilm formation ability (p<0.0001) 
compared to the wild type Figure 4-23. Such a profound biofilm reduction in the NCTC11168 strain and 
marginal reduction in the CJP13 isolate, implies memP has varying degrees of importance in biofilm 
mechanisms depending on the strain. This again highlights the adaptation of strain specific 
mechanisms in C. jejuni. Putative membrane proteins and periplasmic proteins are known to be 
involved in biofilm formation (Kalmokoff et al., 2006), however it is currently unclear if Cj0080 and 
memP are surface exposed or periplasmic. Nevertheless, disruption of membrane proteins may 
interrupt the arrangement of surface exposed proteins such as adhesins, which may have a more 
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profound effect on biofilm formation than the membrane protein itself. Thus, Cj0080 and memP may 
be directly or indirectly responsible for biofilm formation in the reported C. jejuni strains.  
Mutants of trbJ, encoding a putative conjugal transfer protein and hydA, encoding a Ni/Fe-
hydrogenase, also showed reduced biofilm formation ability when the gene(s) were knocked out of 
the genomes of reference strain NCTC11168 and competent biofilm producer representative strain 
CJP13. It is currently unclear how these genes are linked to biofilm formation. However, it is suggested 
that trbJ could encode a surface-exposed protein that aids attachment to surfaces. HydA has been 
shown to aid the translocation of various other proteins in the hyd complex through the TAT protein 
system which may be involved in expressing proteins on the surface of C. jejuni. At this time it is unclear 
how this may directly relate to biofilm formation. 
Complementation of mutants in the NCTC11168 and CJP13 strains did not restore biofilm formation to 
wild type levels (Figure 4-29 and Figure 4-30), suggesting that memP, hydA, Cj0080 and trbJ are not as 
involved in biofilm formation as the transposon and individual knock-out mutants lead us to believe. 
However, complemented mutants do not always fully restore the phenotype. Although it must be 
noted that genetic complementation does not always restore the phenotype to wild type levels. 
However, the Cat promoter was used in all complemented mutants to express the gene of interest, 
with the exception of hydA which used the native promoter. Any promoter that is not native to the 
gene of interest is likely to deliver levels of gene expression that differ from the wild type, which can 
lead to over or under production of the downstream protein. Future work should focus on measuring 
gene expression via qRT-PCR to enable comparisons between wild type, mutant and complement 
strains which may be accountable for the variation in biofilm formation. 
CJP13 displays a strong biofilm phenotype despite genes being knocked out of the genome which are 
found to significantly reduce biofilms in the NCTC11168 strain, namely memP. Therefore, the results 
of this study suggest the CJP13 chicken isolate possesses a hierarchy of mechanisms that are 
responsible for the robust biofilm phenotype – when one mechanism is inhibited, another is triggered. 
Alternatively, the presence of a paralog gene could replace the need for interrupted gene, showing no 
change in phenotype. This concept suggests transposon mutagenesis may not therefore identify key 
genes that directly cause the phenotype. Nevertheless, the CJP13 transposon mutant library was able 
to identify strain-specific genes that contribute to biofilm formation in the assays used in this thesis 
project. 
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The mutant library biofilm screen incorporated nutrient-rich conditions with temperatures and 
microaerophilic atmospheres suitable for C. jejuni growth. The use of sub-optimal conditions, for 
example high-oxygen concentrations and extreme temperatures, may induce C. jejuni stress responses 
that initiate biofilm formation and therefore elucidate mechanisms not described here. A number of 
studies report the importance if oxidative stress in biofilm formation in C. jejuni (Reuter et al., 2010, 
Pascoe et al., 2015), but the experimental conditions adopted in this study do not select for these 
mechanisms to be highlighted. Poultry processing plants would provide environments of normal 
atmospheric conditions, where oxidative stress responses would be key to survival. 
Comparative genomics of the 10 CJP genomes allowed gene content comparisons between i) individual 
isolates and ii) panels of competent and poor biofilm isolates. Bioinformatic sequence analysis (Roary 
software at 99% sequence identity, see Chapter 5) revealed four genes which showed most differential 
presence/absence between competent and poor biofilm groups, two of which were involved in the 
synthesis (neuB1) and transport (cst-III) of sialic acid. These genes were present in 80% of the 
competent biofilm formers. Sialic acids are often located on the outer end of surface oligosaccharide 
chains attached to proteins and lipids, and their presence has been linked to cell-cell interactions (Kelm 
and Schauer, 1997). Cst-II, similar to the sialyltransferase identified in this study (cst-III), is responsible 
for the sialylation of LOS expressed on the surface of C. jejuni, forming both α2,3- and α2,8-linked sialic 
acids (Gilbert et al., 2000). In addition cst-II mutant strains exhibit lower dendritic cell activation and 
subsequent B-cell responses (Kuijf et al., 2010). Interestingly sialic acid has also been reported to be a 
main chemical component of the biofilm extracellular matrix (Turonova et al., 2016). Although the 
exact mechanisms are not clear, sialic acids are surface exposed and are involved in cellular 
interactions, therefore we speculate they are likely to play a role in C. jejuni attachment and the initial 
stages of biofilm formation. 
Two further genes were identified by Bioinformatic sequence analysis. 1) a hypothetical protein 
‘FIG00638667’, predicted to be a membrane protein due to weak homology with a periplasmic protein 
in Yersinia enterocolitica. If correct, the identification of this protein agrees with the general findings 
of this study, that membrane proteins are heavily associated with biofilm formation. 2) dsbA, a gene 
reported to encode a protein involved in folding of proteins, through the formation of disulfide bonds 
between cysteine residues. DsbA has also been previously shown as being essential for motility and 
autoagglutination in C. jejuni (Grabowska et al., 2014), both factors involved in biofilm formation. Both 
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‘FIG00638667’ and dsbA genes were present in all poor biofilm genomes and only one of the 
competent genomes. It is unclear at this time why genes linked to membrane proteins, motility and 
agglutination are mainly present in the poor biofilm formers, as we would normally associate these 
factors with successful biofilm formation.  
CJP13 was found to possess the pCC42-like plasmid which contained the trbJ gene linked to biofilm 
formation (Chapter 4). Distributions of trbJ and pCC42 were dispersed throughout multiple clonal 
complexes and isolation sources. It is not clear at this time if trbJ, or presence of the pCC42 plasmid 
itself, is responsible for the strong biofilm phenotype of CJP13. Studies have suggested that some 
Alphaproteobacteria carry genes responsible for bacterium motility and biofilm formation solely on a 
plasmid (Michael et al., 2016). Although unlikely for Campylobacter in terms of motility, it would be 
interesting to observe the effects of curing the pCC42 plasmid from CJP13 to assess its effect on biofilm 
formation. The presence of a plasmid in general may present a metabolic burden to the bacterium 
causing stress responses, i.e. biofilm formation, to occur, as reported by Teodosio et al. (2012). 
Phylogenetic clustering using CJP isolate genome sequences revealed that CJP17 and CJP19 isolates 
were almost genetically identical, with a number of frame-shift mutations causing protein truncation 
in CJP17. One truncated protein, PflA (the paralysed flagella protein), is thought to be fundamental in 
the reduced motility displayed by the CJP17 isolate (Figure 5-12). Despite its lack of motility, CJP17 is 
a competent biofilm former, again highlighting the multiple mechanisms involved with biofilms other 
than motility. 
Distribution analysis of genes linked to C. jejuni biofilm formation (identified by the transposon mutant 
library screen and genes possessing mutations between isolates CJP17 and CJP19, illustrated in Figure 
5-3, Figure 5-4 and Figure 5-13), were shown to be widely dispersed over a panel of >5,000 C. jejuni 
strains. Genes were present in a number of C. jejuni clonal complexes and strains from multiple 
isolation sources. This implies that these genes are conserved in C. jejuni and part of the core genome, 
suggesting their importance in Campylobacter, but not necessarily linked to biofilm formation. It 
should be noted that isolates within clonal complexes that have been isolated from a variety of hosts 
i.e. ‘host generalist’ ST-21 and ST-45 strains, are more likely to display a strong biofilm phenotype 
(Pascoe et al., 2015). This logic stems from the fact that isolates would have survived environmental 
pressures between the colonisation of different hosts, and likely that the survival of the isolate was 
due to the formation of a biofilm. Due to the small number of isolates used in this study, we were 
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unable to identify trends in host generalist or host specific clonal complexes that relate to biofilm 
formation. 
Phylogenetic clustering of the 10 CJP isolates identified great genetic diversity between isolates, which 
was the original aim of panel selection. However, such diversity made comparative genomics 
challenging, since the difference in gene content attributed to the strain’s clonal complex generated a 
large amount of background noise, which distracted from differentially present/absent genes between 
the phenotypic groups. This is represented by the lack of genes identified as either ‘all present’ or ‘all 
absent’ from either the competent and poor biofilm genomes. A study incorporating a larger set of 
genomes in each competent and poor biofilm panel, with strains of similar clonal complex phylogeny, 
may elucidate more genes linked with the biofilm phenotype. 
7.1.3 Metabolic characterisation 
To investigate a link between C. jejuni biofilm formation and carbon metabolism, the panel of 10 
isolates were screened through the Biolog phenotypic array system which produces quantitative, 
kinetic curves of cells’ respiration in a given well containing one carbon source substrate from which 
further understanding of an organism/cells metabolic capacity can be obtained. Biolog data analysis 
identified three key carbon sources on which C. jejuni competent and poor biofilm forming isolates 
show significantly different utilisation, namely D-ribose and L-lyxose when using lag phase to define 
utilisation, and L-lactic acid when using max utilisation and max slope to represent substrate utilisation. 
Originally it was hypothesised that the utilisation of the two pentose sugars were attributed to false 
positives due to the fragmented pentose phosphate pathway present in C. jejuni. However, recent 
studies have identified subsets of C. jejuni strains that are able to metabolise hexose sugars such as L-
fucose (Muraoka and Zhang, 2011, Stahl et al., 2011) and glucose (Vegge et al., 2016) as a carbon 
source. Moreover, the strains able to metabolise glucose via the Entner-Doudoroff pathway displayed 
increased biofilm formation. Vegge et al. (2016) hypothesise that the conversion from glucose to 
glucose-6-phosphate and/or fructose-6-phosphate could be used for the production of surface 
structures such as capsule or free polysaccharide which could aid bacterial cell attachment and biofilm 
formation. However, l-fucose transport and metabolism has been shown to reduce biofilm formation 
in NCTC11168, suggesting L-fucose may be an intestinal signal to maintain cells in a planktonic state 
(Dwivedi et al., 2016). These findings suggest there are many varying metabolic pathways involved in 
sugar metabolism in C. jejuni. Indeed, variations in sugar metabolism have been shown to be strain-
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specific, which contribute to biofilm formation (Vegge et al., 2016). A greater understanding of the 
metabolic pathways may lead to novel links between carbon source utilisation and biofilm formation 
in C. jejuni. 
L-lactic acid was differentially metabolised in CJP poor and competent biofilm isolates (Table 6.3 and 
Figure 6-2). Interestingly, lactic acid is often used for carcass cleaning in poultry processing plants. This 
study suggests that although lactic acid can significantly reduce the Campylobacter bacterial load on 
the surface of chicken carcasses, sub-inhibitory concentrations may aid the survival of competent 
biofilm isolates. In addition, the ability of the isolate to metabolise carbon sources may affect its 
chemotactic nature, allowing for clustering of C. jejuni cells which may aid the initial stages of biofilm 
formation. 
Similar to the comparative genomic analysis, the Biolog data showed considerable variability in 
isolates’ metabolic profiles (using OmniLg units to quantify), both within and between the panels of 
competent and poor biofilm isolates. This variance could be attributed to the great genetic diversity 
between CJP isolates. Comparing a panel of competent and poor biofilm C. jejuni strains which are 
genetically much closer related, i.e. from the same clonal complex, may generate carbon metabolic 
profiles with greater statistical significance between panels, or even elucidate novel carbon sources 
utilised by C. jejuni that are not highlighted in this study. Moreover, the variation between isolate and 
between replicate could be due to the gene expression profiles which are not considered in the Biolog 
set-up. Further analysis of metabolism by transciptomic approaches will aid further understanding of 
possible links between carbon metabolism and biofilm formation. 
A recent review paper on the formation of biofilms by C. jejuni in food-related environments suggest 
that C. jejuni are more likely secondary colonisers to pre-existing biofilms rather than primary 
colonisers (Teh et al., 2014). However the results presented in this study determine that not only are 
C. jejuni chicken isolates capable of forming strong and complex biofilms, they are genetically and 
metabolically diverse, which would allow survival of C. jejuni within its own biofilm even with the 
inclusion of competing bacterial species. 
7.2 Conclusion 
In conclusion, this study was able to identify genes linked to biofilm formation in NCTC11168 and the 
isolate CJP13 through transposon mutagenesis and comparative genomics. However, the original 
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objective to incorporate genetically diverse isolates may have hindered the potential of the 
comparisons between competent and poor isolates in gene content and metabolic profiles, due to a 
wide variation between the two groups as well as within, which will effect statistical significance. 
Despite this, this study provides new insights in to biofilm formation in C. jejuni; identification of four 
genes (cstIII, neuB1, putative membrane protein ‘FIG00638667’ and DsbA) differentially present or 
absent, and three carbon sources (L-lactic acid, D-ribose, and L-lyxose) differentially utilised between 
grouped competent and poor biofilm isolates. Further investigation into the gene expression and 
incorporation of additional isolates would help determine the relevance of these identified factors in 
the wider scope of Campylobacter. 
7.3 Future perspectives 
The findings of this study have identified some key areas of further research: 
1. Determination of the location of the putative membrane proteins Cj0080 and memP. It is 
clear from the results displayed in Chapter 4 that Cj0080 and memP membrane proteins do 
affect biofilm formation, to some degree, at least within NCTC1168 and CJP13 strains. 
Determining if the membrane proteins are surface exposed or periplasmic may allow a better 
understanding of their role in the phenotype. Experiments identifying all outer membrane 
proteins of C. jejuni, similar to the work conducted by Voss et al. (2014) which determined 
surface exposed membrane proteins in Helicobacter pylori, could be valuable. A detailed 
comparison of the outer membrane profiles between competent and poor biofilm isolates may 
indicate strain specific surface exposed structures which aid attachment and biofilm 
formation. 
2. Construction of knock out mutants of genes identified in Roary analysis. Roary analysis at 
99% sequence identity revealed that four genes were generally differentially present or absent 
between competent and poor biofilm isolates. These included two genes involved with sialic 
acid, one putative membrane protein and DsbA. Confirmation that these genes are linked with 
the biofilm phenotype in C jejuni could be conducted by constructing knock out mutants of 
these genes (using OE-PCR methodology described in Chapter 4) to observe any changes in 
biofilm phenotype. 
3. Investigation into L-lactic acid metabolism. The finding that competent biofilm formers are 
significantly better at utilising L-lactic acid requires further analysis. Constructing knock out 
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mutants in the genes required for lactic acid metabolism, therefore hindering its ability to 
metabolise the substrate as a carbon source, may provide novel links to biofilm formation. 
Taking into consideration the wider scope of this project, a number of considerations have to be 
addressed. The focus of this study has been on the presence/absence of genes related to biofilm 
formation within strains, both in the form of transposon or knock out mutants, or in terms of gene 
content through comparative genomics. However, gene expression has not been accounted for, and 
likely plays a fundamental role in C. jejuni biofilm mechanisms. Firstly, the wild type, mutant and 
complemented mutants should be screened by Real-time PCR (RT-PCR) to confirm that the genes of 
interest are appropriately expressed as predicted. In addition, further analysis of gene expression of 
the biofilm related genes, identified in Chapter 4, may elucidate some interesting results and could 
lead to the understanding of additional biofilm related mechanisms which are strain specific. 
Kalmokoff et al. (2006) published a detailed report on the differential protein expression of biofilm and 
planktonic cells in C. jejuni NCTC11168, however it would be interesting to conduct similar analysis 
using a number of poultry isolated strains to elucidate mechanisms which might allow survival in 
poultry processing plants.  
The research presented in this thesis has focused on detecting mechanisms of single species biofilm 
formation. However it is unlikely that this is a true representation of biofilms in the environment. This 
is especially relevant in poultry processing plants where numerous bacterial food pathogens, such as 
Salmonella and E. coli, are present in high numbers. To be able to understand the individual 
mechanisms of biofilm formation within an isolate or species, it was suggested that they were 
investigated in isolation. However, further work incorporating competent and poor C. jejuni biofilm 
isolates into mixed species biofilms (using a variety of approaches such as metatranscripomics) may 
reveal additional mechanisms involved with biofilm formation that is more appropriate to 
environmental variables. 
Finally, the development of a model that mimics the formation of biofilms on the surfaces of chicken 
skin may identify mechanisms used by C. jejuni for survival during and post poultry processing. The 
models used in this study are lab adapted protocols, using basic culture media. However, some studies 
have used the addition of chicken or meat juices to make investigations more relevant to bacterial 
survival on food surfaces (Brown et al., 2014, Li et al., 2017). The development of an In vivo chicken 
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skin model may identify the location and mechanisms used by C. jejuni to form biofilms on biotic 
surfaces.  
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9 Appendices  
9.1 Appendix I 
SOC media  
Bactotryptone – 10g 
Yeast extract – 2.5 g 
Sodium chloride 0.25g 
miliQ water -  500ml 
Adjust to pH 7.5 using KOH and autoclave. Add 20ml/L of 1M MgSO4 (autoclaved separately) and add 
5mls of 2M glucose solution 
 
C. jejuni electroporation Wash buffer 
272mM sucrose (9.335g in 100 ml) 
15ml glycerol 
Total volume with RO water = 100ml 
 
Himar transposase protocol 
12.5 ml column buffer (CB)  
20 mM Tris-HCl pH 7.4 0.25 ml 1 M stock 
200 mM NaCl  0.5 ml 5 M stock 
1 mM EDTA  25 µl 0.5 M stock 
11.725 ml molecular grade water 
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Transposase wash buffer (TWB) 
20 mM Tris-HCl pH 7.4 0.4 ml 1 M stock 
200 mM NaCl  0.8 ml 5 M stock 
1 mM EDTA  40 µl 0.5 M stock 
2 mM DTT  40 µl 1 M stock  
10% glycerol  4 ml 50% stock 
   14.72 ml molecular grade water to total 20 ml 
 
Transposase elution buffer (TEB) 
1 ml TWB 
10 mM maltose    3.6 mg in 1 ml 
Maltose monohydrate MW 360.31 g/mol 
 
Transposon mutagenesis protocol 
100 µl of 4x transposition buffer 
50 µl 80% glycerol 
0.8 µl 1 M DTT 
20 µl  0.5 M Hepes pH 7.9 
10 µl 10 mg/ml BSA 
8 µl 5 M NaCl 
2 µl 1 M MgCl2 
9.2 µl  Molecular grade water 
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Transposition reaction mix 
5 µl  4x transposition buffer 
2 µg Chromosomal acceptor DNA 
1 µg mariner transposon donor plasmid 
1 µl Purified Himar1 transposase 
x µl Molecular grade water; total volume = 20 µl  
 
Linker PCR protocol 
10x annealing buffer:  
100 mM Tris-HCl pH 8.0,  
500 mM NaCl,  
10 mM EDTA 
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9.2 Appendix II 
 
Figure 9-1: NCTC11168 biofilm formation at 30ᵒC, 37ᵒC and 42ᵒC incubated for 72 
hours in BHI, BB and MHB in microaerophilic conditions. 
Bar chart of biofilm formation of NCTC11168 using methods described in section 2.4.2 using 
Brain Heart Infusion broth (BHI), Brucella broth (BB) and Mueller-Hinton Broth (MHB) incubated 
at 30ᵒC, 37ᵒC and 42ᵒC in microaerophilic or aerobic conditions for 72 hours. Bars show the 
average of five technical and three biological replicates, error bars represent the standard 
deviation. Statistical analysis using one-way ANOVA followed by Tukey’s multiple comparisons 
test. (*, p<0.05; **, p<0.01; ***, p<0.001, ****, p<0.0001). 
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Figure 9-2: Growth of CJP isolates at 37ᵒC. 
Bar chart showing the growth of CJP isolates and NCTC11168 measured by OD600 after 72 hours 
incubated at 37ᵒC in BHI. Inoculation of cultures outlined in section 2.4.2, identical to the biofilm 
assay. The bars represent the averages of three biological replicates, each consisting of three 
technical replicates. Error bars indicate the standard deviation. A one-way analysis of variance 
(ANOVA) followed by Tukey’s multiple-comparison test was performed to compare the isolate 
growth, and no statistical significance was identified (GraphPad Prism software, version 7.0). 
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9.3 Appendix III 
 
Figure 9-3: memP mutant construct sequence. 
Alignment of ‘expected’ and ‘sequenced’ memP mutant construct using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). Asterisks represent base alignment. Grey 
sequence indicates cat cassette interruption of the memP gene, highlighted in yellow. Fragment 
sequenced by Sanger sequencing (GENEWIZ, UK) using primers P1 for forward and P4 for reverse 
reactions. 
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Figure 9-4: Cj0080 mutant construct sequence 
Alignment of ‘expected’ and ‘sequenced’ Cj0080 mutant construct using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). Asterisks represent base alignment. Grey 
sequence indicates cat cassette interruption of the cj0080 gene, highlighted in yellow. Fragment 
sequenced by Sanger sequencing (GENEWIZ, UK) using primers P1 for forward and P4 for reverse 
reactions. 
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Figure 9-5: hydA mutant construct sequence. 
Alignment of ‘expected’ and ‘sequenced’ hydA mutant construct using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). Asterisks represent base alignment. Grey 
sequence indicates cat cassette interruption of the hydA gene, highlighted in yellow. Fragment 
sequenced by Sanger sequencing (GENEWIZ, UK) using primers P1 for forward and P4 for reverse 
reactions. 
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Figure 9-6: trbJ mutant construct sequence. 
Alignment of ‘expected’ and ‘sequenced’ trbJ mutant construct using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). Asterisks represent base alignment. Grey 
sequence indicates cat cassette interruption of the trbJ gene, highlighted in yellow. Fragment 
sequenced by Sanger sequencing (GENEWIZ, UK) using primers P1 for forward and P4 for reverse 
reactions. 
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Figure 9-7: Biofilm formation of CJP13 using stab inoculation and adjusted OD 
inoculation. 
Bar chart showing biofilm formation after 72 hours of incubation at 37ᵒC measured by crystal 
violet staining (OD540). Biofilm assay used inoculated of BHI broth inoculated by stab inoculation, 
i.e. approximately 1 µl of overnight CJP13 culture into 130 µl of fresh BHI broth, or adjusted OD 
inoculation methods as outlined in section 2.4.2. Data shows average of three biological 
replicates, each consisting of five technical replicates, error bars show the standard deviation. 
No statistical significance was observed between the two inoculation methods, using an 
unpaired student t-test. 
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Gene Definition 
aroQ / 
Cj0066c 
K03786 3-dehydroquinate dehydratase II [EC:4.2.1.10] | (RefSeq) aroQ; 3-
dehydroquinate dehydratase 
Cj0128c K01092 myo-inositol-1(or 4)-monophosphatase [EC:3.1.3.25] | (RefSeq) inositol 
monophosphatase family  
Cj0225 o KO assigned | (RefSeq) acetyltransferase 
Cj0261c no KO assigned | (RefSeq) SAM-dependent methyltransferase 
Cj0315 K02566 NagD protein | (RefSeq) HAD-superfamily hydrolase 
Cj0420 no KO assigned | (RefSeq) periplasmic protein  
Cj0487 no KO assigned | (RefSeq) amidohydrolase  
Cj0621 no KO assigned | (RefSeq) hypothetical protein  
Cj0919c K10040 putative glutamine transport system permease protein | (RefSeq) amino 
acid ABC transporter permease 
Cj1032 no KO assigned | (RefSeq) cmeE; mutlidrug efflux system membrane fusion protein  
Cj1035c K21420 leucyl-tRNA---protein transferase [EC:2.3.2.29] | (RefSeq) arginyl-tRNA--
protein transferase 
Cj1380 K03981 thiol:disulfide interchange protein DsbC [EC:5.3.4.1] | (RefSeq) periplasmic 
protein  
Cj1416c no KO assigned | (RefSeq) sugar nucleotidyltransferase  
Cj1534c K04047 starvation-inducible DNA-binding protein | (RefSeq) bacterioferritin  
Cj1621 no KO assigned | (RefSeq) periplasmic protein  
pstB / 
Cj0616 
K02036 phosphate transport system ATP-binding protein [EC:3.6.3.27] | (RefSeq) 
pstB; phosphate ABC transporter ATP-binding protein  
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Table 9-1: Proteins that interact with hydA according to Parrish et al. (2007). 
List of 16 NCTC11168 proteins that interact with hydA reported by Parrish et al. (2007). Results 
generated by using high-throughput yeast two-hybrid screens. Proteins include periplasmic 
proteins, transporters and transferases which suggests hydA’s involvement with protein export. 
 
 
 
Table 9-2: memP complemented mutant construct sequence. 
Alignment of ‘expected’ and ‘sequenced’ memP complemented mutant construct using Clustal 
Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). Asterisks represent base alignment. 
Yellow sequence indicates memP insertion into the pSV009 complementation plasmid multiple 
cloning site. Fragment sequenced by Sanger sequencing (GENEWIZ, UK) using primers 
pSV009_seq_FW1 for forward and pSV009_seq_RV1 for reverse reactions. 
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Table 9-3: Cj0080 complemented mutant construct sequence. 
Alignment of ‘expected’ and ‘sequenced’ cj0080 complemented mutant construct using Clustal 
Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). Asterisks represent base alignment. 
Yellow sequence indicates cj0080 insertion into the pSV009 complementation plasmid multiple 
cloning site. Fragment sequenced by Sanger sequencing (GENEWIZ, UK) using primers 
pSV009_seq_FW1 for forward and pSV009_seq_RV1 for reverse reactions. 
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Table 9-4: hydA complemented mutant construct sequence. 
Alignment of ‘expected’ and ‘sequenced’ hydA complemented mutant construct using Clustal 
Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). Asterisks represent base alignment. 
Yellow sequence indicates hydA insertion into the pSV009 complementation plasmid multiple 
cloning site. Fragment sequenced by Sanger sequencing (GENEWIZ, UK) using primers 
pSV009_seq_FW1 for forward and pSV009_seq_RV1 for reverse reactions. 
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B 
 
 
Figure 9-8: Growth of NCTC11168 mutant and complemented mutants isolates at 
37ᵒC. 
Bar chart showing the growth of (A) NCTC11168 wild type and ΔmemP, ΔCj0080 and ΔhydA 
mutants and complemented mutants and (B) CJP13 wild type and ΔmemP, ΔCj0080 and ΔhydA 
mutants and complemented mutants measured by OD600 after 72 hours incubated at 37ᵒC in 
BHI. Inoculation of cultures outlined in section 2.4.2, identical to the biofilm assay. The bars 
represent the averages of three biological replicates, each consisting of three technical 
replicates. Error bars indicate the standard deviation. A one-way analysis of variance (ANOVA) 
followed by Tukey’s multiple-comparison test was performed to compare the isolate growth, 
and no statistical significance was identified (GraphPad Prism software, version 7.0). 
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9.4 Appendix IV 
Feature 
ID 
start stop strand Function 
1697 665 111 - putative antirepressor 
1698 1108 662 - Phage Rha protein 
1699 3570 1105 - Conjugative transfer protein TrbE 
1700 3859 3572 - Conjugative transfer protein TrbD 
1701 4155 3859 - Conjugative transfer protein TrbC 
1702 5094 4156 - Conjugative transfer protein TrbB 
1703 5918 5505 - putative protein 
1704 6835 5921 - hypothetical protein 
1705 7184 7068 - hypothetical protein 
1706 7582 8229 + hypothetical protein 
1707 8561 8232 - hypothetical protein 
1708 9005 8574 - hypothetical protein 
1709 9216 9599 + hypothetical protein 
1710 9562 11718 + IncP-type DNA relaxase TraI 
1711 11981 11757 - hypothetical protein 
1712 12670 11984 - Chromosome (plasmid) partitioning protein ParA 
1713 13157 12762 - hypothetical protein 
1714 13583 13221 - hypothetical protein 
1715 14394 13693 - cell filamentation-like protein 
1716 14594 14355 - conserved hypothetical protein 
1717 15416 14697 - IncP-type DNA transfer protein TraL 
1718 17250 15427 - Type IV secretion system protein VirD4 
1719 19460 17247 - DNA primase (EC 2.7.7.-) 
1720 19605 19465 - hypothetical protein 
1721 19954 19592 - Single-stranded DNA-binding protein 
1722 20596 20051 - Bores hole in peptidoglycan layer allowing type IV secretion complex 
assembly to occur (VirB1) 
1723 20732 20589 - hypothetical protein 
1724 22063 20834 - Conjugative transfer protein TrbI 
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1725 22511 22074 - hypothetical protein 
1726 23668 22508 - Conjugative transfer protein TrbG 
1727 24374 23679 - Conjugative transfer protein TrbF 
1728 24509 24646 + hypothetical protein 
1729 25126 24704 - Conjugative transfer protein TrbL 
1730 25125 25532 + hypothetical protein 
1731 26093 25869 - hypothetical protein 
1732 26894 26142 - Conjugative transfer protein TrbJ 
1733 27469 26906 - IncQ plasmid conjugative transfer protein TraQ (RP4 TrbM homolog) 
Table 9-5: Genes present in assembled contig 15 from CJP13 genome representing a 
pCC42-like plasmid 
Table listing the 37 genes present in CJP13 contig 15 which shares homology with pCC42.Tables 
lists the feature ID, assigned by RAST (www.rast.nmpdr.org), the start and stop position of the 
open reading frame, whether the gene is present on the + or – strand, and the gene function.  
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9.5 Appendix V 
  
NCTC 
11168 
CJP11 CJP12 CJP13 CJP17 CJP27 CJP01 CJP19 CJP21 CJP22 CJP28 
A01 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
A02 110.000 52.333 75.333 63.667 70.667 37.333 58.667 68.667 56.000 41.667 50.333 
A03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
A04 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
A05 90.667 28.667 115.000 0.000 105.000 28.667 44.333 20.000 52.333 0.000 43.333 
A06 0.000 0.333 0.000 0.000 0.000 0.000 0.000 0.000 1.333 0.000 0.000 
A07 95.667 21.000 117.000 0.000 99.667 18.667 35.667 0.000 41.667 0.000 23.000 
A08 17.667 9.333 112.667 0.000 103.000 0.000 27.667 13.000 41.333 0.000 104.333 
A09 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
A10 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
A11 0.000 10.333 0.000 0.000 0.000 1.333 0.000 0.000 1.000 0.000 2.333 
A12 2.667 0.000 5.667 0.000 4.000 0.000 5.000 0.000 1.333 0.000 5.000 
  B01 0.333 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  B02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  B03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  B04 12.667 43.667 0.000 0.000 117.333 37.667 51.000 18.333 4.000 0.000 1.000 
  B05 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  B06 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  B07 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  B08 95.667 35.333 77.000 49.667 70.000 16.667 62.333 55.333 47.333 31.667 57.667 
  B09 108.333 30.000 117.667 93.333 110.667 27.333 102.000 75.000 59.667 0.000 120.000 
  B10 109.000 28.000 115.667 17.333 96.667 29.333 0.000 27.667 55.000 0.000 61.000 
  B11 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  B12 104.000 20.333 80.333 0.000 102.333 13.667 48.667 16.000 46.667 0.000 46.000 
  C01 4.000 0.000 0.000 0.000 0.000 0.000 0.333 0.000 2.667 0.000 0.000 
  C02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  C03 112.667 29.000 123.333 37.000 109.000 32.000 53.667 68.333 56.667 0.000 80.333 
  C04 108.667 32.333 78.000 65.000 91.667 0.000 71.333 61.000 41.667 35.000 64.333 
  C05 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  C06 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  C07 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  C08 0.000 0.000 3.333 0.000 0.000 0.000 0.000 0.000 5.667 0.000 0.000 
  C09 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  C10 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  C11 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  C12 0.000 0.000 0.000 0.000 0.000 0.000 1.333 0.000 0.000 0.000 0.000 
.D01 107.000 35.000 106.333 9.000 113.333 15.000 60.333 59.000 52.333 0.000 54.000 
 D02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D04 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D05 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D06 106.667 24.000 105.000 0.000 100.000 13.000 49.667 0.000 49.667 0.000 0.000 
 D07 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D08 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D09 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D10 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D11 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 D12 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  E01 10.333 0.000 53.000 0.000 104.000 0.000 0.000 0.000 32.333 0.000 0.000 
  E02 18.333 0.000 13.333 0.000 6.333 0.000 0.000 0.000 2.000 0.000 0.000 
  E03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  E04 2.667 0.000 3.000 0.000 5.667 0.000 0.000 0.000 0.000 0.000 0.000 
  E05 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  E06 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  E07 79.000 1.333 88.667 0.000 93.333 7.000 19.667 4.000 41.000 0.000 27.000 
  E08 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  E09 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
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  E10 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  E11 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  E12 0.000 0.000 2.000 31.333 0.000 0.000 0.000 7.000 0.667 0.000 0.000 
  F01 0.000 8.000 60.667 1.667 6.000 13.000 32.000 5.000 44.667 0.000 43.000 
  F02 55.667 11.333 0.000 0.000 107.000 0.000 21.000 0.000 26.667 0.000 33.667 
  F03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  F04 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  F05 82.333 22.000 106.333 0.000 103.000 9.000 33.333 8.667 47.667 0.000 32.000 
  F06 59.667 0.000 95.000 0.000 85.000 0.000 9.667 15.000 31.333 0.000 19.667 
  F07 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  F08 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  F09 17.667 0.000 31.333 0.000 47.333 0.000 0.000 0.000 13.000 0.000 11.000 
  F10 2.000 0.000 7.000 0.000 18.667 0.000 0.000 0.000 0.000 0.000 0.000 
  F11 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
  F12 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 G01 0.000 8.667 118.667 71.000 109.000 23.000 48.333 47.667 53.000 0.000 87.333 
 G02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 G03 104.667 25.333 55.000 0.000 118.333 18.000 0.000 17.333 52.000 0.000 3.667 
 G04 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 G05 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 G06 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 G07 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 G08 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 G09 56.000 12.333 77.333 0.000 100.000 18.333 38.333 10.000 43.000 0.000 28.000 
 G10 100.333 18.333 49.333 0.000 97.333 10.000 46.000 16.333 44.000 0.000 52.000 
 G11 102.000 6.000 107.667 6.000 99.333 17.000 31.667 0.000 48.667 0.000 58.000 
 G12 58.000 24.333 69.667 0.000 107.667 13.000 41.333 8.000 10.333 0.000 16.333 
 H01 0.000 1.000 100.333 0.000 114.333 8.667 24.667 26.000 2.667 0.000 35.667 
 H02 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 H03 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 H04 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 H05 18.000 24.000 23.000 12.000 22.000 20.667 17.667 24.000 17.000 10.000 18.333 
 H06 115.333 35.667 96.667 66.333 103.000 24.000 96.000 68.000 57.667 46.333 89.333 
 H07 16.667 14.333 16.667 0.000 12.333 19.333 14.333 16.000 20.667 3.000 11.667 
 H08 118.000 34.667 76.667 2.667 123.000 44.667 72.333 29.333 59.333 0.333 59.333 
 H09 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 H10 14.333 5.333 9.333 0.000 7.667 8.000 10.333 1.000 17.667 0.000 8.667 
 H11 0.000 0.000 4.333 0.000 3.000 0.000 6.667 0.000 0.000 0.000 1.667 
 H12 7.667 0.000 11.000 0.000 11.667 0.000 15.000 0.000 3.667 0.000 7.333 
Total 
sources 
utilised 
36 31 38 14 38 27 33 27 40 7 34 
% 
carbon 
sources 
utilised 
37.50 32.29 39.58 14.58 39.58 28.13 34.38 28.13 41.67 7.29 35.42 
Table 9-6: Endpoint utilisation of 96 carbon sources. 
Table of endpoint CJP isolate and NCTC11168 utilisation (96 hours) of 96 carbon substrates 
(labelled A01-12, corresponding to the Biolog plate layout in Figure 2-1) measured in OmniLog 
units. Green colours represent no utilisation (0 OmniLog units), oranges represent moderate 
utilisation, and red represents high utilisation (>100 OmniLog units). Data was normalised to the 
negative control well A01, containing no carbon source. 
 
